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Abstract
The activation of PI3K seems to be a signalling event initiated by many chemokine 
receptors that are expressed on T cells; however, the role of PI3K within T cell 
migration it has not been thoroughly elucidated. The use of knockout murine 
models has been invaluable in assigning function to certain isoforms within this 
family, yet there is potential for other family members to initiate compensatory 
mechanisms and therefore unequivocal isoform function assignment is problematic. 
Furthermore, whether the information generated through the use of murine models 
will provide an accurate reflection of the responses generated within human 
physiology is unclear.
Within these studies pharmacological and siRNA strategies were undertaken to 
assess the contribution of individual PI3K isoforms within human T cell migration. 
The use of broad spectrum PI3K inhibitors demonstrated a role for PI3K within 
CXCL12 mediated migration of freshly isolated T cells. Following CXCL12 
stimulation, isoform selective inhibitors against the class I family furthered this 
observation by revealing a dominant role for PI3Ky in the migratory response and 
PI3K/PKB signalling (as assessed by S6 phosphorylation). Utilizing a non-viral 
method (termed Nucleofection) to deliver siRNA into human T cells requires 
maintenance of cells ex vivo for 3 days and although targeting siRNA reduces 
mRNA levels of PI3K class ly, class II a and p, curiously this silencing has no effect 
on the CXCL12-mediated migratory response. However, it is observed that ex vivo 
culture of T cells in the presence or absence of IL-2 develop a PI3K independent 
migratory response, while maintaining their dependence on PI3K for random 
migration.
The observations within this study suggest limitations for the delivery of siRNA via 
Nucleofection into human T cells. Furthermore, this study suggests a dominant role 
for PI3K class ly within the migratory responses of freshly isolated T cells, however, 
the dependence on PI3K is context-dependent and varies depending on the ex vivo 
maintenance and/or activation state of the cells.
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Table 1 The PKC family and how they are activated. 42






ANOVA Analysis of Variance
AOP-CCL5 Amino-oxpentane-CCL5
AP-1 Activator protein-1




BSA Bovine serum albumin
C2 C2 domain
C5a Complement Component 5
Ca2+ Calcium ions
cAMP Cyclic adenosine monophosphate
Chemokine Chemotactic cytokine
Class I a Phosphoinositide 3-kinase class I a
Class I p Phosphoinositide 3-kinase class I p
Class I y Phosphoinositide 3-kinase class I y
Class I 5 Phosphoinositide 3-kinase class I 5
Class II a Phosphoinositide 3-kinase class II a
Class II p Phosphoinositide 3-kinase class II p
Class II y Phosphoinositide 3-kinase class II y
COPD Chronic obstructive pulmonary disease
cPKC Conventional PKC
CRAC Calcium release activated channels
CTL Cytotoxic T-lymphocytes
CTLA4 Cytotoxic T lymphocytes antigen-4
DAG Diacylglycerol
DAPP-1 Dual adaptor for phosphotyrosine and 3-phosphoinositides




ECL Enhanced Chemiluminescent reagent




FYVE Fab1, YOTB, Vac1 and EEA1 domain
GAP GTPase-activating proteins
GDI Gunanine nucleotide dissociation inhibitor
GDP Guanosine diphosphate
GEF Guanine nucleotide exchange factor
GFP Green fluorescent protein
GM-CSF Granulocyte-macrophage colony-stimulating factor
GPCR G-protein coupled receptor
GRK G-protein coupled receptor kinase
GTP Gunanosine Triphosphate
HRP Horse radish peroxidase
ICAM-1 Intercellular adhesion molecule-1
ICL Intracellular loop




ITAM Immunoreceptor tyrosine-based activation motifs
JAK Janus Kinase
JNK c-jun-NH2 terminal kinase
LAT Linker for activation in T cells
LTA4H Leukotriene A4 hydrolase
LTB4 Leukotriene B4
LY294002 Specific PI3K inhibitor
MAPK Mitogen-activated protein kinase
MHC Major histocompatability complex




mTOR Mammalian target of rapamycin
NFAT Nuclear factor of activated T cells
NNY-CCL5 N-nonanoyl-CCL5
NPKC Novel PKC
PAMP Pathogen-associated molecular patterns
PBL Peripheral blood derived lymphocytes
PBMC Peripheral Blood Mononuclear Cells
PBS Phosphate buffered saline
PDE Phosphodiesterase
PDK-1 Phosphoinositide-dependent kinase-1




PIK Phosphatidylinositol kinase domain
PKB Protein kinase B
PKC Protein kinase C
PLC Phospholipase C
PMA Phorbol myristate acetate
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Introduction
1.1 The immune system
The immune system is a finely controlled system and functions to maintain the 
health of an organism by limiting infection and disease. In mammals this process is 
coordinated via two distinct branches of the immune system, termed innate and 
acquired immunity. These seemingly discrete systems initiate very different 
immunological profiles however, interaction is essential for initiation of the acquired 
response. The innate immune system is triggered rapidly after infection with a 
pathogen; this response can act to limit the infection while the slower adaptive 
response is activated. It is important to note, that identification of self and non-self 
is the primary hurdle within the immunological response.
1.1.1 Innate Immunity
The first response to infection is initiated by the innate immune system, this may 
occur in several forms, the simplest being barrier protection provided by skin, 
pulmonary and gut epithelia. If breached the specialised cells of the innate immune 
system, monocytes and macrophages, neutrophils and dendritic cells (DC) begin to 
clear the infection. Within innate immunity, detection of self or non-self is 
determined by the binding of a region of the pathogen known as PAMP (pathogen- 
associated molecular patterns) (Medzhitov and Janeway, Jr., 1997) to PRRs 
(pattern recognition receptors) such as Toll-like receptors, which recognise the 
conserved sequences shared among pathogens but not the host. Binding of 
different antigens gives rise to activation of different Toll-like receptors, thus 
initiating a variety of responses such as the production of reactive oxygen species 
and nitrogen intermediates.
These cells possess a fixed repertoire of non-specific inherited receptors, in which 
further infections will initiate the same innate immunological response. In contrast, 
cells of the adaptive immune response, such as T and B lymphocytes, respond in a 
highly specific manner against the pathogen, showing immunological specificity and 
memory. The primary infection which initiates adaptive immune response will be
1
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slow, however, subsequent infections will be more rapid due to pools of memory 
cells.
1.1.2 Adaptive Immunity
Adaptive or acquired immunity is split into humoral (B cell mediated) and cell 
mediated (T cell mediated) responses. Humoral responses involve soluble 
antibodies generated by plasma cells, while cell mediated responses are 
specialised into many sub-groups, which can physically bind foreign molecules.
Innate immunity can act as the trigger for activation of the acquired immune 
response by inducing the production of pro-inflammatory cytokines, resulting in 
further leukocytes being recruited to the site of inflammation. Dendritic cells play a 
leading role, with immature DC binding conserved sequences within the pathogen, 
initiating maturation and expression of TLR (Vestweber, 2003) and co-stimulatory 
molecules, such as CD80/CD86 (Akira et al., 2001). During T cell activation, mature 
DC migrate to the lymph nodes and present the processed antigen (bound to the 
major histocompatibility molecule) to naive T lymphocytes, while a second co­
stimulatory signal is given via binding of B7 to CD28 (Banchereau and Steinman, 
1998; Reis e Sousa, 2001).
The complexity of the immune system is only achieved by the dynamic and evolving 
array of specialised cells which make up this system. Central to this is the fine 
control achieved within the cellular migration and response. This control is 
accomplished via up and down regulation of specific receptors expressed on these 
cells, with T lymphocytes exemplifying this process exquisitely.
1.2 T lymphocytes
The work presented within this thesis has been performed primarily on human T 
lymphocytes. In order to provide a background of this cellular system, a detailed 
presentation of the physiological life cycle of the T cell, including the activation of 
these cells will be performed.
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T cells are derived from bone marrow haematopoietic stem cells that enter and 
populate the thymus. At the point of entry, it is not yet determined what sub-group 
of T cells these immature cells (thymocytes) will form, in order for this to be 
determined, cells undergo multiple stages of selection (figure 1.1).








Figure 1.1: Development of y5 and ap T cells within the thymus. Immature T 
cells enter the thymus and must undergo 2 main decisions within their lineage. The first is 
which TCR will be displayed on the surface, the common ap or less common y5 (only 5 %). 
The second decision is between CD4+ T helper cell and CD8+ killer cell.
The circulating pool of naive T lymphocytes pass through their final phase of 
development in the thymus, this is initiated by TCR rearrangement. T cells are 
classified by the heterodimer which comprises their TCR, this may either be the 
most common and studied T cell, a/p TCR or the y/6 TCR which makes up 
between 1-5 % of peripheral blood T cells (Hayday, 2000). Although, y/6 T cells 
make up a relative small subgroup, they have a distinct receptor profile, and have 
been suggested to play a role in immune defence against infection, in particular the 
gut (Glatzel et al., 2002). Following TCR rearrangement there is a massive IL-7 
driven expansion and differentiation into CD47CD8+ double positive thymocytes. 
Through positive and negative selection, cells are selected for either the CD4+ or 
CD8+ lineage. Negative selection determines whether the T cell recognises self 
antigens. If cells recognise self antigens with high affinity, these cells receive 
signals to undergo apoptosis. This process ensures that any autoreactive T cells 
do not enter the circulation, which may result in disease. Positive selection 
determines how capable the T cell is at recognising and binding the MHC complex. 
If cells show high affinity for this process, the cells receive survival signals. This 
selection process ensures that only single positive cells proceed to exit the thymus.
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Within this process, large numbers of thymocytes undergo cell death, leading to 
comparatively few lymphocytes forming the circulating naive T cell pool.
1.2.1 T cell activation
Once the T cells have exited the thymus, these naive cells undertake an 
immunosurveillance role, circulating through the lymph. Only upon encountering an 
antigen will these cells activate and mature into the corresponding effector cell. 
Naive T cells require 2 signals in order to activate. This activation is a tightly 
controlled process, requiring interaction between the T cell receptor (TCR) and its 
ligand, but also binding and activation of co-receptors and orchestrated 






Figure 1.2 Model of T cell activation. Complete activation of the T cell requires 2 signals. 
The first signal is generated through antigen stimulation which is initiated through the APC 
which presents the antigen bound to the major histocompatability complex (MHC). It is this 
complex that has the capacity to bind the TCR/CD3 complex on the T cell. The second co­
stimulatory signal is via the T cell receptor CD28, binding to its complementary ligand B7.
Two signals are required in T cell activation
The initial signal required for T cell activation, is generated by the ligation of the 
TCR with the MHC complex of the antigen presenting cell, (e.g. a dendritic cell). 
However, as the TCR alone is not capable of transmitting the extracellular signal
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into a response, a complementary molecule is required, this is provided via the 
association of CD3 molecules (Kuhns et al., 2006).
The TCR is comprised of a(3 subunits that specifically recognise and bind the 
peptide/MHC (figure 1.3). The signals that are generated from this interaction, that 
subsequently lead to the activation of the T cell, are dependent on protein tyrosine 
kinases, namely Fyn, Lck, ZAP-70 and ITK. Transmittal of the antigen induced 
signal is dependent upon the CD3 molecules, which contain multiple 
immunoreceptor tyrosine-based activation motifs (ITAMs) (Kane et al., 2000; Sun et 
al., 2001).
Zeta C h ains
Figure 1.3 The T cell receptor complex. The TCR is comprised of the ap subunits 
which signal through the association with CD3 and the ^-chain accessory molecules. The 
CD4 receptor aids in stabilizing the TCR association with the peptide/MHC complex.
These conserved motifs found in CD3y, 5 and e cytoplasmic domains, as well as 
the TCR chain, act as tyrosine kinase substrates that bind other kinases, thus 
propagating the signal. Although the mechanism of signal transduction from ligation 
of the TCR, through to the phosphorylation of the ITAM motifs is not fully elucidated, 
it has been proposed that the TCR undergoes a conformational change that is 
relayed to the CD3 interacting subunits (Kjer-Nielsen et al., 2003; Krogsgaard et al., 
2003). It has been proposed that the initial phosphorylation of the ITAM motif is 
primarily due to the Src family kinase Lck, this kinase interacts with the CD4 or CD8 
cytoplasmic domain and following binding of the TCR/MHC, Lck is brought into
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close proximity phosphorylating the ITAM motifs. The ITAM motifs now have the 
capacity to bind and phosphorylate £-chain associate protein kinase (ZAP-70), 
which in turn acts to recruit and activate adaptor proteins such as SH2-containing 
Leukocyte Protein of 76 kDa (SLP-76) and Linder for activation in T cells (LAT). 
The adaptor proteins can bind many different intracellular molecules, thus bringing 
them into close proximity to each other, and facilitating the propagation of the 
signalling response. The culmination of these signals is an increase in the activity 
of transcription factors, such as activator protein-1 (AP-1), nuclear factor of 
activated T cells (NFAT) and NF«B and thereby increasing expression of new 
proteins, such as CD25 and IL-2.
Optimal T cell activation requires a second co-stimulatory signal; this ensures 
amplification of the TCR signal and prevents the T cell from becoming anergic. This 
involves the interaction of the co-stimulatory molecule CD28 with the B7 family of 
proteins CD80 (B7.1) and CD86 (B7.2) on the APC. This interaction facilitates the 
production of IL-2 transcription, CD25 expression, entry into the cell cycle and 
enhanced cell survival. As with the TCR, CD28 lacks direct enzymatic activity and 
therefore is presumed to signal through protein tyrosine kinases, such as Lck and 
ITK. Furthermore the phosphorylation of CD28 by Lck, is essential in the 
recruitment of the p85 regulatory subunit of PI3K, which in turn recruits the catalytic 
p110 domains (a, p or 5) leading to PI3K activation. Further to this, is the discovery 
of the CD28 family member ICOS (inducible costimulatory receptor), a receptor 
which unlike the constitutively present CD28, is upregulated following T cell 
activation and functions to maintain T cell responses (Coyle et al., 2000; Hutloff et 
al., 1999).
T cell activation is also negatively regulated, in order to limit the response of the T 
cell. This inhibitory pathway is initiated by the third member of the CD28 family, 
CTLA-4 (cytotoxic T lymphocytes antigen-4) which is upregulated upon T cell 
activation (Thompson and Allison, 1997). Ligation of CTLA-4 terminates T cell 
activation, thus avoiding the detrimental overstimulation of the system (Sansom and 
Walker, 2006).
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1.2.2 Differentiation of Effector cells
Following activation, the naive T cells differentiate into effector T cells. CD4+ into 
Th1 or Th2 subtypes, and CD8+ into cytotoxic T cells. The process involved in this 
differentiation is described below.
Differentiation of CD8+ T lymphocytes
Differentiated CD8+ or cytotoxic T cells are an essential part of the adaptive 
immunity, recognising antigens presented on DC bound to MHC class I molecules. 
They are an important branch of the immune system which recognize and eliminate 
viral and bacterial pathogens (Maggi et al., 1997).
Following initial activation of the CD8+ T cells, the second phase of maturation 
begins. This involves immense proliferation, normally lasting for about 5-8 days, 
and can lead to an increase of more than 10,000 fold (Badovinac and Harty, 2002). 
Following proliferation, the now differentiated effector T cells are capable of 
migrating to the site of infection (Weninger et al., 2001). The final phase of the 
CD8+ lifecycle is the initiation and maintenance of memory cells. This has been 
shown to be consistently 5-10 % of the peak detected CD8+ levels within the 
response (Kaech et al., 2002).
Differentiation of CD4+ T lymphocytes
Since the discovery of CD4+ T helper cells, there have been significant 
developments in our understanding of the divergence of CD4+ T lymphocytes into 
their respective subsets. These studies have more thoroughly detailed, not only the 
conditions surrounding the development of the most prominent Th1 and Th2 
subgroups, but have further highlighted the importance of regulatory T cells or 
Tregs and the newly discovered Th17 cells. Figure 1.4 illustrates the selection of 
these distinct classes. The role that cytokines play within this system cannot be 
underestimated, as it is clear that the divergence of Th1 and Th2 lineages, and thus 
there response in both normal and pathological conditions, is dependent on the 
cytokine environment that the naive cell is exposed to.
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Figure 1.4 Diversification of CD4+ T cell Lineages. The number of T cell lineages 
has increased from the classical Th1-Th2 fate, to now include Th17 and regulatory T cells 
(Tregs). The cytokines associated with arrows indicate the dominant cytokines involved in 
specification of each of the indicated lineages. The cytokines listed below each cell type 
indicate key effector or regulatory cytokines produced by differentiated cells of that lineage, 
or in the case of nTreg, a contact-dependent mechanism of suppression. The dotted line 
indicates a less well-defined lineage relationship. (Adapted from (Weaver et al., 2006)).
Polarised Th1 or Th2 subsets
Driving of naive CD4+ precursors into the Th1 lineage, is initiated through 
presentation of antigens on APC of the innate immune system (Hunter, 2005; 
Hibbert et al., 2003). Importantly, it is not only one driving force behind the 
production of the Th1 subset, but rather a combination of cytokines. It has been 
well documented that the primary driving force behind Th1 differentiation is the 
cytokine IL-12, which is facilitated by the action IFN-a, plus IL-18 (Robinson et al., 
1997) and IL-23 (Oppmann et al., 2000). Activation of the transcription factor T-bet, 
has been shown to be a ‘master’ regulator of Th1 cells (Mullen et al., 2001). A 
recent report has also elucidated to T-bet independent pathway although this 
process has not been not fully elucidated (Way and Wilson, 2004). Signalling 
through IL-12 potentates IFN-y production and upregulation of the IL-18 receptor, 
giving rise to the mature Th1 effector T cell (Yang et al., 1999).
Th2 cells originate from the same precursor as Th1 cells, yet show an independent 
mechanism for generation. Their activation is a coordinated response between the
8
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TCR and IL-4 stimulating STAT6, which in turn upregulates the master regulator in 
the differentiation of Th2 cells, GATA-3 (Ouyang et al., 2000).
Reciprocal inhibition of Th1 and Th2 cells
The specific circumstances that surround the generation of Th1 or Th2 cells, means 
that not only do cells of that lineage have the ability to stimulate further growth and 
proliferation, but this is reinforced by cross regulation of the opposing sub group 
(Romagnani, 2006). In this regard, generation of a typical Th1 cytokine such as 
IFN-y, or IL-12 inhibits the production of Th2 cells and the corresponding humoral 
responses (Kips et al., 1996; Lack et al., 1996; Manetti et al., 1993; Parronchi et al., 
1992). Conversely, the production of Th2 cytokines such as IL-4 inhibits Th1 
development and activation (Skapenko et al., 2004; Ghoreschi et al., 2003).
1.2.3 Memory Generation of CD4+ and CD8+ T cells
Following antigen presentation, both CD4+ and CD8+ cells produce memory T 
lymphocytes which are further subdivided into central memory and effector memory 
cells. Memory T cells form part of the immunological memory pool, thus on a 
repeated exposure to the same antigen, the cellular response will be rapid and 
specific. To enable this response, central memory T cells are maintained primarily 
within lymphoid circulation. It has been shown that circulation of these cells is 
similar to naive cells, migrating through the lymph node which is mediated by the 
presence of the CCR7 receptor. Effector memory T cells have the capacity to enter 
peripheral tissues, for this task they will specifically express the receptors required 
for migration into the tissue which first encountered the pathogen (Campbell et al., 
2001). For example, if a pathogen was encountered in the gut, there is an 
increased chance the effector memory cell will recirculate through that tissue. This 
is facilitated as the lymph node homing receptor, CCR7, is downregulated and the 
a4(37 homing receptors are upregulated, facilitating entry into the gut and allowing 
the pathogen to be neutralised (Sallusto et al., 1999; Kupper and Fuhlbrigge, 2004; 
Butcher et al., 1999). This feature of effector memory T cells, suggests they may 
play a role in the first line of defence upon a second exposure of the antigen. Upon 
binding of the specific antigen, memory T cells rapidly proliferate, regenerating 
effector T cells which can respond to the antigen (Sallusto et al., 2004).
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1.2.4 Th17
A recently characterised third subset of CD4+ T cells termed Th17 has been 
identified. Derived from the same precursor as Th1 and Th2, they are defined 
through their ability to secrete IL-17 (Langrish et al., 2005). This subset is distinct 
from either Th1 or Th2 and has its own unique master regulator, RORyt (Ivanov et 
al., 2006). The action of IL-6 and TGF(3 on the naive T cell pool are essential in the 
generation of these IL-17 producing cells (Veldhoen et al., 2006). IL-17 is a 
proinflammatory cytokine which has been demonstrated to induce the production of 
other proinflammatory cytokines such as IL-6, IL-8 and CCL2 (Aggarwal and 
Gurney, 2002). The identification of this subfamily has interesting implications, as 
diseases are reassessed and a role for the Th17 subtype is identified. These 
investigations are in the early stages of development but it has already been noted 
that high levels of IL-17 have been identified within autoimmune diseases such as 
rheumatoid arthritis, psoriasis and multiple sclerosis, suggesting a role for this 
lineage in autoimmune disease (Mangan et al., 2006; Komiyama et al., 2006).
1.2.5 Regulatory T cells
In addition to effector T cells, CD4+ T cell can also differentiate into regulatory T 
cells. These adaptive regulatory T cells or Tregs, are produced from the same 
precursor as Th1, Th2 and Th17 cells and have been shown to play a role in the 
suppression of T cell responses and autoimmunity (Sakaguchi, 2000). These cells 
mature in parallel to effector T cells, and as such migrate to sources of 
inflammation, acting to suppress T cell driven inflammation, as pathogen induced 
antigens are resolved (Fantini et al., 2004; Wakkach et al., 2003). Natural Tregs 
have also been identified which develop from distinct T cell lineage, these cells act 
preferentially in secondary lymphoid tissue, suppressing effector T cell activation 
before it begins (Weaver et al., 2006).
1.3 Migration - The Physiological Role of Chemokines
An essential component to the immune response is the ability of immune cells to be 
recruited from the circulating system to areas of functional requirement. For
10
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example, during immunosurveillance T cells traffic into regional lymphoid organs 
such as lymph nodes and the gut-associated Peyer’s patch. Furthermore, during 
the immune response cell undergo activation and differentiation, allowing them to 
migrate into sites infection or injury in response to a large number of 
chemoattracants. The process by which cells pass from the blood into a selected 
region is known as extravasation, and is an essential component of 
immunosurveillance and the immune response (figure 1.5). Briefly, lymphocytes 
within the blood initiate interactions with the endothelial cells of the lumen, 
generating the characteristic rolling effect. Binding of chemoattractants, such as 
chemokines, which are bound to the surface of the lumen via glycosaminoglycans 
(GAGs), mediate integrin activation and firm adhesion. This adhesion and slowing 
of the cell, allows the lymphocyte to migrate across the endothelium. This process 
must be tightly regulated as entry of immune cells into healthy tissue can be 
destructive.
Under the normal flow of blood, immune cells are rushing through the blood 
vessels, therefore in order for cells to cross the endothelium to the required areas, 
cells must undergo a complex series of steps which will be described below.
11
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Figure 1.5 Multi-step model of leukocyte extravasation. This process is a tightly 
control cascade of events. Lymphocytes in the blood initiate interaction with endothelial cells 
via sequential selectin-integrin interactions, mediating the characteristic lymphocyte rolling. 
Upon binding their endothelial-displayed chemokine ligands, chemokine receptors signal to 
mediate integrin activation. Following activation, integrins bind their Ig superfamily ligands 
on the endothelium, mediating firm adhesion, and the lymphocyte can migrate across the 
endothelium (Adapted from (Pribila et al., 2004)).
1.3.1 Tethering and reversible rolling
Due to the fast flowing nature of blood flow, the initial interactions of the immune 
cell with endothelium are transient, these rapid and transient interactions allow the 
cell to ‘tether and roll’ along the endothelium, acting to slow down the speed of the 
passing cell. Tethering and rolling is mediated by specialized lectins e.g. selectins 
and leukocyte integrins sharing an a4 subunit e.g. VLA-4 (Very late antigen-4) and 
mucosal homing receptor a4p7. L-selectin on the surface of leukocytes is perfect for 
this process as it can form rapid weak interactions with mucins on the endothelium 
(Lasky et al., 1992; Grabovsky et al., 2000). Although not involved in the initial 
tethering of the cell, LFA-1 optimises the L-selectin binding decreasing the velocity 
at which lymphocytes pass over endothelium (Salas et al., 2002; Kadono et al., 
2002).
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1.3.2 Activation and stable adhesion
The deceleration of the cell allows for or increases the chance of sufficient 
lymphocyte activation leading to firm integrin-mediated arrest (Grabovsky et al., 
2000; Campbell et al., 1998). Studies have shown that knocking out these 
leukocyte specific integrin genes leads to phenotypes such as impaired leukocyte 
recruitment and inflammatory responses, T cell proliferation defects and deficits in 
gut-associated lymphocytes.
Firm arrest on vascular endothelium depends on modulation of integrin avidity to 
ligand. Most integrins are present on the cell surface but in an OFF state when the 
cell is resting, however, upon activation the integrins are activated, allowing binding 
of the receptor to its complementary ligand (Hynes, 2002). This activation of the 
stimulated by chemokines that are attached to the endothelium. VLA-4 is the major 
vascular ligand for vascular cell adhesion molecule 1 (VCAM-1). Grabovsky and 
co-workers showed that immobilised chemokines can augment reversible VLA-4 
mediated tethering and rolling on VCAM-1, before independent firm integrin 
mediated arrest on the endothelial ligand (Grabovsky et al., 2000).
The arrest of circulating lymphocytes is essential before the cell exits the circulation 
to the site of inflammation. The participation of the lymphocyte chemoattractant 
receptor in conversion from rolling to firm adhesion, has been evaluated and 
confirmed in in vitro models (Campbell et al., 1998). Integrin interaction is dynamic 
and transient, with chemokines acting to modulate integrin activation in 2 ways: 
conformational change that alters integrin ligand binding affinity and integrin lateral 
mobility leading to integrin clustering, and increased avidity of cell adhesion.
1.3.3 Transmigration
Following firm adhesion is the process of diapedesis, in which the cell crosses the 
endothelial membrane (Petri and Bixel, 2006). Compared to other steps in the 
extravasaion process, relatively little is known about the precise mechanism under 
which these cells cross the endothelium. For many years this process was thought 
to occur purely through a paracellular mechanism, i.e. between two adjacent
13
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endothelial cells (as shown in above in figure 1.5). However, it has now become 
clear that leukocytes may also cross the endothelial membrane transcellularly or 
through an individual endothelial cell (Vestweber, 2003; Engelhardt and Wolburg, 
2004). Carmen and Springer have shown that in vitro, monocytes can cross 
through the endothelium both para- and trans- cellularly (Carman and Springer, 
2004; Muller et al., 1993).
Although the molecular basis for diapedesis is yet to be fully elucidated, several 
molecules have been identified within this process. Following arrest of the 
leukocyte, it begins to crawl along the endothelium and within minutes begins to 
cross. Platelet-endothelial cell adhesion molecule (PECAM)-1 has been shown to 
be involved during this process by the use of anti-PECAM-1 blocking antibodies. 
These studies suggest that PECAM-1 is involved not in the crawling of the cell to 
the junction, but in the actual crossing of the membrane. Removal of the blocking 
anti-body allows the leukocytes to cross the endothelium (Bird et al., 1993).
Interestingly, PECAM-1 knockout mice do not show a compromised immunological 
response, suggesting a PECAM-1 independent pathway. This maybe through other 
pathways such as ICAM-2 (Schenkel et al., 2006; Duncan et al., 1999; Huang et al., 
2006).
1.4 Types of chemoattractants and methods of migration
1.4.1 Chemoattractants
Chemoattractants are substances that can induce directed cell migration or 
chemotaxis within motile cells. There are several different types of 
chemoattractant, the most notable is the chemokine family, which has been 
described in detail within this work. Some important chemokines and other 
chemoattractants responsible for the migration of immune cells are described 
below.
In order to provide effective immunesurvailance, T cells are required to migrate into 
and out of secondary lymphoid organs; two receptors that have been demonstrated 
to play essential roles in this process are CCR7 and sphingosine-1 -phosphate, S1P
14
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(respectively). CCL19 and 21 are chemokines that bind the receptor CCR7. CCR7 
is found not only on naive cells but also on central memory T cells and more 
recently on natural killer and y5 T cells, indicating a broader range of cells that may 
utilize these chemokines for migration (Sallusto and Mackay, 2004).
Sphingosine-1-phosphate (S1P) is a lipid that has been shown to play an essential 
role in the migration of T cells out of the thymus. Consistent with S1Ps role in this 
process, mature single positive T cells have been demonstrated to exhibit the S1P 
receptor on the surface of the cell, facilitating the lymphocyte egress, while, S1P 
deficient T cells fail to exit the thymus. Interestingly, following antigen presentation, 
the responding T cell downregulates the S1P receptor (for up to 4 divisions), 
allowing for sustained stimulation of T cells within the lymph node (Sallusto and 
Mackay, 2004).
Following trauma or stimulation by bacterial peptides or immune complexes one of 
the early events of inflammation is the production of leukotrienes (Funk, 2001). Of 
particular importance is leukotriene B4 (LTB4), a potent mediator of neutrophil 
chemotaxis and stimulator of leukocyte adhesion to endothelial cells. Like 
chemokines, LTB4, exerts its actions through GPCRs, namely B-LT1 and B-LT2, 
with expression of B-LT1 restricted to leukocytes (Kamohara et al., 2000; Tager and 
Luster, 2003). LTB4 has been implicated in several inflammatory disorders, and 
increased levels have been recorded in samples from murine models of COPD, 
asthma and RA (Crooks et al., 2000; Montuschi and Barnes, 2002). Concurrent 
with this observation, administration of LTB4 antagonists in models of RA, 
demonstrate a decrease in inflammation and immune cell recruitment into 
subsynovial connective tissue (Griffiths et al., 1995).
The complement system, activated in response to a pathogen, represents an 
effective mechanism in the innate immune system. Furthermore, its activation has 
been implemented in the pathogenesis of acute and chronic inflammatory disorders 
such as MS, RA and asthma (Ffrench-Constant, 1994; Hawlisch et al., 2004). C5a 
has a diverse array of cellular functions from oxidative burst in neutrophils (Mollnes 
et al., 2002), to modulation of cytokine expression (Laudes et al., 2002). However,
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it is also known to be a potent chemoattractant molecule in neutrophils (nM range), 
monocytes and macrophages (Marder et al., 1985).
1.4.2 Types of Migration
Cells of the immune system are capable of migration in several defined ways. The 
term chemotaxis is the directed migration of a cell towards a soluble chemotactic 
gradient, similarly, haptotaxis also describes the directional movement of a cell 
towards a chemotactic gradient but on an immobilized substrate. Chemokinesis 
involves the random movement of cell that is independent of any chemotactic 
gradient. Therefore, cells may spontaneously generate cytoplasmic projections and 
retractions and display migratory properties, yet this movement of the cell is without 
any directionality (figure 1.6). Chemofugetaxis or fugetaxis, are terms used to 
describe the active movement of a cell away from a chemokine source, this 
phenomenon was first described following the observation that high (but not low) 
concentrations of CXCL12 could induce chemofugetaxis in a sub-population of T 
cells and it is thought to contribute to thymic emigration (Poznansky et al., 2000).
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Chemotaxis Haptotaxis
B Chemokinesis Chemofugetaxis
Figure 1.6 Methods of migration. Several methods of migration exist for leukocytes. A) 
Chemotaxis involves the migration of a cell towards the source of the gradient within a 
soluble environment. B) Chemokinesis occurs through random movement of a cell although 
no directionality is observed. C) As seen in chemotaxis, haptotaxis exhibits directional 
migration towards a concentration gradient, however, the chemokine is bound to the surface 
of the cell which the cell then crawls over. D) Chemofugetaxis occurs at high concentrations 
of chemokine, which in contrast to chemo- and hapto- taxis the cell moves away from the 
source of the chemokine. The gray arrow denotes direction of migration and the intensity of 
the yellow corresponds to the concentration of chemokine.
1.5 The processes involved in directed cell migration
Migration towards an extracellular chemoattractant gradient requires 3 distinct 
features of a cell including; extension of pseudopodia, gradient sensing and 
polarization and directional movement.
1.5.1 Extension of pseudopodia
During random migration or chemokinesis, cytoplasm projections are extending and 
contracting over the surface of the cell. Following stimulation (e.g. chemokine 
stimulation), the formation of projections or pseudopodia are focused towards the 
front or leading edge of the cell due to the accumulation of signalling molecules 
such as Ptdlns(3,4,5)P3. This transition and re-arrangement of intracellular 
signalling molecules is an essential element in the initiation of chemotaxis.
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1.5.2 Polarization
An early event within leukocyte migration is the polarization of the cell, this involves 
the production of a ‘front’ or leading edge and ‘rear edge’ or uropod in leukocytes 
(del Pozo et al., 1995). Within directional sensing, it is important that that once a 
cell detects a shallow chemoatttractant gradient, this is amplified within the cell. 
Once a chemoattractant gradient has been established, (for as little as 2 % between 
the anterior and posterior of the cell), reorganisation of the internal environment is 
triggered. This reorganisation includes a change in the distribution of F-actin, from 
throughout the cell, to a concentration within the leading edge of the cell; resulting 
in the polarised shape (Parent and Devreotes, 1999; Howard and Oresajo, 1985; 
Coates et al., 1992; Chung et al., 2001b). Leukocytes do possess some intrinsic 
cell polarity in which there is differential sub cellular localization of F-actin and 
assembled myosin II, allowing rapid responses to chemoattractant gradients 
(Chung et al., 2001b).
Within murine models of neutrophils chemotaxis, phosphoinositide 3-kinase or PI3K 
(a family of lipids capable of phosphorylating the inositiol ring on membrane bound 
phosphoinositides) has been shown to contribute to gradient sensing. Binding of 
chemokines to their receptors results in the rapid activation of this family leading to 
the accumulation of PI3K products in particular Ptdlns(3,4,5)P3 at the plasma 
membrane (Iglesias and Levchenko, 2002). Accumulation of Ptdlns(3,4,5)P3 acts 
to recruit PH-domain contain proteins to the leading edge of the cell which aid in 
driving downstream signalling events (Bokoch, 1995; Servant et al., 2000). The 
PI3K family, its regulation and role in chemotaxis is dissucssed in greater detail 
within section 1.8.2.
Actin polymerisation within motile cells is of fundamental importance and is 
continually being polymerised and depolymerised within the cell, allowing for a 
dynamic environment. Actin’s functional unit is known as globular actin or G-actin, 
and it is the polymerisation of these intrinsically polarised units (by the action of 
ATP), that once bound together generate filamentous actin (F-actin). The building 
of new F-actin is performed by the polymerisation at one end of the filament, known 
as the ‘barbed end’ while depolymerisation occurs at the opposing or pointed end 
(figure 1.7). During migration the generation of a new filament is focused at the
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leading edge of the cell and pushes the plasma membrane forward, resulting in a 
protrusion of the cell. The continued growth of F-actin continues until halted by the 
binding of a capping protein on the barbed end of the filament. This capping 
procedure acts to either maintain or stabilize the filament or promote 
depolymerisation. These capping proteins can be located on the pointed end, in 
which they inhibit the dephosphoylation of the filament, or at the barbed end, 
ensuring that no further G-actin monomers are added. In a process termed as 
treadmilling, the phosphorylation and dephosphorylation rate are comparatively 
equal, thus ensuring the maintenance of the current filament length (Vicente- 
Manzanares et al., 2005; Revenu et al., 2004).
Polymerisation
Barbed end 
2 >_>  > „>
Pointed end 
> >  >1^_>
ATP ADP
Depolymerisation
/  i  Bundling protein ^^C app ing  protein (0)Depolymerising protein
O  Sequestering protein ^^^Severing protein
Figure 1.7 Actin filaments: structure and dynamics. Actin monomers known as G- 
actin bind ATP and assemble much more rapidly at the 'barbed end' compared to the 
'pointed end'. During treadmilling, the polymerization rate and depolymeriztion rate are 
equal thus filament length is maintained at a constant. Several proteins are known to bind 
to actin; capping proteins may bind to the barbed end preventing addition of further 
momomers, while some as demonstrated are known as crosslinking proteins, allowing 
several filaments to bind together.
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In order to maintain motility, cells must release the adhesions at the back of the cell 
and retract the uropod, which is dependent on the motor activity of myosin II. In 
myosin II null cells retraction of the uropod is defective thus resulting in ineffective 
chemotaxis (Clow and McNally, 1999). The most conclusive evidence that PI3K 
plays a role in chemotaxis, has come from the utilization of PI3K inhibitors such as 
wortmannin and LY294002, and the study of PI3Ky knockout mice. Studies indicate 
that mice which are PI3KY'7', have an impaired ability for mounting an immune 
response, in particular the function of neutrophils and macrophages is severely 
impaired both in vitro and in vivo (Li et al., 2000).
The role of PI3K in chemotaxis or directed cell migration has been thoroughly 
established and of particular importance is the role that this molecule plays in the 
migration of cells within the immune system (Ferguson et al., 2007; Hirsch et al.,
2000). The clinical implications of developing an inhibitor against isoforms within 
the PI3K family have a potential therapeutic benefit in diseases as diverse as 
autoimmune disease, cancer and asthma. While it is clear that the PI3K family 
plays a pivotal role in the chemotaxis of neutrophils, the contribution of PI3K within 
T cell chemotaxis is less clear.
Broad spectrum PI3K inhibitors notably LY294002 and wortmannin have highlighted 
a role for this family within migration, although these compounds are unable to 
adequately discriminate between individual members of this family. If a specific and 
directed therapy against the PI3K family is to be developed, the role and relative 
contribution to each function must be dissected out. The data generated thus far 
has demonstrated a certain level of context dependence, in that the role that the 
PI3K family plays within chemotaxis depends on the cell under investigation and or 
the priming before chemokine stimulation.
Chemokines induce migration through G-protein mediated interatctions which have 
been attributed to the Gai subfamily, this has highlighted a role for PI3K class ly 
which has been shown to lie downstream of (3y subunits. Chemokines also have 
the potential to activate other members of the PI3K family, with their contribution to 
optimal migratory responses being evaluated within the Jurkat T cell line, however
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the contriabution of these isoforms within the migratory process of primary human T 
cells has yet to be determined.
The role of knock-out and knock-in murine models have been invaluable in 
assigning function to specific isoforms within this family (Thomas et al., 2005). 
Throughout these studies, the focus was on the effect of these isoforms within 
human T cells, enabling data obtained to reflect the role of these molecules in the 
human physiological setting, particularly migratory responses.
Within the murine neutrophil model, chemotactic responses have been 
demonstrated to be dependent on PI3K class ly, yet within T cells there are mixed 
reports, with some data suggesting a central role for the PI3K family within T cell 
chemotaxis, while others have shown that contribution may only be required for 
optimal chemotactic responses. In a situlation where T cells might rely on 
alternative pathways for migration, the molecular mechanisms under lying this 
process are starting to be explored. A candidate for PI3K independent cell 
migration is the Rac GEF DOCK-2, as mice lacking DOCK-2 show a decrease 
within the chemotactic responses towards several chemokines (Nombela-Arrieta et 
al., 2004; Reif et al., 2004).
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1.6 Chemokines and Chemokine Receptors
1.6.1 Nomenclature and Structural characteristics of Chemokines
Chemokines are highly conserved 8-10 kDa proteins characterized by a 4 cystein 
motif. Dependent on their primary amino acid structure chemokines can be divided 
into 4 sub-families C, CC, CXC, or CX3C depending upon the number of amino 
acids separating the first two cystein residues at the NH2 terminal (Wells et al.,
1998). A further structural sub classification of the CXC chemokine family can be 
made depending on the presence of a tripeptide motif ELR in the NH2 terminus 
Glu-Leu-Arg (ELR)+ and Glu-Leu-Arg (ELR)-. CXC chemokines classified as ELR+ 
are, CXCL1, CXCL2, CXCL3, CXCL5 CXCL6, CXCL7 and CXCL8 with these 
chemokines being known to be strong chemoattractants for neutrophil 
polymorphonuclear leukocytes (PMN) into inflamed tissues.
Further to the structural classification, chemokines may also be classified according 
to their function and expression. Inflammatory or inducible chemokines encompass 
those that are upregulated upon injury or disease and are therefore important 
components of the innate and adaptive immunity. Homeostatic or constitutive 
chemokines are present even during a healthy or disease and injury free state and 
as such are responsible for orchestrating the traffic and homing of leukocytes during 
there immune surveillance role (figure 1.8). Discussed within this work are some of 
the main concepts within chemokine signalling and function as well as some of the 
most recent discoveries within this field.
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Figure 1.8 Classification of human chemokines into functional subfamilies.
Chemokines can be classified according to their function. Homeostatic chemokines are 
responsible for orchestrating the traffic and homing of leukocytes during there immune 
surveillance role, while inflammatory chemokines are important components of the innate 
and adaptive immunity (Adapted from (Moser et al., 2004)).
Chemokines may be classified according to their structure or function, yet common 
to all chemokines is the family of receptors through which they exert their biological 
function, the family of G-protein coupled receptors.
1.6.2 G-protein coupled receptors
G-protein coupled receptors or GPCRs constitute a group of large and diverse 
receptors capable of binding not only chemokines but also hormones and lipid 
mediators. These cell surface receptors couple to intracellular heterotrimeric G- 
proteins which regulate downstream effectors such as adenylyl cyclase, 
phospholipases, protein kinases and ion channels (Armbruster and Roth, 2005). As 
shown in figure 1.9, GPCRs are characterised by a unique structure, a hydrophobic 
core of seven transmembrane spanning domains creating three intracellular loops, 
an amino terminus on the outside of the cell and a carboxyl terminus on the inner 
surface (Allen et al., 2007).
Taking the ‘simplistic’ view within GPCR signalling, a monomeric GPCR binds a 
ligand on the N-terminus side of the receptor, this binding of the ligand induces a
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conformational change within the receptor which is transduced through the 7TM 
domains allowing for interaction and activation of the G-proteins (Armbruster and 
Roth, 2005). However, it has recently become apparent that the signalling through 
GPCRs is more complex, with these receptors combining to form not only 
homodimers but also heterodimers (Breitwieser, 2004). For example, in T cells the 
CCR5 chemokine receptor has been shown to homodimerise, with the dimerisation 
specifically dependent on two residues in transmembrane 1 and 4. Mutation of 
these residues does not give rise to a dimer and importantly leads to lack of 
signalling through CCR5 (Hernanz-Falcon et al., 2004). Biochemical and functional 
evidence has also highlighted the heterodimerisation of CCR5 with CCR2. These 
heterodimers signal and traffic differently from the component receptors. Mellado 
also showed that following stimulation by both CCL2 and CCL5, (agonists for CCR2 
and CCR5), these receptors heterodimerise resulting in an increased sensitivity of 
the receptor complex, leading to a 10 % decrease in the concentration of agonist 
required to produce the same chemotactic and calcium responses (Mellado et al.,
2001).
The functional relevance of this dimerisation may be important in several areas of T 
cell biology. For example, during the extravasation of T cells, chemokines are 
bound to the surface of the endothelium and binding to their respective chemokine 
receptors may induce the characteristic rolling of the cell (figure 1.5). Dimerisation 
of receptors may not only decrease the required threshold for activation and arrest, 
but provide an increased sensitivity and specificity within the system (Rodriguez- 
Frade et al., 2001).
These results suggest that chemokines can act synergistically to facilitate 
responses even to low concentrations of chemokines, but this also means that they 
could suppress some couplings. Although heterodimerisation has been shown for 
certain receptors, this cannot be a generalised for all chemokine receptors and it 
most probably shows that certain chemokine receptors can couple to only a few 
other receptors therefore each case must be evaluated independently. The 
apparent homo- and hetero-dimerisation of these receptors only adds to the 
complexity of chemokine signalling and functional response.
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In order to transmit an extracellular signal into a meaningful signal and function 
within the cell, the ligand and receptor must undergo a 3 step response. This 
response encompasses binding of the ligand or agonist, activation of the receptor 
and initiation or inhibition of second messengers within the cell (figure 1.9).
Figure 1.9 A schematic depicting a GPCR and the interaction of CXCL12 with 
its receptor CXCR4. (A) A 2D representation of an unfolded GPCR within the cell 
membrane, highlighting the N- and C-terminals as well as the intracellular loops (ICL), as 
discussed later ICL2 is essential for the signalling of GPCRs. (B) CXCR4 is shown with the 
seven helices represented as cylinders, which are connected by the surface and 
cytoplasmic loops. (B, left panel) indicates the receptor and ligand separately prior to any 
interaction between the two. B, middle panel indicates the interaction between CXCL12 with 
the N-terminal segment of the receptor. The contact region is in blue. B, right panel shows 
the N-terminal region of CXCL12 bound in groove at the top of the helices (orange). Binding 
of the N-terminal region results in activation of the receptor, which is depicted in right panel 
by the change in conformation of the receptor helices compared with the middle panel 
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The binding of a ligand on the extracellular portion of the receptor, initiates a 
conformational change within the receptor thus activating it. The linking of the 
activated receptor and the second messenger signalling cascade is provided by a 
heterotrimeric guanine nucleotide binding protein (G-protein) on the inner leaflet of 
the cell membrane (Neer, 1995). These G- proteins function as molecular switches 
within the cell and are comprised of an a, p, and y subunit. Binding of the 
heterotrimeric G-protein with the receptor initiates the exchange of guanosine 
diphosphate (GDP) for guanosine triphosphate (GTP) on the a subunit. This 
exchange leads to the removal of the hydrophobic pocket of which G-py binds thus 
reducing the affinity of Ga-GTP and G-py resulting in the dissociation of the Ga- 
GTP from the Gpy complex (Lambright et al., 1994). The importance of the second 
intracellular loop in facilitating the flow of signal into the cell, has been highlighted 
by the discovery of ‘atypical’ chemokine receptors (discussed later).
The free G-py subunits are now available to activate or inhibit downstream 
signalling molecules. Termination of these effects which occurs rapidly within the 
cell, is a result of GTP being hydrolysed back to GDP through the innate GTPase 
activity of the a subunit allowing reassociation of the a, py complex (Hamm, 1998; 
Sprang, 1997).
1.6.3 G-a and G-Py interaction with effectors
Activation of specific downstream effectors is achieved through the variability of G- 
proteins. G-proteins are divided into four families based on the similarity of their a 
subunits; Gs, Gj/0, Gq, G12/13. Historically, it was assumed that it was only the G-a 
subunit that triggered intracellular signalling through well defined pathways such as 
adenylate cyclase and phospholipase C. However, it is now clearly established that 
the G-py complex, couples to and triggers the activation of signalling cascades 
such as PLCP2 and p3 (Katz et al., 1992), ACs (Tang and Gilman, 1991), p- 
adrenergic receptor kinase, PI3K (Stephens et al., 1994; Tang and Downes, 1997), 
components of the MAPK cascade (Inglese et al., 1995), and K+ and Ca2+ channels 
(Cabrera-Vera et al., 2003).
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Class IB is the only class of PI3K shown to be activated by the dissociated G-(Sy 
subunits, with the regulatory subunit p101, sensitising the catalytic subunit to G-py 
(Stephens et al., 1997). It is further proposed that p110y is activated via interaction 
with GTP-bound Ras which via allosteric mechanism or altered orientation of p110y 
in respect to its substrate further increase its activity (Suire et al., 2002). Activation 
of class IA isoforms is thought to be via the Gai activation of Src family kinases, (Ma 
et al., 2000). However although it has been shown that class II isoforms lie 
downstream of chemokine receptors their activation mechanism has yet to be fully 
elucidated (Curnock et al., 2002).
In conclusion, in order for chemokines to exert an effect within the cell, the signal 
must be controlled at several levels. This is performed by each receptor binding a 
specific number of ligands and combination of G proteins, with these G-proteins 
only triggering specific signal transductions cascades within the cell. Amplification 
of this particular signal is ensured, as following dissociation of the G-protein 
complex, the receptor/ligand coupling is then free to bind the next G-protein. 
Furthermore, although deactivation of the functional G-proteins is rapid, the active 
functional complex is stable long enough to ensure the triggering and amplification 
of the second messengers.
1.6.4 Regulation of GPCR signalling
The availability of GPCRs on the cell surface is a tightly controlled process. The 
initial step is the synthesis of the receptor in the endoplasmic reticulum, in which the 
GPCR is then packaged for transport to the surface. The mature glycosylated 
receptor can now interact with its specific ligand. One notable aspect of GPCR 
signalling is the sensitivity of the cell following stimulation of the GPCR via its 
ligands. This sensitivity or negative regulation is often termed desensitization.
Desensitization of the receptor can occur rapidly after exposure to stimuli, reducing 
the responsiveness of the receptor to further stimulation. It occurs due to the action 
of G protein-coupled receptor kinases (GRKs) which phosphorylate the receptor 
following agonist induced conformational changes, this facilitates the binding of the 
inhibitory (3-arrestin proteins that uncouple the receptor from the G-proteins (Vroon
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et al., 2006; Pao and Benovic, 2002). Uncoupling can also occur via second 
messenger dependent kinases e.g. protein kinase A and C. In contrast to GRK 
mediated uncoupling, this method has the capacity to desensitise any receptor in 
the presence or absence of ligand binding, it is often referred to as heterologous 
desensitisation and mediates a generalised cellular hyporesponsiveness 
(Kristiansen, 2004). The extent of receptor desensitization can vary depending on 
the cellular system, from attenuation to complete termination of the signal 
(Ferguson, 2001; Aramori et al., 1997).
Internalization or sequestration of GPCRs is another mechanism in which signalling 
and function through GPCRs is controlled. In comparison to desensitization, this 
process takes longer, occurring over several minutes (Luttrell and Lefkowitz, 2002). 
However, it can be dependent on (3-arrestins. Following chemokine exposure the 
CCR5, CXCR1 and CXCR4 receptors have all been identified to undergo 
sequestration via p-arrestins, this may also be coupled to associated proteins such 
as clathrin which promotes the sequestration process (Ferguson, 2001; Cheng et 
al., 2000; Kristiansen, 2004).
Once the GPCR has been sequestered it undergoes one of two mechanisms; 
receptor recycling or degradation. For recycling back to the plasma membrane, the 
receptor undergoes dephosphorylation and removal of p-arrestin which resensitizes 
the receptor to the ligand. The time course for this process is dependent on the 
ligand/receptor interaction; however the kinetics behind this process can be 
adjusted with the use of modified chemokines. This technique has been 
demonstrated to increase the time the receptor is sequestered within the cell before 
recycling (Pastore et al., 2003). The alternative is degradation of the receptor via 
the lysosomal degradation pathway, this has been highlighted as a process for p2- 
adrenergic and CXCR4 receptor degradation (Wojcikiewicz, 2004).
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1.6.5 Chemokine Receptors
The action of chemokines on their receptors can elicit a plethora of cellular 
responses. In order to fully appreciate the importance of specific ligand / receptor 
interactions it must deciphered what response can be assigned to each interaction. 
This goal is made all the more challenging by the promiscuous nature of 
chemokines, as it has been shown that individuai chemokines may activate several 
receptors and each receptor may be activated by a number of different chemokines, 
indicating redundancy and versatility within the system (Ward and Westwick, 1998). 
Shown in Figure 1.10 is a summary of the chemokine receptors and the ligands 
which activate them, due to this promiscuity there has been difficulties when 
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Figure 1.10 Chemokine receptors and ligands. Chemokines are divided into subclasses 
based on the spacing of the N-terminal cysteine residues. The receptors for the a (or CXC) 
subclass are shown in blue, the receptors for the (3 (or CC) subclass are in red and the 
receptors for the minor subclasses (C and CX3C) are in green. The pairing of chemokines to 
their receptors has been carried out principally by receptor-binding assays, and has 
identified receptors that are specific, in that they bind a single ligand, or shared, in that they 
bind more than one ligand (Adapted from(Johnson et al., 2004)).
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1.6.6 Atypical chemokine receptors
The control of the inflammatory process relies on the intricate control of each stage 
of the process. Chemokine receptors have long been thought to play a role in the 
recruitment of inflammatory cells to the site of injury or infection. However, the 
discovery of ‘atypical’ chemokine receptors with their apparent non-signalling or 
silent properties, introduces an exciting field within chemokine receptor function, 
and raises the question of what role these abundant receptors play within the 
regulation of inflammation.
These modified GPCRs have been termed ‘chemokine interceptors’ for inter­
nalizing receptors. These receptors differ from their counterparts as they show a 
mutation in the second intracellular loop. Typical chemokine receptors display the 
normal ‘DRYLAIVHA’ motif which has been shown to be a key mediator in the 
coupling to downstream signalling. Yet these atypical chemokine receptors have an 
alteration in this critical motif (figure 1.11). This subtle change leads to a silent 
receptor, in that no signalling or functional response following chemokine binding is 
observed (Nibbs et al., 1997; Haraldsen and Rot, 2006).
D6 and DARC (Duffy Antigen Receptor for Chemokines) are two of the most 
studied examples of these ‘atypical’ receptors. These investigations have lead to 
the belief that the primary role for these silent receptors is for chemokine 
sequestration and degradation, thus providing a mechanism for removing the 
chemokine from the inflamed site. By undertaking this role, these so called silent 
receptors play a crucial role in regulating chemokine bioavailability and as such 
have an influence over the inflammatory process (Comerford and Nibbs, 2005; 
Nibbs et al., 2003). Although these receptors do not signal and are therefore 
excluded from the systematic nomenclature of chemokine receptors, they do play 
an important role within the control of the chemokine availability and will therefore 
be discussed in more detail.
D6
The atypical chemokine receptor D6, shows no signalling, calcium flux or 
chemotactic response following binding of a chemokine, yet is indispensable in the
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resolution of inflammation (Fra et al., 2003). In vivo studies have demonstrated that 
a deletion of this receptor can result in susceptibility to skin cancer and 
demonstrates signs of a disease similar to the human condition psoriasis. The 
presence of abnormalities in the skin, correlates with the abundance of the D6 
receptor in the skin (Nibbs et al., 1997).
DRYLAIVHA DKYLEIVHA DRYVAVTKV
Typical
chem okine D6 PPR1
receptor
Figure 1.11 Schem atic  of the  chem okine ‘In te rcep to rs ’. Silent or atypical 
chemokine receptors display a mutation in the ‘DRYLAIV’ motif of the second intracellular 
loop and are unable to induce a signalling or functional response. This alteration suggests a 
possible role in the sequestration of chemokines.
The D6 receptor shows structural similarities to other chemokine receptors and can 
bind at least 13 CC chemokines (Nibbs et al., 1997), all of which are inflammatory, 
interestingly D6 cannot bind constitutive chemokines (Fra et al., 2003; Bonecchi et 
al., 2004). The D6 scavenging receptor retains its ability to associate with (3- 
arrestin and internalize in a clathrin-coated pit dependent mechanism. However, it 
varies from other chemokine receptors as it is constitutively active, performing the 
internalisation function even in the absence of a ligand (Galliera et al., 2004; Weber 
et al., 2004). As well as the modified ‘DRYLAIVHA’ to the ‘DKYLEIVHA’ motif, D6 
also has replaced an aspartic acid residue to an asparagine in the second 
transmembrane domain, both have been shown to be important the G-protein 
dependent signalling (Mantovani et al., 2001).
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DARC
As with D6 the traditional ‘DRYLAIVHA’ signalling motif within GPCRs second 
intracellular loop is altered, in this case to ‘LGH’ and as such the receptor is unable 
to signal. DARC and D6 are both considered to be silent receptors, however, it is 
important to realise the distinct differences between them. As discussed above, D6 
acts to internalise the chemokine, this is followed by degradation of the chemokine 
by lysosomes within the cell. In contrast, chemokines bound to and internalised by 
DARC, maintain their full biological activity.
The maintenance of biological function of the chemokines is essential to the role 
that DARC plays within the immune system. DARC may act as either a sink or a 
transporter to both CC and CXC chemokines. DARC is located on erythrocytes as 
well as vascular endothelial, on erthrocytes, it acts as a chemokine sink maintaining 
the presence of chemokines within the circulation, chemokines can then be 
released when required, moreover, this can aid in the prevention of desensitization 
in leukocytes. On vascular endothelial, the DARC receptor can act as a transporter 
of chemokines from the extracellular space onto the lumen of the vasculator. This 
process allows the chemokine to be bound to the lumen, instead of being released 
into the lumen to act as a free chemokine which may have crossed between the 
endothelial cells.
PPR1
In contrast to D6 and DARC, the PPR1 receptor is unique in that it binds 
homeostatic chemokines CCL19, 21 and 25. As with all ‘interceptors’ it 
demonstrates a mutation in the second intracellular loop, in which the characteristic 
‘DRYLAIVHA’ motif is altered to ‘DRYVAVTKV’ (Murphy, 2002).
Upon first investigation this receptor was termed CCR11, as it was thought that the 
chemokines CCL2, CCL8 and CCL13 bound to this receptor and induced 
chemotactic responses. However, further investigation into this receptor 
determined that this was in fact an atypical or silent receptor and the term CCR11 
was withdrawn (Schweickart et al., 2000).
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CXCR7
The recently identified CXCR7 (RDC-1) chemokine receptor is intriguing. Research 
into its function is still in its infancy and there are contradictions in the possible 
mechanisms of action or even lack of action. It is due to these contradictions that 
the CXCR7 receptor shall be mentioned within this section, although further 
investigations are required to identify if this is indeed an atypical receptor.
Initial observation identified this receptor on isolated T cells, and noted that 
following blockade of either the CXCR4 or CXCR7 receptors, chemotaxis towards 
CXCL12 was diminished (Balabanian et al., 2005). This suggested a possible role 
for this receptor in the chemotactic responses of T cells and its subsequent 
renaming from RDC-1 to CXCR7. However, observations in murine and tumour cell 
lines have demonstrated that signalling through CXCR7 does not induce calcium 
flux or chemotactic responses (Burns et al., 2006). It is interesting to observe that 
within a zebra fish study, the role of CXCR4 and CXCR7 have also been shown to 
play complementary roles in cell migration. Here the leading edge of the cell is 
shown to contain high levels of CXCR4, with the trailing edge containing CXCR7. 
This apparent spatial distinction allows for the same cell to respond differently 
towards the same chemokine depending on the spatial restriction of the receptors. 
It is possible that in this scenario, CXCR7 may act to sequester CXCL12, 
decreasing the available chemokine and preventing binding to CXCR4, furthermore 
the affinity of CXCR7 is 10 X greater than that of CXCR4, which would favour this 
theory (Dambly-Chaudiere et al., 2007). It has also been shown that not only 
CXCL12 binds CXCR7 but also the inflammatory chemokine CXCL11 (Burns et al.,
2006).
Due to the initial observed role of CXCR7 in T cell chemotaxis is unclear how this 
information may relate in the T cell, but it brings an interesting angle to what was at 
one time thought to be a one chemokine, one receptor relationship. The results 
from investigations into CXCR7 are awaited with anticipation.
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1.6.7 Chemokine receptor expression
So far we have briefly alluded to the role that chemokine receptors play in the life of 
the T cell. Although we have demonstrated that the cells can be categorised by the 
CD4 or CD8 receptor and the cytokine expression profile, these cells may also be 
characterised by the chemokine receptors that are present on the cell surface 
(figure 1.12).
The expression profile of receptors on T lymphocytes is indicative of functionally 
distinct T lymphocytes subsets. Naive T lymphocytes have a limited number of 
receptors expressed on the cell surface; the most notable are the CXCR4 and 
CCR7 chemokine receptors. Recirculation of this naive population is observed 
between the blood and lymph nodes, which is aided by the expression of CCR7 and 








Th1 lym phocyte Th2 lym phocyte
Figure 1.12 Example of Chemokine receptor expression on Th1 and Th2 
lymphocytes.
Following activation and differentiation of the T cell, the number of receptors on the 
cell surface are upregulated, this allows migration towards an increased number of 
chemokines. Yet the chemokine receptors that are upregulated are specific for the 
T cell subgroup. For example, the CXCR3 chemokine receptor has been shown to 
be expressed at much higher levels on Th1 lineage than Th2 (Sallusto et al., 1998; 
Bonecchi et al., 1998). Two of the ligands for CXCR3, CXCL9 and CXCL10 have 
been shown to be IFN-y inducible and as Th1 cells produce IFN-y this correlates 
well with the observed CXCR3 expression (Loetscher et al., 1996a). CCR1 has 
been shown to be expressed on Th1 while CCR11 and CCR3 are preferentially
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expressed on Th2. There are conflicting reported about the expression profile of 
CCR5 on T cells, in some cases expression was found on both Th1 and Th2 and in 
others higher in Th1 (Sallusto et al., 1998; Bonecchi et al., 1998). Interestingly this 
discrepancy may be explained by the activation state of the cell, as well as culture 
conditions, with CD3/CD28 down regulating CCR5, whereas culture with IL-2 
increases expression. It is important to note that these receptor profiles are not 
definitive, expression of CCR3 on Th1 and CCR5 on Th2 have been recorded.
1.7 Chemokines in human pathophysiology
A characteristic of inflammation is the increase in the number of chemokines and 
subsequently the number of immune cells that infiltrate the target site. An increase 
in the infiltration of immune cells is also prevalent when disregulation of this system 
occurs, this disregulation may lead to autoimmune diseases such as rheumatoid 
arthritis, multiple sclerosis, Chrons disease, and cardiovascular disease.
Many reviews have described in detail the role of chemokines within disease states 
and provided a summary on the current clinical status of small molecule antagonists 
(Medina-Tato et al., 2006; Ruffini et al., 2007; Szekanecz et al., 2006). This work 
focuses primarily on the chemokine CXCL12, and as such an overview of both this 
chemokine and its receptors CXCR4 and CXCR7 shall be discussed. In addition, 
investigations were also performed into the role of CCL5 and its derivatives and we 
shall discuss this chemokine in the context of HIV.
1.7.1 CXCL12 and its receptors
CXCL12 was first cloned in a mouse bone marrow stromal cell line, PA6 and due to 
alternative splicing of the same gene (located on chromosome 10q), can be found 
in one of two forms, CXCL12a or CXCL12P, (the former being more abundant) 
(Shirozu et al., 1995; Nagasawa et al., 1994). Unusually for cytokines it is highly 
conserved between mouse and human (> 90 %). The action of CXCL12 has been 
found to be a highly potent chemotactic agent within leukocyte populations (Oberlin 
et al., 1996; Bleul et al., 1996)
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CXCR4
The CXCR4 receptor was isolated from a human blood monocyte cDNA library and 
was known as the orphan receptor LESTR, consisting of 352 amino acids 
(Loetscher et al., 1994). As with all chemokine receptors it is seven- 
transmembrane G-protein coupled receptor and has been shown to induce 
chemotactic responses in immune cells, such as monocytes, pre-B cells and T 
lymphocytes (Bleul et al., 1996; Loetscher et al., 1994). CXCR4 belongs to the 
CXC or a -chemokine family, in which the NH2 terminal cystein residues are 
separated by one amino acid residue (Aiuti et al., 1997).
CXCR7
Chemokines are highly promiscuous with many chemokines capable of binding 
more than one receptor and each receptor capable of binding more than one 
chemokine. Early indications suggested that the CXCL12/CXCR4 axis was an 
exception to this, as it was considered that CXCL12 and CXCR4 only bound each 
other. This observation was intriguing as it allowed assignment of signalling 
pathways to be categorically attributed to this signalling axis without any 
interference. However, recent studies have elucidated that the orphan receptor 
RDC-1, can also bind CXCL12 and CXCL11 with high affinity. These investigations 
are only in their infancy, yet due to the signalling and functional responses which 
are initiated through this receptor, it has lead to the reassigning of the orphan 
receptor RDC-1, to be subsequently renamed CXCR7. This recent addition to the 
chemokine/chemokine receptor family only aids to highlight the ever increasing 
complexity of this system.
Study of the CXCL12/CXCR4 axis has implemented this system in several areas of 
development. Murine systems have been the most widely studied, with mice 
lacking CXCR4 resulting in defects of organ vascularisation, with most mice dying in 
utero or perinatally (Tachibana et al., 1998). Furthermore, the CXCR4 receptor was 
the first GPCR to be shown to be involved in neuronal cell migration, with disruption 
in of CXCR4 gene in mice leading to foetal lethality in homozygous mutants (Zou et 
al., 1998).
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CXCL12-/- mice showed defects in cardiac tissue, ventricular septum formation, B 
cell lymphopoiesis, bone marrow myelopoiesis, formation of tissue elements of 
bone marrow or any types of blood cells derived from bone marrow (Nagasawa et 
al., 1996). All of the above indicate that CXCR4 is essential in development and is 
not just limited to the haemotopoietic system.
CXCL12 and its receptor CXCR4 have been identified to play a role in several 
disease states. Rheumatoid Arthritis is a chronic condition characterised by 
inflammation of the joints. It is thought to occur due to accumulation of CD4+ 
memory T cells within the affected joint. Nanki and collegues found CXCR4 
expression on CD4+ memory T cells was enhanced and CXCL12 was expressed 
within the synovium. This observation coupled to the antiapoptotic effects induced 
by CXCL12 in migrating CD4+ cells to the synovium, suggests a role for the 
CXCL12/CXCR4 axis in the accumulation of CD4+ memory T cells in rheumatoid 
arthritis (Nanki et al., 2000). It has also been shown that CXCR4 is expressed on 
23 different types of cancer from haematopoietic origin to breast, prostate, 
pancreatic, and lung (Balkwill, 2004).
1.7.2 CCR5 and CCL5
A huge advancement in knowledge about HIV came with the discovery that a link 
existed between HIV and the chemokine field. It was observed that entry of HIV 
into T cells is mediated through CD4 and two co-receptors CCR5 and CXCR4. This 
observation was of clinical importance, as with this knowledge, agents that block 
the entry of this virus could be developed. Individuals which are homozygous for a 
null CCR5 allele, not only have a decreased risk of infection with the HIV virus, but 
also demonstrate that inactivation of this receptor, does not lead to pathological 
characteristics and individuals display normal cellular responses (Samson et al., 
1996). This observation suggested that targeting and modulating the function of 
this receptor would have limited pathological effects. To further this, individuals 
which are heterozygous for the CCR5 allele show slower progression of the disease 
(renzana-Seisdedos and Parmentier, 2006).
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Taken together, these observations all heightened the excitement around a 
potential CCL5 antagonist as a prophylactic treatment for HIV. Research started by 
modifying CCL5 in order to generate a molecule which was highly specific, showed 
lower agonist activity, but displayed longer sequestration of the receptor. These 
modifications would ensure limited exposure of the functional receptor at the cell 
surface, decreasing the likelihood of HIV binding. Simmons et al demonstrated that 
the N-terminally modified chemokine AOP-CCL5 was capable of blocking the R5 
tropic HIV entry in several different cell types (Simmons et al., 1997). This molecule 
resulted in agonist activity which was assessed via the dimerisation of the receptor, 
measurement of calcium flux and intracellular signalling (Rodriguez-Frade et al.,
1999). As expected with an agonist, it induced internalisation of the receptor, 
however, it was interesting as it also internalised the receptor for increased periods 
of time compared to the parent CCL5 chemokine. In the drive to develop HIV 
inhibitors of even higher potency, several other ligands were developed, including 
PSC-CCL5. This ligand had increased potency against CCR5 sequestering it for 
longer periods of time (Pastore et al., 2003; Sabbe et al., 2001).
The functional and biochemical effects generated by CCL5 within human T cells 
has been contradictory. Some studies demonstrate functional responses in freshly 
isolated T cells, while others have displayed a response profile which indicates that 
activation of the cell is required (Bleul et al., 1997; Loetscher et al., 1996b; Turner et 
al., 1995). Within this study we re-investigate the role of CCL5 and its derivatives 
on T cell responses and clarify the functional responses.
1.8 Chemokine Signal Transduction Pathways
The binding of a chemokine and subsequent activation of G-proteins initiates a 
variety of signalling pathways that result in functional responses. Discussed below 
are some important downstream signalling cascades that may be triggered.
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Phosphoinositide Metabolism
1.8.1 Phospholipase C/Protein Kinase C cascade
The Phospholipase C/Protein Kinase C (PLC/PKC) cascade has been 
demonstrated to be activated downstream of chemokine receptors (figure 1.13). 
The role PLC plays, like PI3K, is critical in the modulation of phosphoinositides at 
the plasma membrane. PLC isoforms (p, y, 6, and the relatively newly identified e, £ 
and n) are a family of membrane bound enzymes that utilize Ptdlns(4,5)P2 as its 
substrate (Harden and Sondek, 2006; Katan, 2005). Following activation of PLC, 
Ptdlns(4,5)P2 is hydrolysed into 2 second messengers; Diacylglycerol (DAG) and 
inositol triphosphate (IP3) (Cicchetti et al., 2002).
The production of IP3 results in mobilisation of intracellular calcium mobilisation via 
interaction of IP3 with its receptor. Following the rise of intracellular calcium, Ca2+ 
ions from the extracellular space enter the cell through calcium release-activated 
channels (CRAC) channels (Fomina et al., 2000; Luik et al., 2006; Luik and Lewis,
2007). The activation and opening of these channels is thought to be directly 
related to the reduction of calcium within the intracellular stores (such as the 
endoplasmic reticulum). The components which facilitate this process are known 
as STIM1 (stromal interaction molecule 1) located within the ER, which functions as 
the calcium sensor and ORAI1 a functional component of the CRAC channel 
(Feske et al., 2006; Roos et al., 2005). It is postulated that the depletion of calcium 
from intracellular stores, triggers a redistribution of STIM1 from a diffuse distribution 
to a focal point near the plasma membrane. This redistribution facilitates the 
interaction with the CRAC channel and refilling of the intracellular stores (Luik et al., 
2006). DAG being highly lipophilic remains within the membrane recruiting PKC 
from the cytoplasm to the cell membrane, directly activating cPKC and nPKC.
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Figure 1.13 PLC/PKC cascade. Upon T cell receptor (TCR) engagement, Lck (a 
member of the Src family of protein tyrosine kinases) phosphorylates immunoreceptor 
tyrosine-based activation motifs (ITAMs) contained within the cytoplasmic domains of the 
chains of the CD3 complex. Subsequently, ZAP-70 (a member of the Syk family of kinases) 
is recruited by its Src homology-2 (SH2) domains, binding to the phosphorylated ITAM sites. 
Activated ZAP-70 propagates signal transduction through the phosphorylation of 
downstream targets including the adapter molecules LAT and SLP-76. These adapters, or 
following chemokine stimulation the dissociated G(3y subunits, in turn, facilitate 
phospholipase C-gamma 1 (PLC-y1) activation, resulting in the cleavage of 
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] to inositol 1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG). IP3 triggers calcium mobilization, which leads to activation of nuclear 
factor of activated T cells (NF-AT). DAG activates Ras-GRP and protein kinase C theta 
(PKC-0), which in turn leads to activation of the Ras-mitogen-activated protein kinase (Ras- 
MAPK) and nuclear factor kappa-B (NF-kB) pathways respectively.
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PLC(3 is the most abundant PLC isoform within immune cells and a role for this 
isoform in neutrophils has been implemented in many cellular physiological 
functions, such as superoxide formation (Rhee and Bae, 1997; Wu et al., 2000), 
regulation of protein kinases, and calcium efflux. Although no role has been shown 
for PLC in neutrophil chemotaxis, the role of PLC in the chemotaxis of Th2 cells has 
been identified (Li et al., 2000; Cronshaw et al., 2006). This observation has been 
furthered recently with the use of murine models. It was observed that PLC(3 plays 
a prominent role in T cell chemotaxis, and was dependent specifically on the 
production of IP3 and the subsequent rise in intracellular calcium and not the 
activation of PKC (Bach et al., 2007). These studies highlight the distinct 
differences that are observed following chemokine stimulation in neutrophils and T 
lymphocytes.
The PKC family of serine/threonine protein kinases is composed of has 9 members, 
split into 3 subgroups, determined on their structure and function (Parker and 
Murray-Rust, 2004). Conventional PKC (cPKC) formed of a, p, y show DAG 
sensitive calcium responsiveness. Novel PKCs 5, e, r), 0 are DAG sensitive and 
calcium insensitive while atypical PKCs A have altered C1 domains and are not 
DAG or calcium sensitive (table 1).
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Class Isoforms Requirem ents for activation
cPKC a.p .Y
o Caz+-dependent
o Activated by DAG in presence of PS
nPKC 5, e, n. 0
o Caz+ -insensitive 
o Activated by DAG in presence of PS
aPKC CA
o Caz+ -insensitive 
o Do not respond to DAG 
o Regulated by PS
In vitro PKC can be activated independently of cell surface receptors with the 
use of phorbol esters such as PMA, (PMA cannot distinguish between the 
different PKC isoforms) resulting in a strong, robust activation of the signalling 
cascade (Kazanietz et al., 2000).
Table 1: The PKC family and how they are activated. Activation of cPKC and nPKC 
have been shown to be activated or have interaction with DAG, in which DAG or Phorbol 
esters (see information box) act as hydrophobic anchors to recruit the PKC isoforms. PKC 
activation requires a membrane factor in the form of phophatidylserine (PS), and it is the 
presence of DAG that results in an increased affinity for PS. The initial recruitment of cPKC 
is calcium sensitive and therefore helped by IP3 induced calcium release aiding cPKCs 
affinity for PS, however, no equivalent step has been shown for nPKC. This process leads to 
the activation of nPKC and cPKC. APKC are activated at least in part via interaction with the 
Cdc42-GTP-Par6 complex. Optimum activation of all PKCs requires phosphorylation of their 
activation loops (Parekh et al., 2000; Newton, 2003) a process catalysed by 
phosphoinositide-dependent kinase 1 (PDK1), which is recruited to the membrane by PIP3. 
Once membrane bound, the open and activated PKC is capable of phosphorylating its 
substrates.
1.8.2 Phosphoinositide 3-kinase
Phosphoinositide 3-kinase or PI3K is a term used to describe a family lipids which 
are characterized by their ability to catalyse the phosphorylation of the inositol ring 
on membrane bound phosphoinositide lipids (figure 1.14). It is these lipid, 
membrane bound products that are key mediators of intracellular signalling. The 
activation of PI3K has been shown to be regulated by several extracellular signals, 
such as chemokines, cytokines and co-stimulatory molecules (Astoul et al., 2001).
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Figure 1.14 Phcsphorylation of the inositol ring of Ptdlns(4,5)P2 converting it to 
Ptdlns(3,4,5)P3 via the action of PI3K.
The PI3K family can be subdivided into three main classes, according to their 
varying in vivo substrates and structural characteristics (figure 1.15). The class I 
PI3Ks are further subdivided into 2 groups, Class IA family are heterodimers 
comprised of a catalytic 110 kDa protein which is encoded by 3 genes p110a, 
p110(3, and p1105 binding a regulatory adaptor protein known as p85. Activation of 
class 1A isoforms is ultimately dependent on activation of receptor or cytosolic 
tyrosine kinases. It was the initial identification and cloning of a class IA isoform 
that highlighted the role of this family of kinases and as such is the best studied 
class within the PI3K family.
Class IB is comprised of only one member, p 110y. P110y also forms a
heterodimers but varies from the class IA isoforms as it lacks the N-terminus p85 
binding site (Foster et al., 2003), binding instead p101 an adaptor subunit unique to 
p110. Class IB also differs from Class IA as it is regulated via G-protein coupled 
receptors. In vitro class IA and IB isoforms have been shown to catalyse Ptdlns, 
Ptdlns(4)P and Ptdlns(4,5)P2 into their respective products, however, in vivo their 
preferred substrate is Ptd!ns(4,5)P2 which is converted into Ptdlns(3,4,5)P3 
(Vanhaesebroeck and Waterfield, 1999; Fruman and Cantley, 2002). Class III is 
comprised of one member the human homologue of the yeast vesicular protein- 
sorting protein, Vps34 (vacuolar protein sorting 34), which both in vitro and in vivo 
only catalyzes Ptdlns and is thought to play a role in intracellular trafficking events 
(Yan and Backer, 2007).
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Class IA PI3K
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p85 binding 1 Rasbinding ■ C2 •] PIK - [ Catalytic domain*"*"}- Catalytic (pilQg/pllOp. pi 106)
Class IB PI3K
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Class III PI3K
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Figure 1.15 The PI3K family. Class I PI3Ks are heterodimeric enzymes consisting of a 
regulatory and a catalytic subunit. The class IA catalytic subunit is comprised of an N- 
terminal p85 binding domain that binds the p85 regulatory subunit, a Ras binding domain 
that mediates activation by the small GTPase Ras, a C2 domain and Phosphatidylinositol 
kinase homology (PIK) domain. The class IB PI3K catalytic subunit p110^ is similar in 
structure to the class IA catalytic subunits, but lacks the p85 binding domain, instead 
associating with a p101 regulatory subunit The p101 regulatory subunit facilitates the 
interaction between pHO'Y and the PVsubunits of the heterotrimeric G proteins that are 
activated by G-protein-coupled receptors. Class II PI3K are comprised of 3 members and 
are similar to class IB but contain additional PX and C2 domains at the C-terminal. Class III 
is comprised of the single member Vps34. (Taken from (Engelman et al., 2006; Okkenhaug 
and Vanhaesebroeck, 2003)).
Class II PI3Ks are encoded for by three separate genes, PI3K Class II a, (3, and y. 
PI3K Class II a  and (3 are ubiquitously expressed, while class II y is located almost 
exclusively in the liver. The isoforms that comprise this family can, at least in vitro, 
bind phospholipids in a calcium independent manner via a C-terminal domain 
(figure 1.15). An interesting aspect of the class II PI3Ks is that they show distinct 
lipid specificity compared to Class I and Class III PI3K enzymes utilizing, in vitro, 
Ptdlns to Ptdlns(3)P and Ptdlns(4)P to Ptdlns(3,4)P2 (Vanhaesebroeck and 
Waterfield, 1999). Class II isoforms are therefore likely to elicit accumulation of 
lipids with a profile distinct from that stimulated by class I and III PI3Ks. The PI3K 
family has been implemented in an abundance of biological process, such as cell 
survival, proliferation and cell migration.
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Formation of phosphoinositide lipids by PI3K
Within mammalian cells, Ptdlns(3)P occurs constitutively in cells, whereas 
Ptdlns(3,4)P2 and Ptdlns(3,4,5)P3 are found in abundance in stimulated cells, this 
differing expression profile suggests a role for Ptdlns(3,4)P2 and Ptdlns(3,4,5)P3 as 
intracellular mediators (figure 1.16). The activation of PI3K leads to transient 
accumulation of these lipid products at the plasma membrane, which act to recruit 
proteins via there PH domains, such as protein kinase B (PKB), this recruitment 
leads to modification of their activity or subcellular localization triggering a cascade 
of signal transduction throughout the cell culminating in functional responses.
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Figure 1.16 Pathways following formation of phosphoinositide lipids by PI3K.
Chemokine ligation of GPCRs stimulates Class IB PI3K through the actions of G(3y subunts 
and the GTPase Ras. This activation leads to the rapid accumulation of Ptdlns(3,4,5)P3 and 
indirectly Ptdlns(3,4)P2 in the piasma membrane, these 2 lipids then coordinate the 
regulation of several effector proteins by binding directly to the PH domains. Direct effectors 
of this pathway are highlighted; Btk, Vav1, Dock2, PDK1 and AKT.
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1.8.3 Regulation of PI3K - SHIP and PTEN
Of central importance to the tight control of PI3K are the lipid phosphatases SHIP 
(SH2-containing inositol phosphatase) and the tumour suppresser PTEN 
(phosphatase and tensin homologue deleted from chromosome 10) (Rohrschneider 
et al., 2000; Cantley and Neel, 1999; Astoul et al., 2001). These molecules 
modulate PI3K signalling by dephosphorylating the products of PI3K. PTEN is a 3- 
phosphoinositide phosphatase converting Ptdlns(3,4,5)P3 to Ptdlns(4,5)P2 while 
SHIP is a 5-phosphoinositide phosphatase converting Ptdlns(3,4,5)P3 to 
Ptdlns(3,4)P2. These regulatory components are essential for several reasons. 
The PI3K lipid products are essential component in many signalling cascades and 
functional responses, therefore the PI3K regulators ensure the signal propagation is 
generated without overstimulaton of the system, and the location of these 
molecules is essential for their function, as highlighted in figure 1.17. PI3K has 
been shown to be involved in the migratory responses of certain cell types. Within 
resting cells, PI3K is cytoplasmic, generating little product within the cell, this is 
aided by the location of PTEN at the plasma membrane. Following stimulation, 
PI3K is translocated to the leading edge of the cell while PTEN is delocalised from 
this area, promoting the generation and maintenance of lipid products at the leading 
edge. Furthermore, PTEN localises at the sides and rear of the cell acting to 
dephosphorylate PI3K products, further maintaining the polarised shape.
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Figure 1.17 Regulation of PTEN and PI3K induces cell polarization in 
response to a chemoattractant signal. A) In un-stimulated cells, class I PI3K is 
mainly cytoplasmic, whereas PTEN is localized at the plasma membrane. B) When cells 
sense the chemoattractant signal, a signalling pathway yet to be identified promotes the 
rapid PI3K translocation to the leading edge facing the high chemoattractant concentration 
and the delocalization of PTEN from the leading edge. C) Ptdlns(3,4,5)P3 recruits and 
activates at the leading edge Rho GEF proteins and other PH domain-containing proteins, 
the activity of these proteins is important to stimulate the actin polymerization necessary for 
cell motility (adapted from (Merlot and Firtel, 2003)).
P I3 K , actin, 
P H -dom a in  
proteins
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1.8.4 Assessing the role of PI3K
There are several methods which can be utilised in order to assess the role of a 
particular gene. Here we shall describes the techniques which can be used and 
highlight the advantages and disadvantages of using these methods. The tools 
used to elucidate gene function can be thought of in terms of a spectrum. At one 
end of the spectrum are antibodies/inhibitors used to block function, these 
molecules are utilized following expression of the protein and modify the effects of 
the protein via binding. At the other end of the spectrum is the use of 
knockout/knockin animal models, where the protein is not transcribed and therefore 
the protein is not formed. Between these 2 extremes is the recent development of 
RNA interference which provides alternative to these methods, in which the specific 
isoform of interest is transcribed but degraded before generation of the protein.
1.8.4.1 Pharmacological intervention
Investigations into the PI3K family and the contribution towards leukocyte 
navigation mechanisms, has been achieved with the use of pharmacological 
inhibitors. The most widely used PI3K inhibitors are Wortmannin and LY294002, 
these are two chemically unrelated compounds that act as irreversible and 
reversible inhibitors of the ATP binding site (respectively). These broad spectrum 
class I PI3K inhibitors that have been invaluable in implementing a role for PI3K in 
the chemotactic responses of leukocytes. Pre-treatment of murine T and B 
lymphocytes or freshly isolated human T cells with LY294002 or wortmannin show a 
requirement for PI3K in optimal chemotaxis towards lymphoid chemokines (Reif et 
al., 2004; Sotsios et al., 1999). Wortmannin has been shown to decrease the 
number of human neutrophils which polarise and undergo locomotion induced by 
chemotactic peptides (Niggli and Keller, 1997), while the use of the specific class I 5 
inhibitor IC87114, suggests a link between p1105 and murine and human neutrophil 
tethering and chemotaxis (Sadhu et al., 2003; Puri et al., 2004). Other work has 
previously shown that activation of PI3K by the chemokine CCL22 is a dispensable 
signal for the chemotaxis of Th2 cells, suggesting that the contribution of PI3K in 
chemotaxis may be determined by the chemokine/receptor coupling (Cronshaw et 
al., 2004). However, the use of these inhibitors is limited as they target the whole
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PI3K family and not individual isoforms. This leads to many cellular processes 
being attributed to the PI3K family, but confusion over which isoforms contribute to 
a particular cellular function. Curiously, investigations into the specificity of 
LY294002 and wortmannin, have suggested that they may in fact have little 
specificity for the class II isoforms leading to question if the biological importance of 
these family members may have previously been underestimated within these 
models.
A recent and exciting development in the field of PI3K research has been the 
development of isoform specific inhibitors. Although in the early stages of research 
these inhibitors are already starting to contribute to our knowledge on isoform 
specific function. PI-103 has been noted as PI3K class la inhibitor and has 
demonstrated a role for PI3Ka in insulin signalling (Knight et al., 2006). IC87114 
and AS605240 the PI3K 6 and y selective inhibitors highlighted a role for these 
isoforms in neutrophils trafficking (Puri et al., 2004; Camps et al., 2005).
The advancement in the specificity of PI3K inhibitors allows the dissection of the 
roles of the PI3K family members. A recent study highlighted that the 
imidazopyridines (e.g. PI-103) preferentially targets PI3Ka, the chromones (e.g. 
TGX-121) preferentially target PI3K0/PI3K5, quinazolinone purine inhibitors (e.g. 
IC87114) selectively target of PI3K5, and the thiazolidinediones (AS605240) 
preferentially target PI3Ky (Table 2).
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Class 1PI3K Isoforms Class II 
Isoforms
a P Y 5 C2a C2p
PI-103 0.008 0.088 0.15 0.048 ~1 0.026
TGX-121 >5 0.05 >50 0.05 ND ND
IC87114 >200 16 61 0.13 >100 >100
AS605240. 0.06 0.27 0.008 0.3 ND ND
LY294002 0.72 0.31 1.3 7.3 19 6.9
Table 2: IC50 values (|jM) for isoform-discriminating PI3K inhibitors. Values are 
based on in vitro assays of inhibitor activity against purified protein activity (Knight et al., 
2006; Camps et al., 2005; Domin et al., 1997).
1.8.4.2 Genetic approaches
It cannot be underestimated the contribution that knockout and knockin murine 
models have played in furthering our knowledge and elucidating the function of 
particular isoforms within a given family, the PI3K family is no exception (reviewed 
figure 1.18). There are 2 possible ways in assessing this information, firstly, the use 
of knockout models in which the isoform or gene of interested is target and not 
expressed within the cell, secondly is the kinase dead or knock in models, in which 
point mutations within the gene of interest are generated, resulting in the 
transcription of the isoform and production of protein, yet it provides no functional 
signals. On a cautionary note, there is difficulty in interpreting isoform specific data 
from knockout models due to compensatory mechanisms in protein expression of 
other PI3K isoforms or subunits. Generation of kinase dead or knockin models 
have overcome this by maintaining protein stoichiometery. Reviewed below is the 
data generated by the use of these 2 models and the functional roles that can be 
attributed to these isoforms.
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Viability Immunological phenotype References
p110a KO Embryonic
lethal
Not applicable (Bi et al., 1999)
p i io p KO Embryonic
lethal
Not applicable (Bi et al., 2002)
p1106 KO Viable Decrease in neutrophils 
tethering and trafficking across 
inflamed venules. B cell 
numbers and proliferation 
decreased.
(Puri et al., 2004; 
Jou et al., 2002; 
Clayton et al., 
2002)
p1106 Kl Viable Decrease in neutrophils 
chemotaxis and PIP3 
production. B cell numbers 
and proliferation decreased. 
Decrease in T cell 
proliferation.
(Okkenhaug et al., 
2002)
p110y KO Viable B cells not affected. Impaired 
in vivo & in vitro chemotaxis of 
neutrophils and macrophages. 
Decrease in proliferation of T 
cells
(Hirsch et al., 
2000; Li et al., 
2000; Rodriguez- 
Borlado et al., 
2003)
p110Y Kl Viable Decrease of in vivo & in vitro 
chemotaxis
(Patrucco et al., 
2004)





Class II p KO Viable Wound healing in the 
epidermis unaffected
(Harada et al., 
2005)





Figure 1.18 Phenotypes of mice that have PI3K catalytic subunits genetically 
targeted (Adapted from (Vanhaesebroeck et al., 2005)).
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Data from p110y knockin models both in vivo and in vitro show chemotaxis is 
severely affected (Patrucco et al., 2004). Further studies have indicated that the 
class I y knockout model demonstrates reduced infiltration of immune cells such as 
neutrophils and macrophages into the peritoneal cavity following E.coli induced 
peritonitis compared to WT controls (Li et al., 2000; Hirsch et al., 2000; Sasaki et 
al., 2000). This data is supported by in vitro observations in which neutrophil 
chemotaxis towards C5a, fMLP and IL-8 is decreased (Hirsch et al., 2000).
It has also been reported that when using knockout animal models there is the 
possibility of functional redundancy between distinct PI3K isoforms 
(Vanhaesebroeck and Waterfield, 1999), while the issue of species variation also 
generates drawbacks when studying this system. It is therefore important, when 
possible, to consider the effect of PI3K isoforms in human cells. The use of siRNA 
technology to specifically target isoforms will be an invaluable tool, not only within 
the elucidation of gene function, but in the application of human cells.
1.8.4.3 RNA interference
One of the problems within knockout models is the issue of functional redundancy 
between the given isoforms, in that, by completely knocking out a particular gene 
other isoforms within this family compensate for this and functionality may be 
artificially driven through other members of the family. This maybe overcome with 
the use of siRNA technology, as knockdown is 80 -  90 % of normal levels, allowing 
background function of the selected isoforms, thus compensatory mechanisms by 
other isoforms within the same family may not be activated.
RNA inhibition is a naturally occurring process by which double stranded RNA 
molecules induce the degradation of the corresponding mRNA, thus inhibiting 
mRNA translation. Gene silencing of target messenger RNA, termed RNA 
interference (RNAi), has been used within research for many years, being exploited 
initially in plants with post transcriptional gene silencing, followed in the late 1990s 
in invertebrates such as C. elegans. However, it was the switch into the 
mammalian system which posed the biggest problem, as introduction of long double 
stranded RNAs into mammalian cells initiate an interferon response leading to
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global protein inhibition (Bass, 2001). In 2001, this was overcome with the use of 
small double stranded RNA molecules (21-23 base pairs) (figure 1.19) which were 
utilized to decrease target mRNA levels correlating to a decrease in protein 
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Figure 1.19 Schematic representation of siRNAs mediating complementary 
mRNA degradation. Long dsRNA are introduced into the cell and are cleaved by 
enzymes known as Dicer, into siRNAs of 21-23 nucleotides in length. These siRNAs are 
then incorporated into RISC complex where the two strands are unwound, allowing one 
strand to bind to complementary mRNA within the cells. The mRNA is then cleaved and 
degraded by nucleases, with the RISC free to bind further siRNAs. Abbreviations dsRNA, 
double stranded RNA, siRNA, short interfering RNA, RISC, RNA-induced silencing complex. 
(Adapted from (Sioud, 2004)).
RNA interference is based on the principle that only targeted genes are down 
regulated. Most studies performed using siRNA, focused on the target gene and 
several additional genes, yet recent data suggests that care must be taken as off 
target effects may be seen. Off target effects are genes within the cell of interest 
which may show similar sequence homology to the target gene and as such are
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targeted indirectly by the introduction of the siRNA. Jackson et al. showed that 
following a genome-wide analysis of the efficacy and specificity of siRNAs, off target 
effects are seen and that both the sense and anti-sense strand may contribute to 
mRNA silencing thus enforcing the need for well designed siRNAs. Reducing the 
effects of off target mechanisms and interferon responses can be achieved by the 
use of selective, potent siRNAs, reducing the amount of siRNA required for the 
same knockdown of the target gene thus reducing the possibility of off target 
effects.
Several methods of delivery can be used to facilitate the entry of siRNA into a cell in 
vitro. Lipid based carriers and viruses have been utilized with varying success 
rates, however, a novel non-viral technique termed Nucleofection has also been 
developed. This technique is based on electroporation and has been shown to 
have high transfection rates in hard to transfect primary cells and cell lines. In vivo, 
one of the current obstacles in delivery of siRNA is targeting the tissue/cell of 
interest. Unless a siRNA can be designed to specifically target a tissue/cell of 
interest, systemic delivery will only increase off target effects and result in 
detrimental knockdown in other tissues. Currently, where possible, direct 
application of the siRNA onto the tissue of interest is reducing off target effects, the 
drawback is this restricts the number of tissues that can be targeted by this 
technology. Direct application of siRNAs onto mucosal membranes have been 
shown to be particularly susceptible to uptake of siRNA explaining why the lung has 
shown some of the most successful applications of siRNA technology in vivo.
1.8.5 PI3K and its Downstream Effectors
As discussed, ligation of chemokine receptors leads to the activation of the PI3K 
family. This activation has been linked to the triggering of a diverse array of cellular 
responses, such as cell survival, mitogenesis, membrane trafficking, glucose 
transport, membrane ruffling, superoxide production as well as actin polymerisation 
and chemotaxis (figure 1.20). A number of cellular proteins have been identified 
that bind the products of PI3K via their lipid binding domains (known as pleckstrin 
homology (PH) domains), and some of these will be considered here.
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Figure 1.20 Downstream targets and functions of PI3K. Phosphatidylinositol (3,4,5)- 
trisphosphate [Ptdlns(3,4,5)P3] recruits proteins that contain a pleckstrin homology (PH) 
domains to the plasma membrane, these direct effectors of Ptdlns(3,4,5,)P3 including 
protein kinase B (PKB), phosphoinositide-dependent kinase 1 (PDK1), guanine nucleotide 
exchange factors (GEFs), protein tyrosine kinases of the Tec family and phospholipase Cy 
(PLC-y). These signalling cascades subsequently activate; protein kinases such as MAPK, 
PKC, GSK3, mTOR and small GTPases and many more. These integrated signalling 
cascades have roles in secretion, movement, adhesion, contraction and apoptosis.
1.8.5.1 Protein Kinase B
One of the core molecules phosphorylated by the activation of PI3K is the 
serine/threonine kinase, Protein Kinase B (PKB, also known as AKT (Burgering and 
Coffer, 1995)) which is recruited to the plasma membrane via its PH domain by 
Ptdlns(3,4,5)P3. It has 3 known members PKBa, PKBp and PKBy which display 
close homology within their kinase domains to the protein kinases A, G and C and 
thus collectively form the AGC kinase family (Manning and Cantley, 2007). 
Although the exact mechanism of activation has not yet been fully elucidated, the 
events that are thought to occur are discussed here and depicted in figure 1.21.
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Figure 1.21 The proposed mechanism of activation of PKB/AKT and its 
downstream effectors. PTO for figure legend.
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Figure 1.21 The proposed mechanism of activation of PKB/AKT and its 
downstream effectors. A) -1) The production of Ptdlns(3,4,5)P3 by the action of PI3K at 
the plasma membrane results in the recruitment of PKB via its PH domain. 2) This binding 
allows a conformational change in PKB facilitating its phosphorylation by PDK1 at position 
Thr308 on the kinase domain. Phosphorylation by the rictor-mTOR complex at the Ser473 
site, in the hydrophobic domain completes this activation. 3) The now active PKB 
translocates into the cell. B) Supporting the role of PKB/AKT as a core signalling molecule is 
the array of downstream effectors that are regulated by the action of this kinase. Displayed 
are an example of these effectors and the subsequent cellular processes that are mediated 
through these interactions. (Arrows indicate activation and blocking arrows indicate 
inhibition. Taken from (Manning and Cantley, 2007)). C) The signal transduction pathway 
linking AKT to S6 signalling. Biochemical studies have shown that activated Akt 
phosphorylates TSC2, part of the TSC1/TSC2 protein complex leading to its inactivation. 
TSC1/TSC2 displays a GTPase activating property for the Rheb GTPase and activated 
Rheb activates mTOR, leading to the subsequent phosphorylation of S6 through the action 
of S6 kinase.
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Phosphorylation of PKB occurs via two key sites, Thr308 within the kinase 
activation loop and Ser473 in the hydrophobic region of the C-terminal regulatory 
domain (Toker and Newton, 2000). Modulation of PKB activation is dependent on 
active PI3K which produces Ptdlns(3,4,5)P3 at the plasma membrane, resulting in 
the recruitment of PKB via its PH domain. Once at the membrane it is suggested 
that PDK-1 (Phosphoinositide-dependent kinase-1) mediates the phosphorylation of 
the Thr308, while the rictor-mTOR complex directly phosphorylates PKB on the 
Ser473 in the hydrophobic region of PKB (Sarbassov et al., 2005). Both of these 
residues must be phosphorylated to induce the full activity of PKB. Following full 
activation, PKB is released into the cytoplasm where is translocates through the cell 
to the site of action. The regulation of PKB activation is controlled by the 
dephosphorylation of Ptdlns(3,4,5)P3 by the cellular phosphatase SHIP. The 
decreased levels of Ptdlns(3,4,5)P3 at the membrane lead to PKB remaining 
inactive in the cytoplasm (Stambolic et al., 1998).
Chemokines have been shown to activate the PI3K family, and the subsequent 
phosphorylation of PKB is therefore a downstream biochemical signal generated 
from this stimulation. Within biochemical studies, the phosphorylation of PKB and 
its subsequent activation can be utilized via immunoblotting as in indirect method to 
assess PI3K activation.
The activation of PKB has been demonstrated to phosphorylate a number of 
downstream proteins, particularly those involved in the regulation of glucose 
metabolism and cell survival such as GSK-3 (Wymann et al., 2003). Further 
downstream pathways include mTOR which is discussed in further detail below. A 
clear role for PKB within chemotaxis has emerged in the mould Dictyostelium 
however the role PKB plays within mammalian cell chemotaxis is still being 
investigated (Meili et al., 1999).
1.8.5.2 S6
S6 kinase is a component of the PI3K / mTOR pathway. PI3K has been shown to 
be a crucial regulator of S6 kinase, which in turn phosphorylates the ribosomal S6
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protein, by measuring the phosphorylated form of the S6 protein, we have an 
indirect method of measuring PI3K activity.
S6 phosphorylation has important implications in chemotaxis and also has been 
found to be the rate limiting step in protein synthesis, allowing cells to pass through 
Gi (Richardson et al., 2004). Additionally, S6 kinases are under the tight control of 
the mammalian target of Rapamycin (mTOR). In fibroblasts, activated mTOR has 
been found to be enriched within the actin arc, (formation of which has been linked 
to migration), suggesting that the PI3K / mTOR pathway is important chemotaxis 
(Berven et al., 2004). Neutrophil chemotaxis and chemokinesis induced by GM-CSF 
(granulocyte-macrophage colony-stimulating factor) is prevented by pre-treatment 
with the immuno-suppressant rapamycin; rapamycin specifically binds to and 
inhibits mTOR (Gomez-Cambronero, 2003) suggesting this pathway plays a critical 
role within both chemotaxis and chemokinesis. Although a clear role for mTOR has 
been observed in neutrophils, the role that this molecule plays in T cell chemotaxis 
has not been elucidated.
1.8.6 Tyrosine kinases
1.8.6.1 The JA K /STA T pathway
It has been well documented, via the use of mutant cell lines and knock-out mice, 
that the cytokine family can induce the activation of the JAK/STAT pathway (Janus 
kinase / signalling transducer and activator of transcription). However, it was not 
until the mid-nineties that a G-protein coupled receptor (GPCR) was shown to 
induce this activation and since this time several reports have suggested 
chemokines may also activate this pathway (Marrero et al., 1995; Soriano et al., 
2003).
The JAK family, are non-receptor tyrosine kinases which are comprised of four 
members, JAK1, JAK2, JAK3 and Tyk2 (Tyrosine kinase 2). Each member 
includes 2 kinase domains known as JAK homology (JH) domains, or JH1 and JH2, 
the first of these domains is thought to infer kinase activity, although both are 
required for full activation. The remaining domains JH3-7 are thought to aid
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receptor binding (Schindler, 1999). STATs are monomeric, cytosolic proteins which 
are recruited to, and activated at the plasma membrane, acting as the substrate for 
JAK family members. Their family comprises of 7 members, STAT1,2,3,4,5a,5b 
and 6, which can be specifically recruited depending on the activated JAK proteins.
Signalling via chemokine receptors has been suggested to activate two different 
pathways, firstly via heteromeric G-proteins and secondly the Jak/STAT pathway. 
Mueller and Strange used pertussis toxin (PTX) a Gj inhibitor and AG490 to inhibit 
JAK2 and showed that the pre-incubation with either inhibitor followed by CCL3 
activation has no effect on the other pathway, suggesting for the first time that 
chemokine receptors could signal via Gr protein and non-Gj-protein pathways 
(Mueller and Strange, 2004).
Compared to cytokine signal transduction the characterisation of the chemokine 
activated JAK/STAT pathway is less well established, however, several reports 
have begun to elucidate this pathway. Activation is initiated via binding of a 
chemokine such as CCL2 to its receptor CCR2, triggering receptor dimerization and 
binding of specific Jaks to the receptor. The subsequent activation of JAK is rapid 
and promotes tyrosine phosphorylation of the receptor (Schindler, 1999). 
Signalling molecules, such as the STAT family members which contain Src 
homology 2 (SH2) domains are then recruited to the plasma membrane. 
Subsequent activation by receptor bound Jaks via phosphorylation of a single 
tyrosine residue is followed by the release, homodimerisation and translocation to 
the nucleus. In the nucleus STATs can bind promoter elements which regulate 
gene expression.
The first chemokine characterised to signal through this pathway was CCL2 (MCP1) 
binding to its receptor CCR2, resulting in the dimerisation of CCR2 and the 
subsequent binding of Jak2 facilitating the activation of STAT 3 (Mellado et al., 
1998). Following this, several chemokines have been shown to signal through the 
Jak/STAT pathway. In the human progenitor cell line (CTS) CXCL12 was shown to 
binds to its receptor CXCR4 and induce the tyrosine phosphorylation of Jak1, Jak2 
and TYK2, leading to the activation of STAT2 and STAT4 (Zhang et al., 2001). 
CCL5 induces the rapid phosphorylation of Jak2 and Jak3 via CCR5 in the T cell
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line, PM1. CCL5 and CCL3 (macrophage inflammatory protein -1a) have also been 
shown to activate STAT1 and STAT3 in the Jurkat cell line.
In contrast to previous reports, Moriguchi et al use genetic approaches to suggest 
that signalling of CXCL12 through the receptor CXCR4, is independent of Jak2 and 
Jak3 (Moriguchi et al., 2005). They attribute this discrepancy to the use of 
pharmacological tools which are not potent Jak inhibitors and show low specificity 
between the Jak family (Changelian et al., 2003). Therefore there is a cautionary 
note, as although the role of Jaks could not be ruled out completely, their role in 
chemokine signalling may not be as assured as first thought.
1.8.6.2 Tec kinases
The Tec family are non-receptor tyrosine kinases which are found within T cells and 
provide an essential signalling cascade. The family is comprised of 5 members; 
Tec, Btk, Itk, Rlk and Bmx but only Itk, Rlk and Tec are expressed in T cells. In 
recent years the role of Itk or IL-2 inducible T cell kinase has generated interest due 
to its role in T cell development, T cell effector function, actin regulation and cell 
adhesion (Berg et al., 2005).
Activation of these family members is downstream of several different receptors, the 
TCR, chemokine receptors and cytokine receptors (figure 1.22). In the case of ITK, 
the inactive form is cytoplasmic and in a folded state due to intramolecular bonding, 
prohibiting the binding of ITKs natural ligands. ITK is recruited via its PH domain to 
the plasma membrane by the action of PI3K generating Ptdlnd(3,4,5)P3. 
Phosphorylation by Lck initiates full activation of Itk by subsequent 
autophosphorylation, through scaffolding proteins such as SLP-76, ZAP-70 and 
LAT. PLCy and Itk are brought into close proximity allowing Itk to phosphorylate 
and activate PLCy (the action of PLC on its downstream effectors is discussed 
above) (Qi and August, 2007).
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Figure 1.22 Signalling through Tec kinases. Binding of ligands to receptors such as 
the TCR, cytokine receptors and chemokine receptors trigger activation of Tec kinases. Itk, 
Rlk and Tec are expressed within T cells and each regulate downstream signalling cascade. 
RTK, receptor tyrosine kinases; TLR, Toll-like receptors (Taken from (Gomez-Rodriguez et 
al., 2007)).
TCR stimulation elicits responses such as proliferation and cytokine production. 
Murine T cells deficient in Itk'7 Rlk'A have further highlighted roles for these kinases 
downstream of the TCR, as these cells display diminished responses, including 
decreased IL-2 production and T cell proliferation, these responses are most 
critically observed in the double knockouts however, single knockout of Itk"7' or Rlk 7' 
generate moderate and minimal effects respectively (Schaeffer et al., 1999).
Further to the observations, Tec kinases are also activated downstream of 
chemokine receptors. Fischer et al demonstrated that Itk is recruited to the 
membrane in a PI3K and pertussis toxin sensitive manner following sitmulation with 
the chemokine CXCL12 (Fischer et al., 2004). This data is extended with the 
observation that CXCL12 mediated chemotaxis is decreased in Itk'7' deficient T 
cells.
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1.8.7 Guanine nucleotide binding proteins: the Ras superfamily of 
small GTPases
Guanosine Triphosphateses (GTPases) are another family of molecular players that 
are shown to be activated downstream of PI3K. Once activated, these molecules 
relay extracellular signals to downstream effectors, producing a number of cellular 
responses, in particular cytoskeletal and membrane rearrangements required for 
cell movement (Hawkins et al., 2006). The Ras superfamily of small GTPases are 
divided into 5 families, Ras, Rho, Rab, Ran and Arf based on their sequence and 
functionality. Here we shall discuss some of the important members of these 
families. These monomeric G-proteins are known as the molecular switches of the 
cell and are seen in many signalling cascades. GTPases and can be found in two 
forms, in their active state they are bound to GTP and following hydrolsis of GTP, in 
their inactive state, bound to GDP. Both forms show similar conformations but 
have significant differences in their ability to recognise specific domains (Shields et 
al., 2000).
To fully appreciate the role of GTPases, it is essential to understand how these 
molecules are regulated. In the case of the GTPase family this is through the 
regulating properties of guanine-nucleotide-exchange factors (GEFs) and GTPase- 
activating proteins (GAPs). GTPases contain a low level of intrinsic GTPase 
function converting GTP to GDP, however, this is further controlled by GEFs and 
GAPs. Rho and Rab GTPases also have a further level of regulation; guanine 
nucleotide dissociation inhibitors (GDI) (DerMardirossian and Bokoch, 2005). For 
all GTPases, activation via GEFs can facilitate the conversion of GDP to GTP thus 
activating the GTPases. In their active state GTPases can now bind to and activate 
downstream effectors. GAPs complete the cycle by increasing the intrinsic GTPase 
activity, allowing rapid conversion back to the GDP bound inactive state. For Rho 
and Rab subfamilies the GTPases are cytosolic and bound to GDIs preventing the 
action of GEFs, therefore maintaining the GTPases inactive state (Bishop and Hall, 
2000; Boguski and McCormick, 1993). Following dissociation from the GDI, Rho 
GTPases insert into the plasma membrane, interact with GEFs and are 
subsequently activated (Robbe et al., 2003).
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1.8.7.1 Ras Family
Ras Sarcoma oncoproteins is family comprised of Rap, Ras, Ral and Rheb, which 
can be activated by GEFs, of which the 3 main classes are Sos (Son of Sevenless), 
Ras-GRF (Ras guanine nucleotide releasing factor) and Ras-GRP (Ras guanine 
nucleotide releasing protein). The best characterised pathway within this family is 
the activation of the Ras GTPases and the subsequent MAPK signalling cascade, 
which shall now be discussed.
Mitogen-activated protein kinase
The mitogen-activated protein kinases (MAPK) pathway, is comprised many 
different subfamiles, the best known of these are ERK (extracellular signal- 
regulated kinase), JNK (c-jun-NH2-terminal kinase) and the p38 MAP kinases, all of 
which play a role in signal transduction from the plasma membrane to the nucleus. 
Although in resting cells MAPKs largely reside in the cytoplasm, following activation 
these molecules have the capacity to phosphorylate nuclear substrates such as 
protein kinases, cell cycle regulators and transcription factors. The activation of 
MAPKs follows a cascade of subsequent phosphorylation via protein kinases, 
namely MAPK kinase kinase and MAPK kinase (figure 1.23). There are numerous 
different kinases involved at each tier of this process, with each being differentially 
regulated through G-proteins, scaffolds, adaptors, substrates and regulator 
proteins. These subfamilies have been implemented in cellular functions such as 
cell proliferation, differentiation, development, the inflammatory response and 
apoptosis (Weston and Davis, 2007).
ERK
ERK is the classical MAPK and is the most well known member of this family. Its 
activation is in response to stimulation via receptor tyrosine kinases, GPCRs, 
cytokine receptors and integrins. This stimulates the recruitment of the small 
GTPase Ras, which in turn activates the serine/threonine kinase Raf, a MAPK 
kinase kinase triggering this signalling cascade. Phosphorylation of ERK 1/2 is 
catalysed by the upstream kinases MEK 1 or MEK 2, (MAPK kinase). Upon 
activation ERK1/2 homodimerize, and translocate to the nucleus where they 
activate additional kinases and transcription factors (Kolch, 2005).
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The action of CXCL12 on the receptor CXCR4, has been shown to activate the 
MAP kinase pathway, in particular the ERK 1/2 response. The involvement of this 
pathway in chemotactic responses has been provided by the use of the MEK1/2 
pharmacological inhibitor PD098059, which has been shown to partially in inhibit 






















Figure 1.23 Schematic representation of the structure of MAPK pathways.
Each MAP kinase family member; p38, JNK and ERK1/2 is activated by successive 
activation of a MAPK kinase kinase and MAPK kinase.
Rap1
Rap1 is the closest homolog to the Ras GTPase and over recent years has gained 
increasing interest due to its role in cell adhesion. It has been shown that 
chemokines in particular CXCL12 and SLC (secondary lymphoid chemokine) can 
induce Rap1 mediated signals that regulate integrin activation and 
transendothethial migration (Shimonaka et al., 2003). Furthermore, murine models 
and human T cells have been shown to be dependent on Rap1 for chemokine and 
PMA induced LFA-1 activation, an integrin essential for the transmigration of cells 
across endothelium (Ghandour et al., 2007 in press).
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1.8.7.2 Ras Homologous Family
Ras Homologous (Rho) family have also been shown to be key regulators of 
chemokine mediated signalling that induce actin organization, cell cycle and gene 
expression. This family is comprised of over 20 members the most well studied 
being Rho, Rac and CDC42 which in regard to actin reorganisation, result in distinct 
filamentous actin structures (Wennerberg et ai., 2005). In order to ensure efficient 
signalling and control, these GTPases are regulated at multiple points through the 
signalling cascade, control through GEF and GAP, regulation of cellular location 
and expression levels (figure 1.24).
Rho
The activation of Rho to promote stress fibre formation and focal adhesion 
assembly has been found to be dependent on activation of both Rho kinase/ROCK 
(Rho-associated coiled-coil forming kinase) a serine/threonine protein kinase and 
mDia. Phosphorylation of the myosin light-chain phosphatase via Rho inhibits 
dephosphorylation of the myosin light chains and increasing myosin II activity and 
stress-fibre formation and contractility. Activation of mDia allows binding to the 
barbed ends of the actin filament enhancing elongation and blocking binding of 
capping proteins (Riento and Ridley, 2003; Watanabe et al., 1999). The action of 
Rho and ROCK at the rear of the cell regulates the assembly of contractile actin 
and myosin. This has been demonstrated to play a key role in both actin assembly 
and contractility, mediating uropod retraction, an essential role in migrating 
leukocytes. In comparison the polymerization of actin and production of 
lamellipodia and filopodia by Rac and Cdc42 is provided at the front or leading edge 
of the cell.
Rac
Rac1 has been demonstrated to be involved in lamellipodium extension, following 
the ligation of chemokine receptors; inhibition of Rac prohibits cell migration. 
Further to these actin dependent process, Rac has also been shown to be involved 
in translational activation, protein synthesis and cell survival (Etienne-Manneville 
and Hall, 2002). In resting cells Rac is cytoplasmic, yet following activation by 
GEFs (which are the same as for the Ras family, Sos, Ras-GRF and Ras-GRP)
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they are located to the leading edge of the cell and critical in the formation of 
lamellipodium (Kraynov et al., 2000). Although observations are context 
dependent, it has been observed in macrophages that constitutively active Rac has 
the potential to inhibit cellular migration. This process is through lamellipodia 
extension over the entirety of the cell, instead of focused at the leading edge, 
demonstrating a requirement in the neutrophils for gradient sensing and orientation 










Figure 1.24 Control of actin filament assembly by Rho GTPases. The signal 
transduction pathways linking Rho, Rac and Cdc42 to the formation of spatially defined actin 
filaments. Activation of Rho promotes acin polymerization through the activation of mDia, a 
forming-containing protein that binds to the barbed ends of filaments promoting the linear 
elongation. The activation of ROCK phosphorylates and inactivates myosin light-chain 
phosphatase, leading to an increase in myosin II activity, which cross-links actin filaments 
generating a contractile force at the rear of the cell. Rac and Cdc42 are located at the 
leading edge of the cell mediating their action through WASP or Sra-1 respectively. Both 
WASP and Sra-1 act on Arp2/3 which interacts with the sides of pre-existing filaments to 
generate a branched network.
Cdc42
During migration Cdc42 can be located at the leading edge and also at the Golgi 
apparatus, where it is thought that it enables the generation of cell polarity. This 
polarity is thought to be generated via Cdc42s reorientation of the MTOC 
(microtubule-organizing centre) and the Golgi in the orientation of migration. This 
rearrangement of the intracellular environment may lead to cellular polarity through 
the control of secretary and endocytic transport to the leading edge, thus 
maintaining the forward protrusions (Raftopoulou and Hall, 2004). Furthermore this 
GTPase is also required for the promotion of directed production of actin
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microspikes and filopodium formation at the leading edge of the cell. The activation 
of Cdc42 triggers activation of WASP (Wiskott-Aldrich syndrome protein), in turn 
activating Arp2/3 (actin-related protein 2/3) a signalling molecule known to promote 
actin polymerization (Millard et al., 2004).
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1.9 Aims of the Study
PI3K plays a central role within a myriad of signalling cascades and subsequent 
physiological process; as such the dysregulation of this system leads to many 
disease states. Infiltration of immune cells into areas of disease is a characteristic 
process within the inflammation setting and as such elucidating the molecules that 
govern this migration is an essentiai process that may provide effective therapeutic 
targets. Instrumental in this process is not only identifying the families involved but 
also the specific isoforms of which these families are comprised.
Thus far the role of PI3K within T cell migration has not been thoroughly elucidated; 
furthermore the functions of specific isoforms within this family have not been 
clarified. It was hypothesed that individual PI3K isoforms may play a role within 
human T cell migration.
Thus the aims of the project were as follows:
o Utilize pharmacological tools to explore the contribution of the PI3K family 
within freshly isolated and previously activated T cell migration and 
signalling.
o Dissect out the functions of individual isoforms with the use of isoform 
specific inhibitors as well as RNAi strategies, 
o Optimise the delivery of PI3K isoform specific siRNAs utilizing a novel non- 
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Materials & Methods 
2.1 Materials
2.1.1 Cell Isolation and Culture Materials
Cell culture media, RPMI-1640, foetal bovine serum, penicillin and streptomycin, 
trypan blue, and phosphate buffer saline (without Ca2+ and Mg2+) and falcon tubes 
were purchased from GIBCO® (Paisley, UK). Lymphoprep (Ficoll-paque 1.077 g/ml 
density) was purchased from Axis-Shield (Cambridgeshire, UK). Sodium citrate, 
Tween-20, Staphylococcal enterotoxin B and Phytohemagglutinin were purchased 
from Sigma-Aldrich (Gillingham, UK) and Dynalbeads® CD3/CD28 T cell expander 
beads from Invitrogen (UK). CD3+, CD4+, CD8+ isolation kits and LS columns were 
purchased from Miltenyi Biotech (UK) Recombinant human IL-2 was purchased 
from Chemicon (Hampshire, UK). All plastics were obtained from Nunc (UK).
2.1.2 Antibodies
Rabbit polyclonal anti-phospho-S6 ribosomal proteinSer235/236 antibody (catalogue no: 
2211), S6 Ribosomal Protein (5G10) Rabbit Monoclonal Antibody (catalogue 
no:2217) and anti-phospho pKBSer473 (catalogue no: 9271) were purchased from 
Cell Signalling Technologies (UK). Goat polyclonal pan PKB (catalogue no: 
sc1618) was obtained from Santa Cruz Biotechnologies (USA). Fluorescein 
Isothiocyanate (FITC)-conjugated mouse Anti-human CD3 FITC and PI3K class II 
beta antibody were purchased from BD Biosciences (UK). Monoclonal Anti-human 
CXCR3-fluorescein (clone 49801, catalogue no: FAB160F), Monoclonal Anti-human 
CXCR4-fluorescein (clone 12G5, catalogue no: FAB170F), Mouse lgG2a isotype 
control carboxyfluorescein (CFS) conjugated (clone 20102, catalogue no: IC003F) 
and Mouse \gGi isotype control (clone 11711, catalogue no: IC002F) were 
purchased from R&D systems (UK).
2.1.3 Chemokines
Human recombinant CXCL9 (catalogue no: 392-MG), CXCL10 (catalogue no: 266- 
NP), CXCL11 (catalogue no: 672-IT), CXCL12 (catalogue no: 350-NS), were
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purchased from R&D Systems (Abingdon, U.K.). CCL5, AOP-CCL5, and PSC- 
CCL5 were a kind gift from Oliver Hartley, Universite de Geneve.
2.1.4 Assay systems and kits
MACS dead cell removal kit (catalogue no: 130-090-101) was purchased from 
Miltenyl Biotech (UK). Chemo Tx® System was purchased from Neuro Probe 
(Gaithersburg, USA). Human T cell Nucleofector™ Kit was purchased from Amaxa 
Biosystems (Cologne, Germany). Lipofectamine 2000 was obtained from Invitrogen 
(UK). QIAshredder kit and the RNeasy mini kit were purchased from Qiagen (UK). 
Quantitative PCR probes for PI3K class I a (catalogue no: Hs00180679), (3 
(catalogue no: Hs00178872), 8 (catalogue no: Hs00192399), y (catalogue no: 
Hs00176916), PI3KC2a (catalogue no: Hs00153223), PI3KC2J3 probes (catalogue 
no: Hs00153248), class III (catalogue no: Hs00176908), TaqMan® Reverse 
Transcriptase Reagents and TaqMan® Universal PCR Master Mix were purchased 
from Applied Biosystems, (Warrington, UK). Molecular weight Markers were 
purchased from Bio-Rad (UK). The Enhanced chemiluminescence detection kit and 
X-OMAT film were purchased from Amersham International (UK). The 
nitrocellulose membrane, 0.45 pM pore was obtained from BDH, (UK). The filter 
paper used in immunoblotting was obtained from Whatman (Maidstone, UK). 
Marvel was purchased from the local supermarket.
2.1.5 Inhibitors and siRNAs
SiGLO RISC-free siRNA (catalogue no: D-001600-01-05) and targeting siRNAs for 
PI3Ka (catalogue no:D005271 -05,-06,-07 and -08), PI3K|3 (catalogue no: D005272 
-05,-06,-07 and -08), PI3K5 (catalogue no: D005273 -01, -02, -03 and -04), PI3Ky 
(catalogue no: D005274 -01, -02, -03 and -04), PI3KCIIa (catalogue no: D006771- 
01, -02, -03 and -04), PI3KC2II|3 (catalogue no: D006772-01, -02, -03 and -04), 
class III Ptdlns 3-kinase (catalogue no: D005250-05, -06, -07, -08) were purchased 
from Dharmacon (Cramlington, UK). Ly294002 and Wortmannin were purchased 
from Sigma (Poole, UK), PI-103 (patent WO01083456), TGX-121 (patent 
WO0153266), IC87114 (patent WO 0181346) and AS605240 (patent
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W02004007491) have been described elsewhere and were synthesised solely for 
this study.
2.2 Cell Types and Culture Conditions
The focus of this work was to further characterise the signalling and functions 
downstream of chemokine receptors in human T cells. The models used were 
freshiy isolated CD3+, CD4+ and CD8+ T cells and in vitro activated human T cells. 
Furthermore, HeLa cells were utilized to aid validation of the siRNA used within this 
study. All cell lines and primary cells were routinely maintained in their respective 
media supplemented with antibiotics, 10 % (v/v) foetal bovine serum and 
additionally non-essential amino acids for the HeLa cell line, as described in detail 
below. Cells were cultured every 2-3 days as required and maintained at 37 °C and 
5 % C02. Prior to experimental procedures, cell viability was determined using 
trypan blue to stain any dying cells.
2.2.1 HeLa Cells
HeLa cells were obtained from Cancer Research, UK and maintained in 175cm2 
tissue culture flasks in DMEM F12 medium supplemented with 10 % foetal calf 
serum (FBS), 10 % non essential amino acids, 10 u/ml penicillin and 10 pg/ml 
streptomycin (complete media). Cells were grown to a maximum of 1.5 x 106 cells 
and diluted with fresh complete medium to 5 x 105 cells every three days. Cells 
were plated at 5 x 105 / well in a 12-well dish 24 hours prior to siRNA knockdown in 
complete media minus antibiotics. HeLas were maintained in a humidified 
incubator at 37 °C and 5 % C02.
2.2.2 Freshly isolated T lymphocytes and activated T lymphocytes
Routinely within this study freshly isolated human CD3+, CD4+, CD8+ T cells were 
obtained from PBMCs, cultured in vitro and utilized in experimental procedures for 
up to 72 hours. Alternatively, PBMCs were activated in vitro using bacterial 
superantigens, lectins or antibodies and cultured for upto 14 days. Experimental 
procedures were performed between 6-14 days post-activation on CD3+, CD4+ or 
CD8+ T cells.
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2.2.3 Isolation of PBMCs by density gradient centrifugation
Blood was collected from healthy volunteers in heparinised syringes (500 U/50 ml) 
and diluted 1:1 with RPMI 1640 medium. 35 ml of the blood/RPMI mix was then 
carefully layered over 15 ml of lymphopreop in a 50 ml falcon tube before being 
centrifuged at 1,500 rpm at room temperature for 30 mins with the brake off. 
Following centrifugation, the PBMCs as seen in Fig 2.1, which contains the 
lymphocytes and monocytes was swiftly removed (as described previously 
(Cronshaw et al., 2004)). Following removal of the PBMCs the protocol proceeded 





Figure 2.1 Diagram of PBMC separation with Lymphoprep after centrifugation.
The diagram is representative of the separated cell layers observed after centrifugation with 
Lymphoprep.
2.2.4 Ex-vivo activation and clonal expansion of T lymphocytes
Activation of T cells and there subsequent expansion in vitro mimics the in vivo 
activation of a T cell in response to antigen presentation. Within this study, the 
contribution of the PI3K family was investigated in previously activated (in vitro) 
human T lymphocytes. Described here are the methods of in vitro activation used 
within this study. Phytohemagglutinin (PHA) is the most commonly used lectin T cell 
activator of human cells; it functions by acting as a crosslinker of glycoproteins on 
the surface of the T cells inducing activation within the cell. Staphylococcal 
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expressed on professional APC in the PBMC population and acting as a linker for 
subsequently binding the TCR, inducing robust activation of the cell. Finally, 
CD3/CD28 antibodies immobilized on beads mimic the stimulation of T cells by 
APC by binding the TCR and the co-stimulatory molecule CD28. As this method of 
T cell activation is the closest to the in vivo activation this provides the most 
physiologically relevant in vitro J  cell activation method.
Freshly isolated PBMCs were washed 3 times in RPMI-1640 and re-suspended at 1 
x 106 /ml RPMI complete media. Mononuclear cells were activated with 
Phytohemagglutinin (PHA) 5 pg/ml, Staphylococcal Enterotoxin B (SEB) 1 pg/ml or 
CD3/CD28 antibodies immobilized on beads (at a ratio of 1 bead per cell). 
Following activation T-lymphocytes were expanded by addition of IL-2 every 2-3 
days (20 ng/ml) extra complete media was added when required. Cells were 
maintained up to a maximum of 14 days.
2.2.5 Isolation and culture of CD3+, CD4+, CD8+ T lymphocytes
An alternative model to the activated T cell system was the utilization of freshly 
isolated T cells. This model was assessed for its potential use Nucleofection 
delivery of siRNA into T cells to determine the role of PI3K class II isoforms in 
chemotaxis. Furthermore, the role of individual PI3K isoforms were tested after 
obtaining isoform PI3K specific inhibitors.
CD3+, CD4+, CD8+ T lymphocytes were purified using the Pan, CD4+ or CD8+ T Cell 
Isolation Kits (Miltenyi Biotec GmbH). This system is an indirect magnetic labelling 
system, in which untouched cells pass through the magnetic column allowing for 
purified unlabelled cells to be utilized within experimental procedures. For CD3+ 
purification, PBMCs are incubated with a cocktail of biotin-conjugated antibodies 
against CD14, CD16, CD19, CD36, CD56, CD123, and Glycophorin A. For CD4+ 
purification PBMCs are incubated with biotin-conjugated antibodies against CD8, 
CD14, CD16, CD19, CD36, CD56, CD123, TCR y/6, and Glycophorin A. For CD8+ 
purification PBMCs are incubated with biotin-conjugated antibodies against CD4, 
CD14, CD16, CD19, CD36, CD56, CD123, TCR y/5, and Glycophorin A. Following
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incubation with these antibodies cells are subsequently magnetically labelled with 
Anti-Biotin MicroBeads for depletion allowing for a pure population.
The protocol was followed as per manufacturers instructions. Briefly, freshly 
isolated PBMCs were washed 3 times in MACS buffer (phosphate buffered saline 
pH 7.2, 0.5 % BSA and 2 mM EDTA), resuspended in 40 pi of buffer with 10 pi of 
specific Biotin-Antibody Cocktail per 10' total cells and incubated at 4 ’ C for 10 
minutes. 30 pi of buffer plus 20 pi of Anti-Biotin MicroBeads per 107 total cells were 
added and incubated at 4 'C  for a further 15 minutes. Cells were washed once in 
MACS buffer and resuspended in 500 pi. T cells were negatively selected using an 
LS MACS Separator column. Total cells were applied to the column and the 
column washed 3 times with 3 ml buffer (see fig 2.2). The eluted, enriched T cell 
fraction was collected, washed in RPMI and resuspended in RPMI plus 0.1 % BSA 
for use in biochemical and functional assays or resuspended in complete RPMI 
supplemented with or without IL-2 (20 ng / ml) and cultured for up to 3 days.
Figure 2.2: Diagram of CD3+, CD4+ or CD8+ T lymphocyte enrichment by
magnetic separation. The diagram is representative of the magnetically labelled PBMCs 
retained within the magnetic field allowing unlabeled CD3+, CD4+ or CD8+ enrichment 
through negative selection.
2.2.6 Evaluation of T lymphocyte population purity
In order to verify that the purification procedure was successful flow cytometery 
analysis of the percentage of cells expressing CD3+, CD4+, CD8+ was carried out as 
described in the flow cytometery section. Purity was always > 95 %.
Magnetic labelling of non-T lymphocytes
Depletion of non-T lymphocytes
Enriched T lymphocytes
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2.2.7 Freezing/Thawing of cells
For storage, 1 x 106 cells/ml in exponential growth were re-suspended in freeze 
medium containing 10 % dimethylsulphoxide (DMSO), and 90 % foetal calf serum. 
The cell suspension was transferred to cryotubes (1 ml/tube), cooled overnight at 1 
°C/ minute in ethanol to -80 °C and transferred to liquid nitrogen tanks for long-term 
storage. For resuscitation of cells from liquid nitrogen, cells were rapidly defrosted 
for one minute in a 37 °C water bath, washed once in RPMI and re-suspended in 50 
mis complete medium and cultured as stated previously.
2.3 Target specific knockdown of RNA expression using RNA 
interference
Within this study, siRNA was transfected into both primary cells and cell lines in the 
interest of determining specific isoform function and siRNA validation. The siRNA 
is delivered into the cell of interest, then targets and degrades complementary 
mRNA within the cell. The decrease in mRNA can be quantified using qPCR, 
while the functional significance that this knockdown had was assessed primarily 
through chemotactic assays.
Lipid based delivery was used to transfect HeLa cells. The HeLa cell line was 
utilized to provide a ‘high throughput’ screen for siRNA validation (compared to 
cultured human T cells) which was essential for the large number of siRNAs being 
tested against each expressed PI3K isoform. HeLas were ideal for this function as 
they provide high transfection efficiency while maintaining cell viability and strong 
RNA quality, which are essential components when detecting subtle differences in 
target gene knockdown. In comparison to the lipid based methods used in HeLa 
transfections, primary human T cells are notoriously difficult to transfect and 
therefore although lipid and adenoviral methods were assessed, our focus in T 
cells was siRNA delivery via Nucleofection.
Nucleofection is a non-viral technique that is based on the use of electrical 
parameters, much like electroporation, and the use of cell-type specific 
nucleofection solutions. Within this study freshly isolated and previously activated T 
cells a human T cells were used (fig 2.3). Following 72 hours of recovery, the RNA
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was extracted from the cells, and quantified using the Bioanalyzer. Following 
reverse transcription, qPCR was used to analyze the levels of RNA in test samples 
compared to controls.
Freshly isolated T cells Previously activated T cells
Dav 0 Fresh|visolated CD3+
”  cells, Nucleofected 
with targeting siRNA
V
Day 3 Functional assays
performed on viable cells
Dav 0 PBMCs isolated, 
y  stimulated and expanded 
g  in vitro for 6 days
V
H aw  f i Previously activated T 
°  cells, Nucleofected with 
3. targeting siRNA
V
D a v  Q Functional assays uaV performed on viable cells
Figure 2.3: A comparison of timelines in freshly isolated vs. previously 
stimulated T cells.
2.3.1 Lipid based transfection of the HeLa cell line
SiRNA was serially diluted in Opti-MEM® I media minus antibiotics (see figures for 
final concentrations), Oligofectamine™ Reagent was mixed and diluted into Opti- 
MEM® I media minus antibiotic, both were incubated at room temperature for 10 
minutes. SiRNA and Oligofectamine™ dilutions were mixed and incubated at 
room temperature for a further 15 minutes. Cells were washed once in medium 
without serum. 800 pi media minus serum and antibiotics were added to the cells. 
Drop wise the siRNA and Oligofectamine™ Reagent was added to each well. 
Cells were incubated for 4 hours at 37 °C and 5 % C 0 2. Following incubation 
growth medium containing three times serum was added to the cells. Cells were 
incubated for 24 hours, lysed and total RNA was isolated using Qiagen RNeasy kit 
and analysed via Quantitative-PCR, (as described below).
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2.3.2 Lipid based transfection of previously activated human T cells
Previously activated human T cells (1 x 106) were alloquoted into 12 well plates. 
Cy3-tagged siRNA was diluted in complete media minus antibiotics, 
lipofectamine™ 2000 was mixed and diluted into complete media minus antibiotic; 
both were incubated at room temperature for 15 minutes. SiRNA and 
Lipofectamine™ 2000 dilutions were mixed and incubated at room temperature for 
a further 15 minutes. 620 pi media was added per well and 230 pi of 
lipofectamine™ 2000 and siRNA dilution was added to each well drop wise. Cells 
were incubated for 24 hours, and analysed by light and fluorescence microscopy.
2.3.3 Nucleofection of freshly isolated and previously activated human 
T lymphocytes
Freshly isolated CD3+ T lymphocytes or day 6 activated T lymphocytes were 
Nucleofected as per manufacturer’s instructions. Briefly 5 x 106 cells per sample 
were centrifuged at 1500 rpm, room temperature, for 5 minuets. All supernatant 
was removed and the pellet re-suspended in 100 pi Human T Cell Nucleofector™ 
Solution / 5 x106 cells (fig 2.4). The sample was mixed (100 pi) with 4 pM siRNA 
and transferred to an Amaxa certified cuvette, and nucleofected on program V-24 
for freshly isolated T lymphocytes and T-20 or T-23 for activated T lymphocytes. 
Samples were removed and cultured in 2 ml RPMI 1640 at 37 °C 5 % C02. After 6 
hours the media was changed and supplemented with IL-2 (20 units /ml). 72 hours 
after nucleofection dead cells were removed using a dead cell removal kit (Milteny 
Biotech) and the viable cells were used in functional studies.
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Figure 2.4: Diagram illustrating the components of the Nucleofection
system. T cells are mixed with the T cell specific nucleofection solution and siRNA, this 
mixture is added gently into the curvette (right panel). Quickly and gently the curvette is 
placed into the Nucleofection device (left panel) and which is pre-programmed depending 
on the cell type within the study. Following Nucleofection cells are transferred to pre­
warmed media.
2.3.4 Adenoviral delivery of shRNAs
During the course of these investigations, we had the opportunity to test the 
effectiveness of adenoviral delivery of shRNA. In contrast to the siRNA we used 
shRNA is introduced into the cell and then must be transcribed and cleaved in 
order to produced the functional siRNA. Under normal circumstances this method 
of delivery would be ineffective due to the lack of expression of the receptor which 
facilitates the delivery of the virus into the T cell. However, this system was unique 
as a chimeric adenovirus was created that uses a receptor which is expressed on 
T cells.
PBMCs were isolated from whole blood as previously described, and activated with 
PHA (1pg/ml). Twenty-four hours post activation; T lymphocytes were seeded in 
24 well plates and infected or co-infected with the adenoviruses (multiplicity of 
infection 5000). Single control infections were performed for an empty vector 
control and with shRNA encoding for eGFP or CD46. Co-infections using shRNA 
CD46 and the gene of interest PLC Gamma V1, V2 or V3 were performed. On day 
5, 6 and 7 FACS analysis was performed on cells infected with the shRNA for 
eGFP to determine infection efficiency. RNA was isolated from each sample on 
day 7 (as detailed below) and analysed via quantitative PCR to determine 
knockdown of the gene of interest.
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2.4 Determination of mRNA and protein knockdown
To determine how effective the siRNA had been at targeting the isoform of interest 
levels of mRNA of the target gene were compared to control levels in each cell 
model. Total cellular RNA was isolated from the cell and quantified via the 2100 
Bioanalyser. Reverse transcription generates the cDNA that will be utilized as the 
template for qPCR analysis. QPCR is a multi-step process in which probes which 
bind a fluorescent reporter dye and quencher bind to complementary cDNA within 
the reaction mixture. While intact the fluorescence is suppressed by the close 
proximity of the quencher. During replication of the cDNA the polymerase cleaves 
the fluorescence reporter from the probes which are hybridized to the target, any 
non-specific amplification is not detected. This results in an increase in 
fluorescence which can be detected and analysed.
Determining the knockdown at the RNA level, is a strong indication of the effect of 
the siRNA, but further validation can be obtained by assessing the expression of the 
protein at the time of functional studies. Within these investigations we used 
immunoblotting and flow cytometery to determine the expression levels of the 
protein of interest.
2.4.1 RNA extraction and Reverse Transcription
Total cellular RNA was isolated from the cells using RNeasy mini kit (Qiagen Ltd) 
according to the manufacturer’s instructions, (all buffers used are as supplied). 
Briefly, 5 x 106 activated T-lymphocytes were lysed in RLT buffer, and homogenised 
with the QIAshredder™ column. 70 % ethanol was mixed with the lysate and 
applied to an RNeasy mini column. Contaminants were removed via washing with 
Buffer RW1 and RPE. RNA was double eluted in 30 pi RNase free water. The 
concentration of RNA was determined on a 2100 Bioanalyzer using the RNA 6000 
LabChip kit described in fig 2.5 (Agilent Technologies).
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Figure 2.5: Examples of the RNA 6000 Nano Series II kit (left panel) and LabChip 
(right panel) used within this study. Samples are prepared as described above and the 
concentration of RNA within a given sample is determined by loading samples carefully into 
the chip. Pressure within the system allows movement of samples through channels that 
are etched onto the chip. The process separates nucleic acid fragments based on their size 
as they are driven through the channels electrophoretically. This method can be used to 
detect RNA concentration as well as purity, with the advantage that detection and analysis 
can be performed within the same chip. Analysis was performed on the 2100 Bioanalyser.
RNA was reverse transcribed in the presence of TaqMan RT buffer (10 X), MgCI2 
25 mM, dNTP 25000 pM each, required primers 50 pM, RNase inhibitor 20 units/pl, 
RT enzyme 50 units/pl, RNase. Reactions were performed in a Biometra UNO II 
thermocycler (Biometra, Gottingen, Germany). 25 °C for 10 minutes, 48 °C for 30 
minutes, followed by 5 minutes at 95 °C, samples were stored at 4 °C prior to Q- 
PCR.
2.4.2 Quantitative-PCR
For each 25gl of TaqMan reaction 40 ng cDNA was mixed with 12.5 |il of 2X 
TaqMan Universal PCR Master Mix, 1.25 pi of primer probe mix plus 6.25 pi H20  
and briefly centrifuged. The reactions were carried out using the following 
parameters: 50 °C for 2 min, 95 °C for 10 min, then 40 cycles of 95 °C for 15 
seconds, 60 °C for 1 min. TaqMan data was analysed using the Sequence 
Detector Software (SDS version 2.1). Relative levels of expression were 
determined by comparison against a standard curve of known concentration, values 
are then normalised against the house keeping gene GAPDH. This protocol was 
followed for each PI3K probe, (Class I a, [3, and 5, class II a, (3, and y, class III).
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2.5 Determination of protein expression
Immunoblotting and flow cytometery are techniques which can be utilized to 
facilitate the detection of a protein of interest. As these techniques are also used 
in the analysis of signalling pathways and functional studies, these topics will be 
discussed in greater detail within that section (see below), and an overview of the 
technique will be presented here. Immunoblotting uses whole cell lysates which 
are then analysed for the expression of a particular protein using electrophoresis to 
separate the proteins according to their size. The transfer of these proteins onto a 
nitrocellulose membrane facilitates their detection by incubating this membrane in 
the presence of antibodies against the protein of interest which can be detected by 
the use of HRP-secondary antibody. Flow cytometery has an advantage over 
immunoblotting as fewer cells need to be used in order to quantify the amount of 
protein within a given sample. This technique again uses whole cell lysates but 
differs in that antibodies can be added directly to the sample without the need for 
protein separation. With the use of fluorescently labelled antibodies, the sample is 
passed through a laser which can detect and record the fluorescence.
2.6 Assessment of T cell Signalling and Functionality
In order to characterize T cell signalling and functionality and furthermore to assess 
the role of PI3K and the individual isoforms which make up this family we utilized 
several methods. Signalling downstream of chemokine receptors and the 
involvement of PI3K isoforms was assessed utilizing immunoblotting and flow 
cytometery. Functional responses were assessed using the chemotactic assay 
following utilization of broad spectrum PI3K inhibitors as well as isoform specific 
inhibitors and target specific siRNAs. Cytokine release was assessed following 
delivery of target specific siRNAs.
2.7 Immunoblotting
Immunoblotting or Western blotting is a technique that facilitates the detection of a 
protein of interest or the phosphorylated form of that protein. Within this study, cells 
were stimulated with numerous chemokines; this stimulation triggers downstream 
signalling events, characterized by the phosphorylation of proteins within that
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pathway. By lysing the cells, the mixture of proteins contained with the cell can be 
extracted. The whole cell lysates are then dispensed into wells within a 
polyacrylamide gel, upon applying an electrical current across the gel, the proteins 
separate according to their molecular weight, smaller proteins migrating the 
furthest. These separated proteins are then transferred onto a nitrocellulose 
membrane which can be ‘probed’ using an antibody against the protein of interest. 
Following incubation and binding of the primary antibody to the protein of interest, a 
secondary antibody is applied which is coupled to a horseradish peroxidase tag. 
Upon delivering a chemiluminescent agent there is a reaction which produces 
luminescence that is in relation to the amount of protein detected. This 
luminescence is detected using a sensitive photographic film, allowing for 
visualization of the protein of interest.
Immunoblotting was utilized within this study to allow visualization of the 
phosphorylation of PKB and S6. This phosphorylation was observed as a readout 
of chemokine stimulation (CXCL12, CCL5, AOP-CCL5 and PSC-CCL5) in freshly 
isolated, cultured or activated T cells. Furthermore, to determine the involvement of 
PI3K isoforms within this pathway, we studied the effect of PI3K inhibition on this 
response.
2.7.1 Sample Generation -  Stimulation of cells and collection of whole 
cell extracts
2 x 106 T lymphocytes or activated T lymphocytes per point were washed twice in 
RPMI 1640 and incubated at 37 °C in serum free RPMI for 60 minutes. Cells were 
or were not stimulated with CXCL12 (1-100 nM) diluted in RPMI 0.1 % BSA. 
Stimulations were terminated by aspiration of the supernatant followed by the 
addition of ice cold lysis buffer (50 mM Tris-HCL pH 7.5, 150 mM sodium chloride, 1 
% Nonidet P40, 10 % Glycerol, 5 mM EDTA, 1 mM sodium vanadate, 1 mM sodium 
molybdate, 10 mM sodium fluoride, 40 pg/ml PMSF, 0.7 pg/ml Pepstatin A, 10 
pg/ml Aprotinin, 10 pg/ml leupeptin, 10 pg/ml soyabean trypsin inhibitor). Lysates 
were rotated at 4 °C for fifteen minutes, followed by centrifugation at 14,000 rpm. 
The supernatants (containing protein) were diluted with 5x loading buffer (10 %
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SDS, 50 % glycerol, 200 mM Tris HCI pH 6.8, Bromophenol blue) heated to 95 °C 
for 5 minutes and stored at -20 °C.
2.7.2 Electrophoretic separation, transfer and immunoblotting of 
cellular proteins
Solubilised proteins were electrophoresed on a one dimensional 10 % sodium 
dodecyl sulphate - polyacrylamide gel (SDS-PAGE). This was carried out using the 
Bio-Rad Mini Protean II system (Biorad Labs, UK). Samples were loaded into a 
stacking gel and run at 80 V in running buffer containing 25 mM Tris base, 192 mM 
Glycine and 0.1 % (w/v) SDS. Upon reaching the resolving gel samples were 
electrophoresed at 180 V. The proteins were transferred by electroblotting for 60 
minutes at 40 mV onto nitrocellulose membrane 0.45 pM soaked in semi-dry 
transfer buffer (70 % H20, 20 % methanol, 10 % blot buffer (39 mM Glycine, 48 mM 
Tris base and 0.0375 % SDS). Membranes were incubated for 60 minutes at room 
temperature in block buffer, (Tris Buffered Saline (20 mM Tris-HCI pH 7.6, 150 mM 
sodium chloride) with 0.1 %Tween (TBS-Tween) containing 5 % milk), with slight 
agitation and rinsed three times for 5 minutes in TBS-Tween. The membrane was 
incubated in the specified 1° antibody dilution 1:1000, in TBS-Tween supplemented 
with 0.01% sodium azide and 5 % milk, overnight at 4 °C with slight agitation. The 
membrane was washed three times for 5 minutes in TBS-Tween, and incubated in 
the 2° antibody coupled to horse radish peroxidase (HRP) diluted 1:10,000 in block 
buffer, for 60 minutes at room temperature and washed in TBS-Tween three times 
for 5 minutes. Visualization of the proteins was performed by incubating the 
membrane in 5 ml of Enhanced Chemiluminescent reagent (ECL), for one minute 
and exposing to Kodak X-OMAT film.
2.7.3 Membrane Stripping and reprobing
In order to verify whether the samples were equally loaded the membranes were 
stripped of antibody and reprobed with a pan antibody that detects absolute levels 
of protein. Firstly, the membrane was rehydrated in TBS for 10 minutes and then 
placed in 50 ml of stripping buffer to remove bound antibody, (100 mM 2 
Mercaptoethanol, 2 % SDS, 62.5 mM Tris-HCL pH 6.7) and incubated at 60 °C for
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30 min. After extensive washing with TBS-Tween, the membrane was incubated for 
60 minutes at room temperature in block buffer washed three times in TBS-Tween, 
blots were reprobed with a different primary antibody and the immunoblotting 
procedure is carried out as described above.
2.8 In Vitro cell migration Assay
The ChemoTx® System is a disposable 96-well format migration assay. The 
system is set up with the appropriate ligands in the lower wells, over which a 5 pm 
pore size filter is placed, through which the cells migrate. This filter is designed to 
mirror the 96 well plate structure beneath, in that, surrounding each well is a 
hydrophobic material that focuses the cell suspension directly over the ligand 
below, eliminating the need for the upper chambers (see fig 2.6). Following the 
incubation time, the migrated cells are counted.
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RPMI or chemokine 
Lower chamber
Figure 2.6: Diagram of a filter used in chemotactic chamber and a 
representation of a single well setup. A left panel, picture of a 96-well chemotactic 
chamber. A right panel, diagram of 96-well chemotactic filter, black circles are hydrophobic 
forming a single drop in the centre above the chemokine below. B, a single well setup, 
showing the cell suspension focused in the centre of a well over media or chemokine lower 
chamber.
Chemotaxis assays were performed in 96-well chemotaxis chambers (Neuro Probe, 
USA) with polycarbonate membranes (5 pm pore size). The lower chambers were 
filled with 29 pi of chemokine diluted in RPMI-1640, 0.1 % BSA and carefully 
overlaid with the polycarbonate membrane. Cells were washed twice in RPMI- 
1640, and re-suspended in RPMI-1640, 0.1 % BSA at 3.2 x 106 cells/ml. 25 pi of 
the cell suspension was loaded on top of the filter.
Migration was performed at 37 °C, 5 % C 0 2 for 180 minutes, after which non­
migrated cells on the top of the filter were rinsed off with PBS. Following 
centrifugation (1,500 rpm, 10 mins) the filter was removed, and the migrated cells 
were re-suspended in 300 pi PBS, 0.1 % BSA. Analysis of migration was performed 
using FACS Vantage (BD Biosciences, San Jose, CA), samples were analysed for 
60 seconds. Data is expressed as cell number.
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2.9 Human Cytokine Assay
The Meso scale cytokine assays are based on the principles of the ELISA, in that the 
system is designed to detect the presence of proteins within a given sample. We 
utilized this technique to detect levels of Th1ATh2 cytokines following nucleofection of 
PI3K targeting and non-targeting siRNAs into freshiy isolated T celis. The MSD 
MULTI-SPOT® plate used in this investigation is a 96-well format, each well contains 
10 different spots that correspond to 10 different cytokines, thus allowing for up to 10 
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Figure 2.7: Schematic of 4 wells of a MSD MULTI-SPOT plate. Each well 
contains 10 spots each with a particular capture antibody.
For this technique to work successfully each spot within a well is comprised of capture 
antibodies for a particular cytokine and it is important to note, that each spot within a 
well works independently of every other spot and is optimised for that particular 
cytokine.
Human cytokine assays were performed in a 96 well format, with a 10-spot layout. 
(All reagents are provided within the assay). The plate was blocked for 1 hour in
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0.1 % (w/v) blocker B solution, washed 3X with PBS plus 0.05 % Tween. Undiluted 
supernatants or calibrator solutions, 10,000, 2500, 625, 156, 39, 9.8, 2.4 and 0 
pg/ml (25 pi) were dispensed, the plate sealed and incubated for 2 hours with 
shaking (900 rpm) room temperature. Twenty-five pi of antibody detection solution 
(1.0 pg/ml) was dispensed into each well, the plate sealed and incubated at room 
temperature for 2 hours with shaking (900 rpm). The plate was washed 3X with 
PBS plus 0.05 % Tween and 150 pi of 2X read buffer was added to each well of the 
plate, and analysed immediately on the SECTOR™ Imager.
2.10 Flow Cytometery
Flow cytometeric analysis is a highly sensitive technique used to count, examine 
and sort single cells with the use of a laser. Within this study this technique was 
utilized in several different ways. This technique was used to count the number of 
migrating cells following a chemotactic assay, to determine purity of cell 
populations or expression of cell surface receptors, and finally this technique was 
used as an alternative to western blotting by using antibodies against 
phosphorylated forms of proteins within a lysed cell population.
The sample being analysed is directed into a stream of fluid that passes through a 
number of detectors which can analyse the properties of the particles that pass 
through it, such as size, and density. With the use of fluorescently labelled 
antibodies surface receptors, or intracellular proteins can be detected and the 
expression levels compared to other samples. For example, following inhibition 
with a PI3K isoform specific inhibitor, phosphorylation of downstream effectors can 
be determined and compared to control samples to observe if this inhibition has an 
effect on downstream signalling.
2.10.1 Assessing cell number following chemotaxis
Following migration of cells during chemokinesis and chemotaxis, the cells are 
located within the lower chambers of a 96 well in vitro migration assay system. The 
number of cells that have migrated are analysed by resuspending the cells in 400 pi 
of PBS and counting using the FACS Vantage (BD Biosciences, San Jose, CA).
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Samples are analysed for 60 seconds, with each point performed in at least 
triplicate. Data is expressed as cell number.
2.10.2 Determining expression of cell surface receptors
Freshly isolated T lymphocytes and activated T lymphocytes were washed twice in 
PBS 0.1 % BSA and resuspended in 100 pi. 10 pi of FITC-conjugated anti-human 
antibodies against the receptor of interest or the respective immunoglobulin isotype 
control was added and incubated on ice and darkness for 30 mins. Cells were 
washed twice in PBS 0.1 % BSA and resuspended in 400 pi for analysis. This 
technique can also be utilized to determine the purity of cell populations by 
analysing expression of a receptor that is present on only the sub-population of 
interest (e.g. CD3+ T cells).
2.10.3 Determining expression or phosphorylation levels of 
Intracellular proteins
2 x 106 T lymphocytes or activated T lymphocytes were incubated at 37 °C in serum 
free RPMI for 60 minutes were stimulated with or without CXCL12 (1-100 nM) in 
RPMI 0.1 % BSA. Stimulations were terminated and the cells fixed by aspiration of 
the supernatant and addition of 2 % formaldehyde in PBS, for 10 min, at 37 °C 
followed by 1 min. on ice. Cells were washed in PBS and permeabilised by the 
addition of 90 % methanol at -20 °C, while slowly votexing, followed by incubation 
at 4 °C for 30 min. Cells were washed, resuspended in 100 pi of PBS 0.1 % BSA, 
and blocked for 10 min. at room temperature. Primary antibody or isotype control 
was added (200 ng antibody in PBS) and incubated at room temperature for 30 min. 
Cells were washed twice and incubated in 100 pi FITC-conjugated secondary 
antibody dilution (1 in 25 dilution) at room temperature for 30 min. Cells were 
washed twice and re-suspended in 500 pi PBS, for flow cytometric analysis using a 
Becton Dickinson FACS Vantage flow cytometer and analysed using CellQuest 
software.
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2.11 Statistical analysis
Statistical analysis was performed using one way analysis of variance (ANOVA) 
with Dunnets correction where necessary. These calculations were carried out to 
test for statistical significance following chemotactic or basal migration assays. A 
statistical cut-off of P<0.05 was used. These calculations were performed using the 
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Results, Section I
T cells are an integral player within both immune surveillance and the immune 
response to injury and disease. It is therefore crucial to characterise not only the 
chemokines that trigger circulating T cells to enter a specific tissue, but also the 
cascade of intracellular signalling events that they govern.
The chemokines that govern the migration of T cells into specific tissues, can be 
divided into two distinct subsets, homeostatic and inflammatory (Moser et al., 
2004). Homeostatic or constitutive chemokines are present during a healthy or 
disease free state and as such are responsible for orchestrating the trafficking and 
homing of leukocytes, during their immune surveillance role. Inflammatory or 
inducible chemokines, encompass those that are upregulated upon injury or 
disease and are therefore important components of the innate and adaptive 
immune system (Kashiwazaki et al., 2003).
In order to fully elucidate the role of PI3K in T cell migration, a panel of chemokines 
were examined. Initial studies began by reinvestigating the role of the chemokine 
CCL5. These investigations were undertaken due to the contradictory results 
obtained for not only the expression profile of CCR5 but the subsequent response 
to in vitro stimulation.
To facilitate the tight control during long term immunosurveillance, only a limited 
number of chemokine receptors are expressed on the cell surface, (responding to 
chemokines such as CXCL12, CXCL13 (Okada et al., 2002), CCL2 (Palframan et 
al., 2001), and CCL19 (Baekkevold et al., 2001)). During an inflammatory 
response, certain receptors are upregulated e.g. CXCR3. However, the expression 
profile of CCR5 and its in vitro functions are not yet fully elucidated. Some reports 
state only activated T cells migrate to CCL5, while other investigations observe 
migration in freshly isolated T cells (Turner et al., 1995; Bleul et al., 1997; Loetscher 
et al., 1996b).
Clinical interest surrounding CCR5 and its ligand CCL5, has intensified following the 
observation that CCR5 acts as a co-receptor for HIV entry and that CCL5 could act 
as a weak antagonist, by blocking the binding of HIV (Capoulade-Metay et al.,
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2006). This focused work in this field into developing antagonists based on CCL5, 
which may block the entry of HIV into T cells.
3.1 Introduction to the study
The aim of this study was to re-investigate the role of the chemokine CCL5 and 
clarify its functional response in both freshly isolated and previously activated T 
cells. To achieve this, the chemotactic and biochemical responses towards CCL5 
and its derivatives PSC-CCL5 and AOP-CCL5 were investigated. These responses 
were compared against the chemokine CXCL12, which is known to be expressed in 
both freshly isolated and activated T cells. CCL5 has been reported to bind CCR1, 
CCR3 and CCR5 and the expression of all 3 of these receptors was monitored over 
a 14 day period (Murphy, 2002; Capoulade-Metay et al., 2006).
CCL5 derivatives were generated through the truncation of CCL5. The amino 
terminal was truncated and modified with a methionine to produce Met-CCL5, and 
subsequent modifications generated AOP-CCL5 (Amino-oxpentane-CCL5), NNY- 
CCL5 (N-nonanoyl-CCL5) and finally the most potent PSC-CCL5 (L-Thia-Pro2, L-a- 
cyclohexyl-GI^NN-CCLS) (Notohamiprodjo et al., 2006). These derivatives were 
produced with the aim of developing a clinically successful inhibitor of HIV entry. It 
has been suggested that signalling downstream of these CCL5 derivatives, may be 
altered compared to CCL5 itself this was assessed by monitoring downstream 
signalling events (Vila-Coro et al., 1999).
Although the exact mechanism of action for the derivatives of CCL5 are not known, 
it is clear that they result in the rapid downregulation of CCR5 and inhibit the re­
cycling of the internalised receptor, leading to prolonged and profound receptor 
sequestration. Through this action the level of CCR5 at the surface of the cell is 
reduced and the HIV virus is unable bind (Mack et al., 1998; Sabbe et al., 2001).
3.2 Characterisation of CCL5 and its derivatives
To establish the role of CCL5 in freshly isolated T cells, CCL5-mediated chemotaxis 
was performed over a range of concentrations. Biochemical studies focused on the
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phosphorylation of S6, following stimulation with CCL5 and its derivatives AOP- and 
PSC-CCL5.
The ribosomal S6 protein is a downstream component of the PI3K/mTOR pathway 
and its subsequent phosphorylation has been observed following chemokine 
stimulation. PI3K is a crucial mediator of S6 kinase, which is responsible for the 
phosphorylation of the ribosomal S6 protein, therefore phosphorylation of S6 can be 
used as an indirect readout of PI3K activity. Strong biochemical and chemotactic 
responses have been reported following stimulation with CXCL12, in both in freshly 
isolated and activated T lymphocytes (Reif et al., 2004). For this reason, CXCL12 
was utilized as a comparison within chemotactic and biochemical analysis.
3.2.1 CCL5 fails to induce chemotaxis in freshly isolated CD3+ T cells
Figure 3.1 (left panel), demonstrates the chemotactic response and biochemical 
signalling of freshly isolated T lymphocytes, following stimulation with CCL5, its 
derivatives and CXCL12. Flow cytometery was used established the surface 
expression of the receptors CCR1, CCR3 and CCR5.
No detectable surface expression of either CCR1, 3, or 5 was observed (figure 3.1a 
left panel) and increasing concentrations of CCL5 (up to 100 nM) did not induce a 
significant chemotactic response within freshly isolated CD3+ cells (figure 3.1c left 
panel). Furthermore, CCL5 and its derivatives PSC-CCL5 and AOP-CCL5 (100 
nM) induced no detectable phosphorylation of S6, while pre-incubation with 
LY294002 had no effect on this response (figure 3.1b left panel). In comparison, 
CXCL12 induces a chemotactic response in freshly isolated CD3+ T cells that is 
concentration dependent. Stimulation with CXCL12 induces phosphorylation of S6 
which is sensitive to inhibition with 10 pM LY294002 (figure 3.1b & c left panel).
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3.2.2 CCL5 and PSC-CCL5 fail to induce chemotaxis in day 6 PHA 
activated T cells
In day 6 PHA activated T cells, the surface expression of CCR1 and CCR3 
remained undetectable, yet interestingly, following activation and culture, an 
increase of CCR5 was observed (figure 3.1A right panel). The increase in 
detectable surface expression of CCR5, did not translate into a functional or 
biochemical response, as increasing concentrations of CCL5 and its derivative 
PSC-CCL5, failed to induce a significant chemotactic response or detectable 
phosphorylation of S6 (figure 3.1 B & C right panel). CXCL12 induced chemotaxis in 
a concentration dependent manner, and phosphorylation of S6 was inhibited by 10 
pM LY294002 (figure 3.1B & B right panel).
3.2.3 CCL5 and its derivatives initiate chemotactic and biochemical 
responses within day 10 and day 14 PHA activated T cells
Following expression of CCR5 at day 6, no further increase in expression was 
observed. Expression of CCR1 and CCR3 were not observed (figure 3.2A). In 
contrast to day 6 T cells, day 10 and day 14 activated T lymphocytes, stimulated 
with CCL5 and its derivatives, induced strong phosphorylation of S6. Furthermore, 
this induction was PI3K dependent, as the phosphorylation of S6 was inhibited by 
pre-incubation with 10 pM LY294002 (figure 3.2B).
Surprisingly, although CCL5 does not induce a significant chemotactic response, 
PSC-CCL5 is more potent, giving rise to a small increase in chemotactic response 
on day 10 and by day 14 a robust and significant response is observed that is 
comparable to that of CXCL12 (figure 3.2C right & left panels).
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Figure 3.1 Freshly isolated and Day 6 activated T lymphocytes migrate in a 
CXCL12-dependent but CCR5 independent manner. PTO for figure legend.
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Figure 3.1 Freshly isolated and Day 6 activated T lymphocytes migrate in a 
CXCL12-dependent but CCR5 independent manner. (A) Surface expression 
profiles of CCR1, 3 and 5 are indicated. The respective immunoglobulin isotype control is 
shown. Briefly, 1 x 106 cells were washed in PBS and incubated with the respective PE 
conjugated antibody at 4 °C, cells were washed in PBS analysed by flow cytometery. (B) 
Day 10 activated T lymphocytes were treated with either 10 nM or 100 nM CXCL12, CCL5, 
PSC-CCL5 or AOP-CCL5 for the times indicated. Protein lysates were generate and 
resolved by SDS-PAGE, transferred to nitrocellulose membrane and immunoblotted with 
anti-phospho S6 antibody. The blots were stripped and reprobed with anti-S6 antibody to 
verify equal loading and efficiency of protein transfer. (C) Cells were treated with either 10 
nM CXCL12, 100 nM CCL5, PSC-CCL5 or AOP-CCL5 for 10 mins, as control or in the 
presence of 10 pM LY294002 (30 mins pre-incubation). Protein lysates were generate and 
analysed as described above. (D) CXCL12, CCL5 or PSC-CCL5 mediated chemotactic 
responses of freshly isolated and day 6 activated T lymphocytes. Cells (8 x 104 /  25 pi) 
were placed on the upper membrane of a 96-well chemotaxis plate above lower chambers 
containing varying concentrations of CXCL12 (circle) CCL5 (black square) or PSC-CCL5 
(white square). Chemotaxis across a 5 pm pore size membrane was determined after 3 
hour incubation at 37 'C  in 5 % C 0 2 as described in Materials and Methods., The data are 
derived from a single experiment with quadruplicate replicates that is representative of three 
other experiments. Data are expressed as mean ± SD. Data were analyzed by ANOVA and 
Dunnetts correction where required (*, p < 0.05).
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Figure 3.2 Day 10 & 14 activated T lymphocytes migrate in a CXCL12 and 
CCR5-dependent manner. (A) Surface expression profiles of CCR1, CCR3 and CCR5 
are indicated. The respective immunoglobulin isotype control is shown. Briefly, 1 x 106 cells 
were washed in PBS and incubated with the respective PE conjugated antibody at 4 °C, 
cells were washed in PBS analysed by FACS. (B) Day 10 or 14 activated T lymphocytes 
were treated with either 10 nM CXCL12, 100 nM CCL5, PSC-CCL5 or AOP-CCL5 for 10 
mins as control or in the presence of 10 pM LY294002 (30 mins pre-incubation). Protein 
lysates were generate and resolved by SDS-PAGE, transferred to nitrocellulose membrane 
and immunoblotted with anti-phospho S6 antibody. The blots were stripped and reprobed 
with anti-S6 antibody to verify equal loading and efficiency of protein transfer. (C) CXCL12, 
CCL5 or PSC-CCL5 mediated chemotactic responses of day 10 & 14 activated T 
lymphocytes. Cells (8 x 104 / 25 pi) were placed on the upper membrane of a 96-well 
chemotaxis plate above lower chambers containing varying concentrations of CXCL12 
(circle) CCL5 (black square) or PSC-CCL5 (white square). Chemotaxis across a 5 pm pore 
size membrane was determined after 3 hour incubation at 37 'C in 5 % C02 as described in 
Materials and Methods. The data are derived from a single experiment with quadruplicate 
replicates that is representative of three other experiments. Data are expressed as mean ± 
SD. Data were analyzed by ANOVA and Dunnetts correction where required (*, p  < 0.05).
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3.3 Summary
In characterising the role of CXCL12, CCL5 and its derivatives in freshly isolated T 
cells and previously activated T cells, the following observations were made:
o Freshly isolated T lymphocytes do not express CCR1, CCR3 or CCR5 
and are unable to chemotax towards CCL5. Furthermore, CCL5 and its 
derivatives do not induce phosphorylation of the S6 ribosomal protein, 
o Freshly isolated T cells show concentration dependent CXCL12- 
mediated chemotaxis and CXCL12 dependent phosphorylation of S6 is 
PI3K dependent.
o Day 6 activated T lymphocytes express CCR5 but not CCR1 and CCR3. 
This expression does not translate this into a chemotactic or biochemical 
response.
o In day 6 activated T cells, CXCL12 induces a concentration dependent 
chemotactic response and phosphorylation of S6 is PI3K dependent, 
o Day 10 and 14 activated T lymphocytes chemotax towards PSC-CCL5 
and to a limited extent CCL5. 
o By day 10-14, activated T cells stimulated by CXCL12, CCL5 and its 
derivatives PSC-CCL5 and AOP-CCL5 signal through S6, this signalling 
is dependent on PI3K.
These investigations were performed in order to further characterise the ligands that 
induce migratory responses in freshly isolated and activated T cells. This panel of 
ligands would then be used to assess the role of PI3K within this process.
Although by day 10 - 14, CCL5 did induce small chemotactic responses, these 
responses were superseded by the induction seen with PSC-CCL5. This 
compound was generated in the search for a therapeutically viable CCL5 derivative. 
The aim was to generate a molecule that would potently bind the receptor but 
demonstrate no or lower agonist potential before sequestering the receptor within 
the cell. However, as seen within these investigations it induces strong chemotactic 
responses within T cells. It is clear this is not an ideal compound and ensures this 
product will not be clinically developed.
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In conjunction with other studies it may be proposed that it is the presence of IL-2 
within the culture that induces the expression of CCR5 and the subsequent 
functional responses. This suggests an essential role for this cytokine within 
inflammatory settings in order to induce the full migratory response. These 
investigations support the view that CCR5 expression is upregulated over time, and 
that chemotactic and signalling responses are only demonstrated 10 -14  days post 
activation/culture. Unfortunately this chemotactic response is not statistically 
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Results - Section II
With the established role for CXCL12-mediated migratory responses in the freshly 
isolated T cell model; the aim within these investigations was to elucidate the role of 
individual PI3K family members.
Freshly isolated T cells mimic the migration that occurs during continual 
immunosurveillance of the body. This system is highly specialized, therefore 
described here is an overview of how the components of the peripheral T cell pool 
are generated and subsequently maintained.
In the long term, T cell numbers within the immune system are steadily maintained 
(Jameson, 2002). However, for this pool of cells to respond adequately during 
times of injury or disease, cell numbers must be capable of identifying specific 
antigens, in order to address the immune requirements at that precise moment. To 
perform this task adequately, this pool must be comprised of several subsets of 
cells. The most abundant class of T cells in peripheral blood are a/p T cells, 
comprised of CD4+ and CD8+ T cells, these are further divided into 3 types of 
functionally diverse cells; naive, effector and memory.
Following positive and negative selection, naive CD4+ and CD8+ cells exit the 
thymus, and circulate the lymph and peripheral tissues as naive cells, where their 
role is one of immunosurveillance. Following stimulation by an appropriate antigen, 
these naive CD4+ and CD8+ cells undergo activation and expansion, resulting in the 
mature effector cell capable of eliminating the antigen. By their nature a large 
proportion of these cells undergo apoptosis, however, those that do survive 
differentiate into circulating memory T cells (Mahajan et al., 2005).
In a healthy individuals, the pool of T cells that are found within the peripheral 
blood, are a mixture of primarily naive and memory cells with a small number of 
effector T cells; it is from these healthy individuals that peripheral CD3+ T cells are 
isolated. As the majority of these cells are naive or memory cells, they express a 
limited repertoire of receptors on the cell surface and consequently respond to a 
restricted number of chemokines. It is from this pool of cells that the investigations 
within this study will be drawn.
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Investigations into the role of PI3K in the freshly isolated T cell model, was 
addressed through the use of the PI3K broad spectrum inhibitors LY294002 and 
wortmannin. This was assessed using the phosphorylation of PKB and CXCL12 
mediated chemotaxis as biochemical and functional readouts. This work was 
furthered by highlighting the role of specific PI3K isoforms in biochemical and 
chemotactic responses, following the utilization of isoform specific inhibitors.
3.4 Freshly isolated T cells demonstrate a dependence on PI3K for their 
chemotactic response
Within this investigation, the role of PI3K in the chemotactic response of freshly 
isolated T cells was addressed. To evaluate this thoroughly, dose responses to 
CXCL12 were performed and the effect of LY294002 and wortmannin were 
assessed against the peak chemotactic response. Biochemical assays were 
utilized to determine coupling of the receptor to intracellular signalling events. The 
signalling molecule PKB is dependent on the activation of PI3K for its activation and 
subsequent propagation of the signalling cascade. The close relationship between 
PKB and PI3K enabled the phosphorlyation of PKB to be utilized as an indirect 
method to assess PI3K activity.
The CXCR4 chemokine receptor is constitutively expressed on naive T cells and 
ligation of this receptor is a pivotal axis within the immune system. Regulation of 
this coupling is essential in the homing/trafficking of cells such as neutrophils (Link, 
2005), T cells (Butcher et al., 1999) and stem cells (Molyneaux et al., 2003) and has 
been implicated in roles such as organogenesis, angiogenesis and tumorigenesis 
(Bagri and Tessier-Lavigne, 2002; Ratajczak et al., 2006; Jin et al., 2006). A role 
for PI3K has been demonstrated within T cell chemotactic responses (Reif et al., 
2004).
CXCL12 provides a strong, robust chemotactic signal in freshly isolated T cells 
(figure 3.3A left panel). All isoforms except class II y are expressed at the RNA 
level within freshly isolated T cells (figure 3.3E). Following pre-treatment with the 
PI3K inhibitor LY294002, CXCL12-mediated chemotaxis in freshly isolated T 
lymphocytes, is inhibited in a concentration dependent manner (figure 3.3B). 10 pM
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LY294002 decreased the CXCL12-mediated chemotactic response significantly, 
while 30 pM almost completely abrogated this response. Furthermore, pre­
incubation with LY294002 also exhibited a significant concentration dependent 
decrease in basal migration. The effect on both CXCL12-mediated chemotaxis and 
on basal migration was corroborated with wortmannin (figure 3.3C). At the 
biochemical level, PI3K also inhibited the phosphorylation of PKB in a concentration 
dependent manner, suggesting that CXCL12 intracellular signalling events are 
coupled through PI3K (figure 3.3D).
To determine if the response was driven by a particular subset of T cells, CD4+ and 
CD8+ T lymphocytes were isolated and the biochemical and functional responses 
assessed (figure 3.4). CD4+ and CD8+ T cells both displayed strong chemotactic 
responses. Following pre-incubation with LY294002, CD4+ and CD8+ T cells were 
inhibited in a concentration dependent manner, with 3 pM producing significant 
decreases in CXCL12-mediated chemotaxis.
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Figure 3.3 CXCL12-mediated chemotactic responses in freshly isolated CD3+ T 
lymphocytes are PI3K dependent. PTO for figure legend.
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Figure 3.3 CXCL12-mediated chemotactic responses in freshly isolated CD3+ T 
lymphocytes are PI3K dependent. (A) Effect of increasing concentrations of CXCL12 on 
the chemotactic responses of freshly isolated CD3 T lymphocytes, in the presence of 
LY294002 (B) and Wortmannin (C). Cells were pre-incubated with either vehicle, LY294002 
(3- 30 pM) or Wortmannin (30- 300 nM) for 30 mins (left panels) and expressed as number 
of cells migrating. Cells (8 x 104/ 25 pi) were placed on the upper membrane of a 96-well 
chemotaxis plate above lower chambers containing 10 nM CXC12 as described in Materials 
and Methods. The percentage inhibition by LY294002 or Wortmannin for basal (black lines) 
and stimulated (red lines) is depicted in B & C right handside panels. The data are derived 
from a single experiment with quadruplicate replicates that is representative of four 
(LY294002) or two (Wortmannin) other experiments. Data were analysed using ANOVA with 
Dunnets correction where required. (Data from all donors were further analysed using 
ANOVA with repeated measures followed by Dunnets correction. Significance was observed 
at each concentration of inhibitor for both stimulated and basal levels, P < 0.05). D) Aliquots 
of T cells (2 x 106 cells/ml) were left untreated or stimulated in parallel for 2 mins and lysed 
by the addition of 1 x sample buffer. Cell lysates were resolved by SDS-PAGE, transferred 
to nitrocellulose membranes, and immunoblotted with a phospho-specific PKB Ab with 
affinity for the active Ser473-phosphorylated form of PKB and protein was visualised with 
ECL. The blots were stripped and reprobed with anti-PKB Ab to verify equal loading and 
efficiency of protein transfer. Data are expressed as mean ± SD. (E) Expression of class I, 
class II and class III PI3K isoforms in freshly isolated T lymphocytes. T lymphocytes were 
isolated from whole blood using negative selection as described in Materials and methods. 
Total human RNA (5 x 106 cells) was isolated using the Qiagen RNeasy kit and DNA was 
obtained by RT-PCR followed by quantitative PCR as described in Materials and methods. 
Levels of individual PI3K mRNA are normalised to levels of standards which are an equal 
mixture of human brain/spleen/thymus RNAs.
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Figure 3.4 CXCL12-mediated chemotaxis of CD4+ and CD8+ freshly isolated T 
lymphocytes are sensitive to LY294002 inhibition. (A) Effect of increasing 
concentrations of CXCL12 on the chemotactic responses of freshly isolated CD4+ and 
CD8+ T lymphocytes, and in the presence of LY294002 (B & C). Cells were pre-incubated 
with either vehicle or LY294002 (3- 30 pM) for 30 mins. Cells (8x104 cells / 25 pi) were 
placed on the upper membrane of a 96-well chemotaxis plate above lower chambers 
containing 10 nM CXCL12. Chemotaxis across a 5 pm pore size membrane was 
determined after a 3 hour incubation at 37 ”C in 5 % C 02 as described in Materials and  
Methods. The percentage inhibition by LY294002 for basal (black lines) and stimulated (blue 
or red lines) is depicted in the right panels. The data is taken from a single experiment in 
quadruplicate and is representative of 3 individual donors, data above were analyzed by 
ANOVA with Dunnets correction where required (* P < 0.05). Data are expressed as mean 
± SD. (N.B. Data from 3 donors were further analysed using ANOVA with repeated 
measures followed by Dunnets correction. Both CD4 and CD8 exhibited significance at each 
concentration of inhibitor, P < 0.05).
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3.5 The use of Pharmacological tools to explore the roles of individual 
PI3K in T cell responses
Phosphatidylinositol-regulated signalling pathways, can be used as an indirect 
method by which to measure PI3K activity, one such example is PI3K/mTOR, in 
which PI3K has been shown to be a crucial mediator of S6 kinase (Sasaki et al., 
2000). S6 kinase phosphorylates the ribosomal S6 protein, by measuring this 
phosphorylation, with and without specific PI3K isoform inhibition, provides an 
indirect method to measure the contribution that each isoform may play within this 
signalling cascade. Although a role for S6 phosphorylation in the migration of T 
cells has not been established, S6 phosphorylation has implications in chemotaxis 
of other cell types. S6 kinases are under the tight control of the mammalian target 
of Rapamycin (mTOR), which is enriched within the actin arc and formation of which 
has been linked to migration (Berven et al., 2004). Neutrophil chemotaxis and 
chemokinesis induced by GM-CSF (granulocyte-macrophage colony-stimulating 
factor) is prevented by pre-treatment with the immuno-suppressant rapamycin, 
which specifically binds to and inhibits mTOR, suggesting this pathway plays a 
critical role within both chemotaxis and chemokinesis (Gomez-Cambronero, 2003). 
Rapamycin, the broad-spectrum PI3K inhibitor LY294002 and class I isoform 
selective inhibitors, were utilized to assess the effect on the phosphorylation of S6 
following CXCL12 stimulation (figure 3.5).
3.5.1 PI3K isoform selective inhibitors
The advancement in the selectivity of PI3K inhibitors, allows the dissection of the 
role of the PI3K family. A recent study highlighted that the imidazopyridines (e.g. 
PI-103) preferentially targets PI3Ka, the chromones (e.g. TGX-121) preferentially 
target PI3K(3/PI3K5, quinazolinone purine inhibitors (e.g. IC87114) selectively target 
of PI3K5, and the thiazolidinediones (AS605240) preferentially target PI3Ky.
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3.5.2 PI3K-dependent phosphorylation of S6
Phosphorylation of the S6 ribosomal subunit is dependent on PI3K activity and can 
be measured via a flow cytometry based assay. Following stimulation with CXCL12 
the phosphorylation of S6 increases. Figure 3.5 A-F demonstrates the effect of 
LY294002, Rapamycin and isoform selective inhibitors on the phosphorylation of S6 
following CXCL12 stimulation. Figure 3.5 G demonstrates (in a graphical form) the 
phosphorylation of S6 with and without selective inhibition. This data was used to 
calculate the mean fluorescence for each treatment, which is demonstrated within 
figure 3.5 A -  F.
Pre-treatment with LY294002 inhibits the phosphorylation of S6 in a concentration 
dependent manner, although residual phosphorylation is still observed (figure 3.5A). 
The dual class I a/y inhibitor AS605240 produced the most robust effects on 
inhibition (0.3 - 3 pM), although phosphorylation of S6 was not completely inhibited 
(3 pM), suggesting contribution of other PI3K isoforms (figure 3.5F). The class I p/5 
inhibitor, TGX-121, had no effect on the phosphorylation of S6 even at 500 nM, 
which is higher than its known selectivity range (figure 3.5D). Inhibition with 
IC87114 (5 selective) exhibited a modest decrease in phosphorylation, and at 30 
pM exhibited a statistically significant decrease (figure 3.5E).
The a selective inhibitor (PI-103) produced a concentration dependent decrease in 
S6 phosphorylation, with 100 and 300 nM producing significant responses (figure 
3.5C). However, PI-103 also inhibits mTOR with a similar IC50 to that for PI3Ka (20- 
100 nM), therefore as S6 lies downstream of both mTOR and PI3K, the relative 
contribution of mTOR and PI3Ka cannot be dissected out. However, inhibition with 
Rapamycin, an inhibitor of mTOR, demonstrates a significant decrease in the 
phosphorylation of S6, suggesting at least in part, the result obtained with PI-103 
may be due to an effect on mTOR (figure 3.5B).
3.5.3 The role of class I PI3K isoforms in CXCL12-mediated chemotaxis
The use of classical pharmacological PI3K inhibitors, such as LY294002, has 
highlighted the importance of PI3K in CXCR4-mediated chemotaxis of freshly
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isolated T lymphocytes. However, these inhibitors can only imply a role for the 
class I PI3K family as a whole. The use of knockout models in particular p110y 
knockouts, have been invaluable in implementing this isoform within the chemokine 
mediated chemotactic response, yet the role of other class I isoforms within this 
response is yet to be fully elucidated (Hirsch et al., 2000; Li et al., 2000; Sasaki et 
al., 2000; Thomas et al., 2005). In order to clarify the specific PI3K isoforms that 
are involved in T cell chemotaxis, class I isoform specific inhibitors were utilised.
In freshly isolated T cells, increasing concentrations of the chemokine CXCL12 
were used to build a profile of the chemotactic response. The effect of increasing 
concentrations of specific class I PI3K isoforms upon this response were assessed 
(figure 3.6). The CXCL12-mediated chemotactic response displayed the typical bell 
shaped curve associated with chemokine induced chemotactic responses, with a 
peak response seen between 10-30 nM depending on the donor (figure 3.6A-D).
The class I alpha inhibitor, PI-103 shows 5-10-fold selectivity for a over 6 and (3 
isoforms respectively (table 1). At 30 nM PI-103 showed no significant effect on the 
CXCL12-mediated chemotactic response, yet, there is a trend to see an increased 
chemotactic responsiveness at 10-30 nM CXCL12, this was replicated for each 
donor tested. Although there was a decreasing trend for chemotaxis following 
inhibition with 300 nM PI-103, this effect was not significant. No effect on basal 
migration was observed even at the highest concentration (figure 3.6A). Inhibition 
of class l|3/5 PI3K with the inhibitor TGX-121 demonstrates around 100-fold 
selectivity against PI3K a/y, and showed little effect on the CXCL12-mediated 
chemotactic response at concentrations ranging from 5 -  500 nM (figure 3.6B).
IC87114 displays around 100-fold selectivity against PI3K 5 vs. p isoforms and > 
1000 fold over a and y. Concentrations of the class I delta PI3K inhibitor IC87114, 
up to 10 pM, showed no effect at the lowest concentrations of CXCL12-mediated 
chemotaxis (1-10 nM figure 3.6C). Interestingly, when inhibiting at 10-30 pM 
IC87114 (a concentration which in non-selective between PI3K isoforms) there was 
a concentration dependent decrease in chemotactic response which was significant 
at 30 pM. No effect on basal migration was observed. Similarly, PI-103 impaired
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cell migration at concentrations where it would be expected to target PI3Ky activity, 
in addition to the primary isoform target (table 1).
The dual class I y/a inhibitor AS605240 displays 10-fold selectivity against PI3Ky 
over a but 40-fold selectivity against p/5. A concentration dependent decrease in 
CXCL12-mediated chemotactic responses was observed from 0.3 -  10 pM 
AS605240. A concentration dependent decrease in basal migration was observed 
within these studies (figure 3.6D & E).
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Figure 3.5 CXCL12-stimulated PI3K-dependent S6 phosphorylation is 
inhibited by PI-103 and AS605240 inhibitors. Freshly isolated T lymphocytes were 
pre-incubated in the presence of (A) 3-30 pM Ly294002, B) 100 nM Rapamycin (C) 0.03-0.3 
pM PI-103, D) 0.005- 0.5 pM TGX-121, E) 3-30 pM IC87114 F) 0.3-3 pM AS605240 for 30 
mins. T lymphocytes (1 x 106) were then either left untreated or stimulated with CXCL12 (10 
nM) for 10 mins. Cells were fixed, permeabilised and stained for phosphorylated S6 as 
described in materials and methods. Cells were analysed by Flow cvlometery. Data is from 
a single donor, and is representative of 4 others. Statistical analysis was performed using 
ANOVA with Dunnetts correction (* p < 0.05) when required. Further analysis using ANOVA 
with repeated measures and Dunnetts correction was performed. The significance indicated 
above is representative of what was observed with further analysis. Data are expressed as 
mean ± SD. G) Example of histogram overlays generated using software on the FACS 
Vantage following flow cytometery analysis. Figures A-F were generated through the 
analysis of the mean fluorescence of the histograms presented in figure G.
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Concentration PI-103 TGX-121 IC87114 AS605240
Basal NS NS NS 10 (lM
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Figure 3.6 Effect of isoform specific inhibitors on CXCL12 mediated 
chemotactic responses of freshly isolated T cells. Freshly isolated T lymphocytes 
were pre-incubated in the presence of (A) 0.03-1 pM PI-103, (6) 0.005-0.5 pM TGX-121, (C) 
1-30 pM IC87114 or (D) 0.3-10 pM AS605240 for 30 mins. E) Effect of AS605240 on basal. 
T lymphocytes (8 x 104/ 25 pi) were placed on the upper membrane of a 96-well chemotaxis 
plate above lower chambers containing varying concentrations of CXCL12 as described in 
Materials and Methods. Chemotaxis across a 5 pm pore size membrane was determined 
after 3 hour incubation at 37 °C in 5 % C02. The data (A-E) are derived from a single 
experiment performed in triplicate that is representative of three other experiments. Data 
are expressed as mean ± SD. F) For ease of viewing, statistical analysis for 3 identical 
experiments have been analysed using ANOVA with Dunnets correction where required. 
The table indicates the concentration or concentrations of inhibitor which show statistical 
significance (P<0.05) at each concentration of CXCL12. If no concentrations of inhibitor 
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3.6 Summary
By investigating the role of PI3K in freshly isolated T cells the following 
observations were made:
o CXCL12-mediated chemotaxis of freshly isolated T lymphocytes is PI3K 
dependent.
o CD4+ and CD8+ T lymphocyte subsets chemotax towards CXCL12 and are 
sensitive to increasing concentrations of LY294002 inhibition, 
o PI3K isoform specific inhibition suggests a role for class I y in freshly 
isolated T cell chemotaxis. 
o Signalling through S6 is dependent on PI3K class I y.
In this section of work it has been demonstrated that freshly isolated T cells are 
dependent on PI3K isoforms for both CXCL12-mediated migration, chemokinesis 
and signalling through PKB. This data is in support of other studies which have 
also identified PI3K as having a role within this system (Butcher et al., 1999). In 
furthering these observations, CD3+ T cells were subdivided into CD4+ and CD8+ T 
cells and the investigation repeated to determine if this response was primary 
dependent on one of these subgroups. The data suggests that both CD4+ and 
CD8+ T cells generate robust CXCL12-mediated chemotactic responses that are 
dependent on PI3K.
The use of class I PI3K isoform selective inhibitors demonstrated a role for PI3K y 
in CXCL12-mediated phosphorylation of S6. Significant decreases in 
phosphorylation were observed at all concentrations of inhibition. At non-selective 
concentrations, IC87114 (5 selective) significantly inhibited phosphorylation, 
although no role for (3/5 was established when using any concentration of the (3/5 
selective inhibitor. PI-103 (a selective) showed significant decrease of S6 
phosphorylation at 100-300 nM, yet within this inhibition may be due to inhibition of 
mTOR.
Within the migratory response, limited roles for a and (3 were observed. At the 
highest concentrations of IC87114 there is inhibition of migration, but at this 
concentration the inhibitor loses its selectivity. The use of isoform selective
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inhibitors identified a predominant role for PI3Ky within migration and chemokinesis. 
However, residual migration was still observed suggesting an alternate isoform 
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Results, Section III
The use of broad spectrum PI3K inhibitors LY294002 and wortmannin has revealed 
a role for the PI3K family within migration of freshly isolated human T cells. With 
the use of isoform specific inhibitors a dominant role for the PI3Ky isoform has been 
established. However, 2 lines of evidence suggest additional signalling events are 
required to facilitate optimal migratory responses; first, following inhibition with 
LY294002 and AS605240 residual chemotaxis is still observed; second, ex vivo 
cultured and activated T cells are insensitive to broad spectrum PI3K inhibitors 
(Smit et al., 2003). The possibility that class II a and |3 PI3K isoforms, which both 
exhibit resistance to LY294002 and wortmannin (Domin et al., 1997; Arcaro et al., 
1998), may contribute to this response was therefore investigated. PI-103 has 
inhibitory effects on PI3K class ll[3 (which is resistant to LY294002). However, as 
some inhibitory effects on cell migration are observed and pharmacological analysis 
of this isoform is limited, (as there are no class II specific inhibitors), an siRNA 
strategy was adopted to further characterise the role of PI3K isoforms in human T 
cell migration.
This work focuses on both the freshly isolated and in vitro activated T cell, therefore 
a briefly overview of the generation of these cells and the advantages that this 
system affords shall be discussed. In a physiological setting naive or memory T 
cells are performing an immunosurveillance role, when such cells encounter an 
antigen, presented by an APC the T cell subsequently undergoes activation leading 
to proliferation, release cytokines, chemokines and upregulation of the receptor 
repertoire on the surface of the cell. This upregulation allows biochemical and 
functional responses towards a myriad of chemokines. The in vivo activation of T 
cells is a complex mechanism, therefore, the discovery that bacterial antigens and 
lectins can replicate this activation in vitro, by mimicking some of these events, 
initiated a huge growth in this field of research, leading to 1,000s of publications 
utilizing this tool of investigation.
Activation of T cells and their subsequent expansion in vitro, mimics the in vivo 
activation of a T cell in response to antigen presentation and is the closest 
comparable model of human T cell activation. The advantage of using this in vitro 
model is two-fold. Firstly, investigations can be performed on mature T cells which
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participate in responses to injury or disease, secondly, this activation leads to 
upregulation of receptors on the surface of the cell, allowing for greater investigation 
of the downstream signals that are generated through a plethora of chemokine 
receptors. This allows for greater investigation within the in vitro system, and for 
these investigations provides a greater insight into the role of PI3K downstream of 
these receptors.
Common in vitro methods of activation include; Staphylococcal enterotoxin B (SEB), 
Phytohemagglutinin (PHA), Concanavalin A (Con A), Pokeweed mitogen (PWM). 
Activation of T cells can also be performed with CD3/CD28 stimulation which is the 
closest physiologically relevant activation method. These methods of activation are 
independent of antigen stimulation and circumvent the normal T cell activation 
mechanism, allowing for strong and robust activation, proliferation and release of 
pro-inflammatory cytokines and chemokines (Krakauer et al., 2005).
This body of work will be discussed in 3 parts; the first presents the expression 
profile of PI3K in human T cells. Part 2 stresses the importance of strong siRNA 
design, and illustrates the effectiveness, potency and selectivity of the siRNAs used 
within this study. Finally, part 3 reports in detail the optimisation of Nucleofection 
and effect of ex vivo culture and activation.
3.7 Expression levels of PI3K isoforms following activation
The aim of this experiment is to determine which PI3K isoforms are present within 
activated T cells and the expression profile throughout the life cycle of the cell. 
Both PHA and CD3/CD28 activated T cells were analysed for PI3K expression to 
allow comparison throughout the spectrum of in vitro activation methods.
Figure 3.7 illustrates the expression profile of each individual PI3K isoform for both 
PHA and CD3/CD28 activated T cells as determined by qPCR. The cells are 
monitored over a 5 -  13 day time course, as activated cells can be first used within 
experimental procedures (e.g. Nucleofection) on day 6 and can be cultured and 
used in experimental procedures up to day 13. As expected class II y which is 
expressed predominantly in hepatocytes, is not expressed in activated T cells,
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however all other PI3K isoforms were present. Of particular note is the different 
expression profiles of each isoform following either PHA or CD3/CD28 activation, 
(with the exception of class I p which shows low levels following both types of 
activation). Up to a week after activation, levels of each isoform in PHA and 
CD3/CD28 activation are very similar, however, after this time expression in PHA 
activated cells increases rapidly. In comparison, levels in CD3/CD28 activated cells 
remain relatively constant.
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Figure 3.7 mRNA expression levels for PI3K isoforms in activated human T 
cells. Expression of PI3K isoforms. (A) Class I alpha, (B) class I beta, (C) class I delta, (D) 
class I gamma, (E) class II alpha, (F) class II beta and (G) class III. PHA activated T 
lymphocytes were obtained from PBMCs isolated from whole blood and stimulated with PHA 
(72 hours, 5 pg/ml). RPMI-1640 media supplemented with 10 % FCS and IL-2 (20 units/ml) 
was added every 2 days to expand the PHA activated cells. Total human RNA ( 5 x 1 0  
cells) was isolated using the Qiagen RNeasy kit, RNA quantity was determined on a 2100 
Bioanalyzer (Agilent Technologies), using the RNA 6000 LabChip kit. cDNA was obtained 
by RT-PCR followed by quantitative PCR as described in Materials and Methods. Ratio of 
expression is relative to standards.
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3.8 siRNA validation
When designing an experiment that incorporates the use of siRNA, it has been 
thoroughly established that the most critical factor is ensuring an effective and 
specific siRNA. The field of siRNA design is growing rapidly, and many studies 
have focused purely on investigating the ‘rules’ surrounding solid siRNA design; 
giving an invaluable insight into the generation of these tools. At this time, due to 
the complex nature of the system, theoretical knowledge of siRNA design goes only 
part way in identifying strong in vitro siRNA candidates, and full validation within 
experimental setting is still an essential tool.
The ability to induce a decrease in target mRNA and yet show specificity for not 
only that gene but a particular isoforms within that family, determines the 
effectiveness of that siRNA. Any effects on other isoforms or proteins, which are 
known as ‘off-target effects’, limit the strength of data that can be obtained by 
utilizing that siRNA.
Within this study each of the expressed PI3K isoforms, were targeted by four 
different siRNAs and evaluated for their ability to decrease/target that particular 
isoform. The most effective siRNAs were subsequently assessed for their off-target 
effects, this was determined through quantification of the other PI3K isoforms. This 
method was established to identify the effective siRNAs. Furthermore, titration of 
individual siRNAs was used to highlight the differing potencies that can be achieved 
even within the same siRNA pool.
3.8.1 RNA quality
Validation of the PI3K targeting siRNA was initially performed in the previously 
validated PHA activated T cell model. This system was utilized to ensure 
consistency would be maintained throughout the experimental design, for example, 
cell type, expression of PI3K, concentrations of siRNA to be used and the delivery 
method. Before quantification of the target gene can occur, levels of total RNA 
within the samples are assessed via an RNA 6000 labchip. Figure 3.8 exemplifies 
the readout which is obtained from which the quantity and quality of RNA can be 
assessed. An example of good quality RNA can be seen in the left panel generated
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from a control sample of 5 x 106 T cells. This readout shows 2 sharp peaks from 
which the area under the curve is used to calculate the RNA concentration. The 
two peaks correspond to the 28s and 18s ribosomal peaks within the RNA sample. 
The middle panel is the RNA from 5 x 106 T cells that have been nucleofected with 
non-targeting siRNA, within this sample no clear peaks can be seen and the RNA 
concentration cannot be determined. Doubling the concentration to 1 x 107 cells 
increases the concentration of RNA to a level which can be analysed on this 
system, yet the quality of RNA obtained was not sufficient to ensure confidence that 
subtle differences within the targeting effects of the siRNA could be determined. In 
order to generate reliable and accurate results an alternative model to validate the 
PI3K siRNAs was established.
The classic immortalized HeLa cell line is routinely used and has been shown to 
undergo efficient transfection of both plasmid and siRNA. Importantly for this 
particular study, HeLas demonstrate high transfection efficiency, with little effect on 
cell viability, RNA yield or quality, all of which were identified as hurdles in the 
activated T cell model (figure 3.8). This ensured a comparatively ‘high throughput’ 
screen compared to cultured human T cells, which was essential for the large 
number of siRNAs being tested against each expressed PI3K isoform.
Figure 3.9A illustrates the expression of PI3K isoforms with the HeLa cell line. As 
expected class I and class II y isoforms were not present, and as class II y is not 
expressed in human T cells this posed no constraints on future experiments. Due 
to the lack of class I y expression, no validation of the targeting siRNAs could be 
performed, and therefore future experiments within human T cells used all 4 
targeting siRNAs. All other PI3K isoforms were expressed in HeLas with 
comparative levels of class I a and class lip at 3 or 4 times that of the housekeeping 
gene GAPDH. PI3K class I (3, class II a and class III were all expressed at around 
20 times that of GAPDH. This confirmed that each of the isoforms present could be 
targeted for siRNA validation.
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3.8.2 siRNA effectiveness
Four siRNA sequences against each of the isoforms present were tested within this 
system. The class I alpha isoform was successfully targeted by 2 of the 4 siRNAs, 
the other 2 siRNAs induced only minimal knockdown of mRNA when compared to a 
non-targeting siRNA (figure 3.9B top left panel). Each of the 4 siRNA sequences 
tested against class I beta, delta, class II alpha, beta and class III produced strong 
mRNA silencing of the targeted isoform compared to a non-targeting siRNA (figure 
3.9B).
As discussed previously, residual chemotactic responses had been identified even 
following the inhibition of class I PI3K isoforms or using knockout models in 
combination with class I isoform specific inhibitors. This suggested a role for either 
an alternative pathway or utilization of other isoforms within the PI3K family within 
the chemotactic response. Therefore within this present study the primary objective 
was to assess the contribution of class II PI3K family members. In order to achieve 
this goal the two most effective siRNAs against class II a and p were further 
assessed for potency and ‘off-target’ effects to ensure effectiveness and selectivity. 
SiRNA concentrations were titrated to 0.1 nM and compared at each concentration 
to control levels of the target isoform and to non-targeting siRNA (figure 3.10 left 
panels). As a comparison, identical studies were also performed for class I beta 
and delta. Initially the study was designed to incorporate the comparison between 
all PI3K isoforms; this was to provide an overview of the siRNAs available against 
the whole PI3K family not just for work within this study, but within the lab as a 
whole. However, during the validation studies of siRNA in activated T lymphocytes, 
all the siRNA against class I alpha was exhausted. As the focus for this study was 
the class II isoforms no additional class I a siRNA or specific probes were 
purchased.
Increasing the concentration of all of the siRNAs from 0.1, 1 to 25 nM produced a 
concentration dependent decrease in the quantity of knockdown seen within each 
targeted isoform (figure 3.10 left panels). Delivery of non-targeting siRNA did have 
a minimal effect on isoform expression, although these differences were not
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concentration dependent and they were seen at even at the lowest concentrations 
of siRNA, suggesting no effect on specific targets.
SiRNAs specific for class I p suggest that although both sequences were effective 
in reducing the mRNA levels, sequence 5 shows the highest potency, as it 
produced a greater knockdown at lower concentrations. The lowest concentration 
of siRNA tested against class I 5 (0.1 nM) was unable to produce a knockdown of 
the targeted isoform. Strong knockdown of class I 6 was achieved with 1 nM of 
sequence 4 siRNA while sequence 2 only gave this level of potency by 25 nM. The 
class II alpha siRNAs gave strong and comparable concentration dependent 
knockdown of the target isoform even at 0.1 nM. Class II (3 siRNAs were 
comparatively less potent than a, with sequence 1 showing no effective response 
until 1 nM, although potencies of sequence 1 and 3 were comparable at this 
concentration.
Figure 3.10 right panels, demonstrates the ‘off-target’ effects of the siRNAs which 
will be used within this study. Here 25 nM target specific siRNA was used (the 
highest concentration tested within this system) to assess the effect not only on the 
target isoform but against other PI3K isoforms. Delivery of class I p siRNAs 
induced strong knockdown of the class I p isoform compared to control and non­
targeting siRNA, with no decrease in the other PI3K isoforms. This target 
specificity was observed following delivery of class I 5, class II a or p, all of which 
demonstrated a decrease in target specific RNA and no decrease in any other PI3K 
isoforms tested. It is however interesting to note, that following delivery of either 
class I p or class II a siRNA there was a slight increase in the RNA levels of class I 
delta. This trend was observed for each sequence of siRNA and over the triplicate 
experiments.
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Figure 3.8 Validation of siRNA is ineffective in activated T lymphocytes. PHA
activated T lymphocytes (5 x 106 cells) were left untreated or nucleofected with 4 pM of PI3K 
Class I alpha siRNA (siRNA 5). 72 hours post treatment dead cells were removed and cells 
lysed and homogenised. Contaminants were removed and the RNA isolated. The 
concentration and quality of the RNA was determined on a 2100 Bioanalyzer (Agilent 
Technologies) using the RNA 6000 LabChip kit. 5 x 106 cells in the control sample (left 
panel) was compared to 5 x 106 nucleofected cells (middle panel) and 1 x 107 nucleofected 
cells. Data is representative of 2 individual donors analysed in triplicate.
123
Chapter 3 - Results, Section I I I
25
Alpha Beta Gamma Delta Alpha Beta Gamma III 
PI3K Class I PI3K Class II
B
E> SiRNA Numberg> siRNA Number SiRNA Number
E? SiRNA NumberSiRNA Number SiRNA Number
Figure 3.9 Validation of siRNAs in HeLa cells. Target specific knockdown of PI3K 
class I alpha, beta, delta, class II alpha, beta and class III in Hela cells. Briefly, HeLa cells 
were transfected using Oligofectamine for 24 hours, and total cellular RNA was isolated 
using the Qiagen RNeasy kit according to manufacturer’s instructions. The concentration 
and quality of the RNA was determined on a 2100 Bioanalyzer (Agilent Technologies) using 
the RNA 6000 LabChip kit. RNA was reverse transcribed using a Biometra UNO II 
thermocycler. Quantitative PCR was performed and analysed using Sequence Detector 
Software (SDS version 2.1). Data was obtained in triplicate. mRNA levels are expressed as 
mean ± SD.
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Figure 3.10 Concentration dependent knock down of PI3K isoforms displays 
limited effects on the other P!3K isoforms. Concentration dependent target specific 
knockdown of PI3K class I beta (A, left panel), delta (B, left panel), class II alpha (C, left 
panel), beta (D, left panel) in HeLa cells. PI3K isoform off target effects monitored following 
delivery of 25 nM siRNA PI3K class I beta (A, right panel), delta (B, right panel), class II 
alpha (C, right panel), beta (D, right panel) and class III (E, right panel) in HeLa cells. 
Briefly HeLa cells were transfected using Oligofectamine for 24 hours, and total cellular RNA 
was isolated using the Qiagen RNeasy kit according to manufacturer’s instructions. The 
concentration and quality of the RNA was determined on a 2100 Bioanalyzer (Agilent 
Technologies) using the RNA 6000 LabChip kit. RNA was reverse transcribed using a 
Biometra UNO II thermocycler. Quantitative PCR was performed and analysed using 
Sequence Detector Software (SDS version 2.1). Data was obtained in triplicate. mRNA 
levels are expressed as mean ± SD.
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3.9 Lipid based delivery of DNA and siRNA into activated T lymphocytes is 
ineffective.
Before embarking on the optimisation of a new transfection method (Nucleofection), 
the efficiency of other methods of siRNA delivery were evaluated. Delivery of DNA 
such as plasmids, have been successfully transfected into cell lines using a variety 
of techniques; including viral methods such as lenti- and adeno- viral, or non-viral 
methods such as lipofection and electroporation. Initially, there was no capacity to 
test viral methods of delivery, therefore lipid based systems were tested. This 
technique is advantageous as it enables high transfection efficiencies coupled with 
low toxicity.
Within these investigations, delivery of GFP-encoding plasmids and the smaller Cy 
3 tagged siRNAs into day 6 activated human T cells were compared. Figure 3.11A 
upper panel, demonstrates the effect using a lipid based methods to introduce a 
GFP encoding plasmid (open blue histogram). This figure illustrates no increase in 
fluorescence (this would be indicated with a shift in the histogram to the right) when 
compared to control samples which had no plasmid (filled purple histogram), control 
sample mixed with plasmid but no lipid carrier (open pink histogram) or transfected 
with an empty vector (open green histogram).
In figure 3.11A lower panel, the cells were transfected via a lipid carrier with a Cy3 
tagged siRNA, control cells (filled purple histogram) or cells transfected with a non­
targeting siRNA (open green histogram) show no fluorescence. However, an 
increase in fluorescence is seen in cells transfected with Cy3 tagged siRNA and 
those just mixed with the Cy3 tagged siRNA (i.e. no lipid carrier). This is further 
explained in figure 3.11B, in which cells have been mixed with Cy3 tagged siRNA 
and analysed under a light and fluorescence microscope (upper and lower panel 
respectively). This figure demonstrates that the siRNA binds to the cell surface and 
because it has a Cy3 tag, fluoresces even in the absence of transfection into the 
cell. Thus the ‘expression’ seen following mixing of the siRNA and the cells, can 
actually be attributed to extracellular binding and is a ‘fake positive’. These results 
suggest that lipid based delivery of both plasmid and siRNA was met with limited 
success and should not be carried forward for the delivery of PI3K siRNA. Instead, 
the novel method of Nucleofection was tested.
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Figure 3.11 Lipid based delivery of plasmids or siRNA is ineffective in day 6 
PHA activated T lymphocytes. PHA activated T lymphocytes were transfected using 
lipofectamine 2000, with either GFP encoding plasmids (A, top panel) or Cy3 tagged siRNA 
(A, bottom panel) (open blue histograms) and analysed using flow cytometery (A) or 
microscopy (B). These samples were compared to control which where either non- 
transfected cells (filled purple histograms), non-transfected and mixed with GFP plasmid or 
Cy3 tagged siRNA (open pink histogram) or transfected with an empty plasmid or non­
targeting siRNA (open turquoise histogram). Briefly, plasmid or siRNA were added alone or 
mixed with lipofectamine and added to cells in RPMI-1640 supplemented with 1 % FCS with 
no antibiotics, after 4 hours at 37 °C and 5 % C 02, FCS was added giving a final 
concentration of 10 %. Cells were incubated for 24 hours, and analysed by flow cytometery 
or microscopy.
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3.10 Delivery of DNA & siRNA into activated human T cells
Previous studies have utilised nucleofection as a technique to deliver siRNA or DNA 
into primary human cells, such as CD4+ T cells. Within these investigations, 
activated T cells, which mimic the in vivo development of T cells following antigen 
presentation, were used. This in vitro activation and maintenance of the T cells, 
results in the up regulation of chemokine receptors, allowing for a panel of 
chemokines to be investigated within the chemotactic response.
3.10.1 Optimising the Nucleofection Procedure
Nucleofection is based on electroporation, in which a short electrical pulse creates 
transient pores within the plasma membrane, allowing siRNA to enter the cell. 
Within most electroporating systems the electrical pulse can be varied in order to 
optimise the transfer of DNA/RNA into the cell, yet this cannot be performed with 
the Nucleofector, as only the program numbers are disclosed. Within the 
Nucleofector system there is one nucleofector solution for activated T cells and the 
device has two different Nucleofector programmes which can be used, either T20 or 
T23. T23 gives higher transfection efficiencies, yet is harsher on the cells, whereas 
T20 is less harsh but is reported to give lower efficiencies.
Initial studies focused on assessing the efficiency of the nucleofection method to 
deliver GFP encoding plasmids (figure 3.12). During optimisation of this delivery, 
the effect of different nucleofector programs (figure 3.12A), increasing 
concentrations of plasmid (figure 3.12B) and different GFP encoding constructs 
(figure 3.12C) were evaluated. The experimental procedures mirrored those that 
would be used for siRNA experiments and could therefore highlight any potential 
issues that may arise within the system.
In control samples (figure 3.12A upper left panel) less than 1 % of cells were 
positive for fluorescence, this was comparable to cells nucleofected without a 
plasmid (mock), however, and larger cell death was observed (10 % and 54 % 
respectively). The nucleofection device afforded two setting for delivery of DNA or 
siRNA into activated T lymphocytes. These 2 delivery programs, termed T20 and 
T23, were assessed for efficiency of transfection, within this system. Both settings
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delivered GFP-encoding plasmids into approximately 5 % of the nucleofected 
population, with 85 % cell death (figure 3.12B bottom panels). Increasing the 
concentration of the GFP-encoding plasmid showed limited effect although 2 \ig 
consistently yielded the highest efficiency, while cell death increased with the 
concentration of DNA, 77, 85 and 90 % respectively. Figure 3.12C, illustrates the 
effect of plasmid sequence on nuclofection efficiency. A panel of GFP- and protein 
encoding plasmids (GFP, GFP-Arno, -TAPP, -PKB and -CXCR4) were nucleofected 
into day 6 activated T cells. This study indicated that altering the sequence of the 
plasmid could not significantly increase the percentage of cells transfected and that 
nucleofection efficiency was limited within this system. Furthermore, it is clear that 
nucleofection has a detrimental effect on cell viability.
It was established with the delivery of plasmids into activated T cells (figure 3.12) 
that cell viability may be a hurdle which needed to be overcome to facilitate a 
successful protocol. In order to achieve this outcome, it was essential that the 
protocol was fully optimised, therefore each step of the protocol was scrutinised and 
tested. The optimisation process that was undertaken is detailed here.
3.10.2 Influence of the T cell activating stimuli on survival and 
functionality
The process began with identifying the best T cell activator for the Nucleofecting 
protocol. The expression profiles of PHA and CD3/CD28 activated T cells, showed 
all PI3K isoforms were present over the full time course of the study. Both T cell 
activation methods were tested for not only cell viability but functional responses in 
a CXCL12 mediated chemotactic assay (figure 3.13).
Six days post activation with PHA or CD3/CD28, cells were nucleofected and left to 
recover for 72 hours before proceeding with functional assessment. The viability of 
cells after this 72 hour recovery period is very low for both PHA and CD3/CD28 
activated cells (figure 3.13A left panel). This data suggests that CD3/CD28 
activated T cells are more sensitive to the nucleofection process as fewer viable 
cells are available for functional studies. Furthermore, on some occasions when 
CD3/CD28 was utilized to activate the cells, there were not enough viable cells to
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complete the chemotaxis study. This variability both within PHA and CD3/CD28 
activated T cells would suggest that there is also a donor dependent variability 
within this study.
3.10.3 Effect of T cell age at time of Nucleofection
PHA activated T lymphocytes were expanded in vitro and used in studies up to 12 
days following activation, after this time the cells show diminished/altered functional 
and biochemical responses. The manufacturer’s protocol for nucleofection of 
activated T cells, states the best time point for nucleofection is day 6. Within these 
investigations the effect of age on nucleofecting process was assessed. This 
included nucleofecting activated T cells with non targeting siRNA at day 9, for use in 
studies 72 hours later. These older T cells were not as robust as day 6 cells, and 
are more susceptible to cell death resulting in fewer cells to perform functional 
studies. For this technique, the age of the activated T cell is a critical factor for the 
viability of the cells.
Figure 3.13B left panel, shows that PHA activated T cells gave a strong chemotactic 
response to 10 nM CXCL12. Following nucleofection, the cells chemotaxed 
towards CXCL12 although the response was not as robust. CD3/CD28 activation of 
T cells showed a strong chemotactic response, although not as robust as PHA 
activation, and following nucleofection the functional response was impaired (figure 
3.13B right panel). Taking into account both the viability and functionality data, 
these studies suggest that PHA activation gave the most consistent viability and 
robust functional response and would be used as the T cell activator of choice for 
these studies.
3.10.4 Effect of the Nucleofection program on functionality
Figure 3.14 shows activated T cells Nucleofected with non targeting siRNA on 
program T20 or T23, analysis was performed using CXCL12-mediated chemotaxis 
as a functional readout. These results indicated that nucleofection on either T20 or 
T23 shows comparable detrimental affects on the CXCL12-mediated chemotactic 
response.
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3.10.5 Targeting siRNAs produce a decrease in corresponding mRNA 
levels
The design and subsequent potency of an siRNA is difficult to predict within a given 
system. Therefore during the optimisation of the Nucleofection protocol, it was 
imperative to test this system with a potent and previously characterised siRNA. 
This test ensured that the system is effective and results in the subsequent 
knockdown of a target gene. For this the Phosphodiesterse 7A (PDE7a) was 
chosen.
Figure 3.15 demonstrates the effect on mRNA levels following the introduction of a 
non-targeting siRNA, compared to PDE7A siRNA via qPCR analysis. Analysis of 
the mRNA levels in control samples was compared to levels in samples which have 
been nucleofected with a non-targeting siRNA; this allows for any alteration in the 
levels of the RNA due purely to the presence of a siRNA molecule to be assessed. 
Figure 3.15 shows TaqMan analysis compared to the housekeeping gene GAPDH. 
There is no significant difference between control and the non-targeting siRNA. 
Nucleofection on program T20 and T23 with the potent PDE7a siRNA, resulted in a 
decrease in the levels of PDE7a mRNA when compared to nucleofection of a non­
targeting siRNA or control sample (analysis was perform 72 hours post 
nucleofection). Using this well characterised potent siRNA, it was shown that 
targeting siRNA could knock-down a specific gene within PHA activated T cells, 
therefore there is the potential within the system to effectively target PI3K if the 
siRNAs are effective.
As T23 is considered to be a harsher treatment for the cell (according to 
manufacturer’s protocol) and RNA knockdown from either T20 or T23 is comparable 
(figure 3.15) the T20 setting was used in future experiments.
3.10.6 Cellular uptake of Cy3 tagged siRNA
When performing siRNA knockdown experiments, it is essential that the optimum 
conditions are used in order gain maximum knockdown, while minimising off target
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effects. Cy3 is a fluorophore that can be coupled to siRNA molecules, and following 
nucleofection into a cell allows visualisation (via flow cytometry or microscopy) of 
the cellular uptake of the siRNA. To determine the optimum conditions for highest 
transfection efficiency, increasing concentrations of Cy3 tagged siRNA were 
introduced into the cells and analysed over 96 hours to ensure the siRNA could be 
sustained over the time course of the experiment (figure 3.16A). This study allowed 
for the optimum concentration of siRNA being determined (i.e. highest 
concentration which is delivered into the cell without resulting in a detrimental effect 
on the cell). This technique was further validated using flow cytometery to 
demonstrate the effect of CXCL12-mediated chemotaxis on cells Nucleofected with 
a Cy3 tagged siRNA (figure 3.16B).
This study indicates that Cy3 tagged siRNA was delivered into activated T 
lymphocytes in a concentration dependent manner (figure 3.16A). Control cells 
which have no siRNA are represented by the purple filled histogram, any cells 
which fall within this region are therefore negative for fluorescence, and contained 
no siRNA. A shift to the right indicated by all other unfilled histograms suggests an 
increase in fluorescence within the sample, and transfection with the Cy3 tagged 
siRNA. The lowest concentration of siRNA 0.1 pM (green line) has been 
transfected into these cells as early as 2 hours post nucleofection, a concentration 
dependent response is seen, with 1 (pink line), 4 (green line), and 10 (orange line) 
pM, each delivering increasing amounts of siRNA into the cells. Over the 96 hour 
time course, all samples remain positive for increased fluorescence, indicating that 
the siRNA is still present within the cells at this time point.
It was shown that Cy3 tagged siRNAs can be successfully introduced into activated 
T cells, yet it must also be ensured that the cells which chemotax contain the 
siRNA. Figure 3.16B shows that 72 hours post nucleofection with a Cy3 tagged 
siRNA, viable cells chemotax in a CXCL12 dependent fashion. Moreover, flow 
cytometery analysis, demonstrates that these cells display a similar profile to those 
cells of the starting population (cells that contain the siRNA but have not been 
chemotaxed). This suggests that the chemotaxing cells do contain siRNA.
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Figure 3.12 Limited expression of a panel of GFP encoding plasmids in PHA 
activated T lymphocytes 24 hours post nucleofection. Day 6 PHA activated T 
cells (5 x 106) cells were re-suspended in T cell specific nucleofecting solution, without 
nucleofection, Nucleofected without siRNA, Nucleofected with GFP-ARNO on program T20 
or T23 (A). Increasing concentrations of GFP-ARNO were Nucleofected on program T20 
into day 6 activated T cells, 1 pg (B, left panel), 2 pg (B, middle panel), and 5 pg (B, right 
panel). (C) A panel of plasmids encoding GFP, GFP-ARNO, GFP-TAPP, GFP-PKB or GFP- 
CXCR4 were Nucleofected on program T20. Following nucleofection samples were 
transferred to RPMI-1640 supplemented with 10 % FCS and IL-2 and analysed for GFP 
expression after 24 hours via flow cytometry. Data is representative of 3 individual donors.
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Figure 3.13 The method of T lymphocyte activation and age of the cel! at 
nucleofection can influence viability and functionality. A (left panel) Viability of T 
cells 3 days post nucleofection comparing PHA and CD3/CD28 activation methods. A (right 
panel) The viability (72 hours post nucleofection) of PHA activated T cells following 
nucleofection on either day 6 or day 9. In control or non-nucleofected cells the percentage of 
dead cells was 10.5 %. B) CXCL12-mediated chemotaxis of PHA (left panel) or CD3/CD28 
(right panel) T cells following nucleofection of non-targeting siRNA. Briefly, 5 x 106 cells 
were Nucleofected or not with 4 pM non-targeting siRNA, transferred to complete media and 
after 4 hours resuspended at 1 x 106 with the addition of IL-2 (20 ng/ml) at 37 °C. Dead cells 
were removed and following 72 hours of recovery, cells were chemotaxed to 10 nM CXCL12 
or assessed for viability (see materials and methods, data is from 3 combined experiments 
for PHA and CD3/CD28).
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Figure 3.14 Delivery of siRNA into activated T lymphocytes via program T20 
or T23 demonstrated detrimental effects on CXCL12-mediated chemotactic 
responses. PHA activated T lymphocytes (5 x 106 cells) were re-suspended in T 
lymphocyte specific nucleofecting solution (control) or were Nucleofected with non-targeting 
siRNA on program T20 or T23 as described in Materials and Methods. Following 
nucleofection samples were transferred to RPMI-1640 and after 4 hours transferred to fresh 
RPMI-1640 supplemented with 10 % FCS and IL-2 (20 units/ml). Following 72 hours of 
recovery dead cells were removed and viable cells were chemotaxed to 10 nM CXCL12 see 
materials and methods. Data is expressed as number of cells (mean ± SD). The data are 






Figure 3.15 Target specific knockdown of PDE 7a following nucleofection of a PDE 7a 
siRNA into day 6 PHA activated T lymphocytes. Activated T lymphocytes (5 x 106 cells) 
were re-suspended in T lymphocyte specific nucleofecting solution (control) or were 
Nucleofected with non-targeting or PDE 7a siRNA as described in Materials and Methods. 
Following nucleofection samples were transferred to RPMI-1640 and after 4 hours 
transferred to fresh RPMI-1640 supplemented with 10 % FCS and IL-2 (20 units/ml). Total 
human RNA (5 x 106 cells) was isolated using the Qiagen RNeasy kit, RNA quantity was 
determined on a 2100 Bioanalyzer (Agilent Technologies), using the RNA 6000 LabChip kit. 
cDNA was obtained by RT-PCR followed by quantitative PCR as described in Materials and 
Methods. The data are derived from one experiment in triplicate, which is representative of 
3 different donors (mean ± SD).
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Figure 3.16 Concentration dependent cellular uptake of Cy3 tagged siRNA by PHA 
activated T lymphocytes. PHA activated T lymphocytes, were analysed i) 2 hours ii) 24 
hours iii) 48 hours iv) 72 hours and v) 96 hours post nucleofection. Briefly 5 x 106 cells were 
re-suspended in T lymphocyte specific nucleofecting solution and were or were not 
Nucleofected with 0.1 (green line), 1 (pink line), 4 (blue line) or 10 pM (orange line) Cy3 
tagged siRNA on program T20 as described in Materials and Methods. Following 
nucleofection samples were transferred to complete media, after four hours cells were 
resuspended at 1 x 106 and cultured in complete media with IL-2 for up to 96 hours. Data is 
representative of 5 donors. One sample was saved for flow cytometry analysis and one 
sample of cells (8 x 104/ 25 pi) was placed on the upper membrane of a 96-well chemotaxis 
plate, above lower chambers containing 10 nM CXCL12. B), Cells Nucleofected with 10 pM 
Cy3 tagged siRNA were then chemotaxed across a 5 pm pore size membrane after a 3 hour 
incubation at 37 " C in 5 % C 02 (dark grey line) were compared to the original non- 
chemotaxed sample (light gray line) and a control non Nucleofected (black filled histogram) 
sample using flow cytometry. Data is representative of 5 individual donors.
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3.11 Characterization of chemotactic responses to a panel of ligands
CXCL12 is a ligand for the CXCR4 receptor, has been found to be a highly potent 
chemotactic agent within leukocytes and is found not only on activated T cells but 
also freshly isolated T cells (Loetscher et al., 1994; Bleul et al., 1996). Following 
activation T cells upregulate certain receptors on their cell surface, thus allowing 
them to respond to a greater number of chemotactic agents. Therefore, to create a 
fuller profile of PHA activated T lymphocyte chemotaxis, a panel of ligands was 
utilized. Here the migratory responses of activated T cells towards the chemokines 
CXCL10 and CXCL12 were assessed.
Figure 3.17A compares the dose response curves for CXCL12 (left panel) and 
CXCL10 (right panel) in control cells and cells Nucleofected with a non-targeting 
siRNA. Furthermore, expression profiles for CXCR4 and CXCR3 (the receptors for 
CXCL12 and CXCL10 respectively) before and after nucleofection are examined 
(B).
CXCL12 induces a concentration dependent chemotactic response, with a peak 
response at 10 nM. This is also the peak response seen in samples Nucleofected 
with non-targeting siRNA, yet, functionally the response is diminished, with overall 
less cells chemotaxing to any given concentration of CXCL12. CXCLIO-mediated 
chemotaxis, gave a strong concentration dependent response with a peak at 10 nM, 
however, this response was strongly reduced by the effect of nucleofection with a 
non-targeting siRNA. Interestingly, neither the CXCR4 nor CXCR3 receptors 
displayed altered expression following nucleofection. It is worth while noting that 
chemotaxis towards CXCL10 was donor dependent. The data shown in figure 3.17 
right panels, is representative of 3 donors, however 6 further donors were studied 
yet control samples showed no CXCL10-dependent migration.
3.12 Limitations in the use of Nucleofection in activated T cells
Optimisation of the nucleofection procedure for activated T lymphocytes was 
thorough. However, it was clear that the nucleofection process had detrimental 
effects on the CXCL12-mediated chemotactic response.
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Figure 3.17C analyses this further by addressing the effect of mock nucleofection, 
(activated T cells Nucleofected without any siRNA) compared to control cells (left 
panel) and cells Nucleofected with non-targeting siRNA compared to control (right 
panel). Following mock nucleofection, the number of viable cells chemotaxing to 10 
nM CXCL12 is reduced from 19,000 to 7,000. Following nucleofection with non­
targeting siRNA, chemotaxis drops from 17,000 in control to 8,000 in Nucleofected 
samples. These data suggest that the act of nucleofection with or without siRNA 
has a detrimental effect on the chemotactic functional readout.
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Figure 3.17 Effect of nucleofection on CXCL12- and CXCL10- mediated chemotactic 
responses in PHA activated T lymphocytes. CXCL12- (A, left panel) and CXCL10- (A, 
right panel) mediated chemotactic response of control and Nucleofected PHA activated T 
lymphocytes, compared to CXCR4 and CXCR3 receptor expression (B). C) CXCL12- 
mediated chemotaxis of PHA activated T cells following Mock nucleofection (left panel) or 
nucleofection with a non-targeting siRNA (right panel). Briefly, 5 x 106 cells were 
Nucleofected or not with 4 pM non-targeting siRNA, transferred to complete media and after 
4 hours resuspended at 1 x 106 with the addition of IL-2 (20 ng/ml) at 37 “C. Following 72 
hours of recovery dead cells were removed and viable cells were chemotaxed to 10 nM 
CXCL12. (see figs for details). Chemotactic data is expressed as number of cells. Data is 
expressed as mean ± SD. The data are derived from a single experiment in triplicate that is 
representative of two other experiments. A sample of these viable control and Nucleofected 
T cells were assessed for CXCR4 (B, left and middle panel) and CXCR3 (B, right panel) 
expression levels (see materials and methods).
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3.13 Adenoviral delivery of siRNA into activated T cells is ineffective
With Nucleofection an ineffective tool for transfection of activated T cells, attention 
turned to a novel adenoviral system for delivery of short hairpin RNA. This 
technology was unavailable at the beginning of the study, however, had been used 
successfully within the lab for transfection of primary human fibroblasts and was 
marketed as a tool for transfection of activated primary T ceils.
Before purchasing shRNA against PI3K, the system was tested utilizing a shRNA 
against PLC y which had been previously validated with primary human fibroblasts. 
The protocol used for these studies was defined by the manufacturer as the optimal 
conditions for activated T cell transfection and if successful would be utilized with 
PI3K shRNA.
The hallmark receptor utilised by adenovirus to infect a cell is the CAR receptor 
(Bergelson et al., 1997), (coxsackie/adenovirus receptor), yet T cells do not express 
this receptor and therefore are not susceptible to infection by the traditional 
adenovirus. However, certain adenovirals utilize CD46 (MCP, Membrane Cofactor 
Protein (Nakanishi et al., 1994)) which is expressed on T cells. With this 
knowledge, a chimeric virus was created that utilised the CD46 receptor and 
increased its expression on the cell thus allowing for increased rates of transfection. 
It is these advances in adenoviral delivery that suggested that T cells could in fact 
benefit from this.
Delivery of the EGFP expressing virus showed that expression of EGFP peaked at 
day 7 at 40 % (figure 3.18A). Yet following delivery of 3 different siRNA sequences 
against PLC y, this did not correlate with a knockdown of mRNA levels of the 
targeted isoform, when compared to control and mock nucleofections (figure 3.18b). 
These results suggest that the adenoviral delivery system is ineffective in the 
transfection of activated T cells.
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Figure 3.18 Adenoviral delivery of target specific siRNA into day 7 PHA activated T 
lym phocytes is ineffective. EGFP expression in PHA activated T lymphocytes with an 
empty adenoviral vector (A, left panel) or an eGFP encoding adenoviral (A, right panel). 
Expression of PLC y in PHA activated T lymphocytes (B). PBMCs were isolated from whole 
blood and activated with PHA. Twenty-four hours post activation, T lymphocytes were 
infected with an adenovirus encoding for the eGFP shRNA an empty adenovirus encoding 
for eGFP alone, CD46 alone, or co-infected with PLC Gamma sequence V1, V2 or V3 with 
CD46 shRNA (multiplicity of infection 1:5000). Total RNA was isolated using the Quigen 
RNeasy kit, RNA quantity was determined on a 2100 Bioanalyzer (Agilent Technologies), 
using the RNA 6000 LabChip kit. CDNA was obtained by RT-PCR followed by quantitative 
PCR as described in Materials and Methods. The data are derived from one experiment in 
triplicate.
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3.14 Optimising Nucleofection of freshly isolated T cells
Following the thorough optimisation of the nucleofection procedure in activated T 
cells, it was clear that this model could not fulfil the requirements necessary to 
assess the role of PI3K isoforms.
Although the number of varied receptors on the cell surface is lower on freshly 
isolated T cells compared to activated cells, CXCL12 is expressed on both 
populations and provides an insight into the mechanism involved within the 
migratory processes of the human T cell.
3.14.1 Nucleofection affects Viability but not functionality of freshly 
isolated T cells
The ultimate problems faced when utilizing the activated T cell model, were issues 
of viability and subsequent functionality, it was therefore essential to determine the 
effects that nucleofection would have on freshly isolated T cells. Figures 3.19 &
3.20 address these issues. Although utilizing an alternate cell model, the 
nucleofection protocols were very similar, differing only in the program from which 
the cells were Nucleofected on. Figure 3.19A highlights the effect of nucleofection 
on viability of freshly isolated cells compared to activated cells 72 hours post 
nucleofection. Freshly isolated cells are more robust within the nucleofection 
procedure, averaging 35 % viability compared with 9 %. Considering the number of 
cells that can be isolated from each donor, this is a feasible viability to continue with 
and functionality was assessed. Although, 72 hours recovery time was 
recommended before functional studies commence, a time course highlighting the 
functionality of the cells was established. Twenty-four hours post nucleofection (left 
panel) demonstrates that both basal and CXCL12 mediated chemotaxis is 
decreased compared to control samples. This is the case for 48 hours post 
nucleofection (middle panel). However, resting human T cells for 72 hours post- 
nucleofection allows for the recovery of a strong CXCL12-mediated chemotactic 
response that is comparable to the control sample (right panel). Figure 3.19B 
supports the finding that recovery time at least for freshly isolated cells is an 
essential component to restore functionality.
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3.14.2 Transfection efficiencies in freshly isolated T cells.
To determine the optimum conditions for the highest transfection efficiency, 
increasing concentrations of Cy3 tagged siRNA, was introduced into the cells and 
analysed over 72 hours (figure 3.20A). Furthermore, fluorescence microscopy was 
employed to visualise T cells 72 hours post-nucleofection (figure 3.20B). This 
technique was validated using flow cytometery, to demonstrate the effect of 
CXCL12-mediated chemotaxis on cells Nucleofected with a Cy3 tagged siRNA 
(figure 3.20C).
Cy3 tagged siRNA was delivered into freshly isolated T lymphocytes in a 
concentration dependent manner (figure 3.20). Control cells without Cy3 tagged 
siRNA are represented by the filled purple histogram, any cells which fall within this 
region are therefore negative for fluorescence, and contained no siRNA. A shift to 
the right indicated by all other unfilled histograms suggests an increase in 
fluorescence within the sample, and transfection with the Cy3 tagged siRNA. The 
lowest concentration of siRNA 0.1 pM (green line) showed no transfection of the 
siRNA at any time point, increasing the concentration of the siRNA resulted in a 
concentration dependent increase in the amount of siRNA incorporated into the 
cells, 1 (pink line), 4 (green line), and 10 (orange line) pM. Over the 72 hours 1, 4 
and 10 pM all show expression of the Cy3 tagged siRNA.
At 72 hours, viable cells were analysed by confocal microscopy (figure 3.20B). 
Control cells show no fluorescence (upper panel); while cells transfected with Cy3 
tagged siRNA demonstrate that the siRNA has been incorporated into the cell and 
is maintained within the cytoplasm but not the nucleus of the cell 72 hours post- 
nucleofection (as assessed by DAPI staining).
A CXCL12-mediated chemotaxis assay followed by flow cytometeric analysis (figure 
3.20C) shows that the fluorescence profile of these cells is similar to that of cells 
that just underwent flow cytometeric analysis. This expression profile suggests that 
cells that have undergone nucleofection and incorporated the siRNA, do respond to 
a chemotactic stimulus, and thus migrate in a CXCL12-dependent manner.
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3.15 PI3K targeting siRNA had no effect on CXCL12 induced 
chemotactic responses.
Thus far, data has been collected and the protocol optimised to ensure that there is 
confidence in the results obtained in the functional studies. Tests in this freshly 
isolated T cell model had a favourable outcome, suggesting this may be a 
successful protocol. Other studies using murine T cell models have demonstrated 
efficiency. Following this observation, freshly isolated T cells were Nucleofected 
with class II PI3K isoform specific siRNA, as a comparison, both class I 5 and class 
I y were tested. The two most potent siRNA (as determined within the HeLa cell 
line) were selected. However, as HeLas contain no class I y. all 4 of the siRNAs 
were tested within the freshly isolated T cell model. 72 hours post nucleofection the 
number of cells chemotaxing towards CXCL12 was determined. Furthermore, 
samples of each treatment were analysed by qPCR for the levels of the targeted 
PI3K isoform, compared to non-targeting siRNA and control levels.
In some donors, delivery of non-targeting siRNA resulted in a decreased 
chemotactic response compared to control samples (figure 3.21 C, D left panels). 
However, this effect was not significant. Furthermore, delivery of PI3K target 
specific siRNA against class I delta, gamma, class II alpha and beta did not produce 
any significant effects on basal or CXCL12-induced chemotactic responses 
compared to the responses of cells nucleofected with non-targeting siRNA (A-D left 
panels).
Knockdown of the PI3K isoform mRNA varied considerably depending on the 
sequence of the siRNA. Limited knockdown was also seen within some isoforms 
following delivery of non-targeting siRNA (figure 3.21 B, C & D right panels). Class 
I delta, sequence 3 produced limited knockdown (25 %) while sequence 4 was 
capable of producing 60 % knockdown (figure 3.21 A right panel). However, all 4 
siRNAs tested against class I gamma produced knockdown of 50- 60 % (figure
3.21 B right panel). Both class II alpha and beta siRNAs produced knockdown of 
40-45 % (figure 3.21 C & D right panels respectively).
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3.16 Class II (3 siRNA produced limited knockdown at the protein level
Quantifying the amount of RNA knockdown of a particular isoforms is a good 
indicator of siRNA effectiveness. However, experience within our lab has 
highlighted that different quantities of silencing at the RNA level can produce 
different impacts on protein and functionality dependent on the gene being targeted. 
It is therefore essential, that the effect or lack of effect seen at the functional level is 
only assessed within the scope of the subsequently determined protein level. The 
silencing at the mRNA level was between 50-60 %, however, a limitation when 
working with human T cells is the high level of cell death over the 3 days of culture 
(35 % cell viability after nucleofection). Consequently, there were difficulties in 
recovering enough protein from viable Nucleofected samples, to allow detection by 
immunoblot. Although attempted many times, only 1 immunoblot was successful 
(figure 3.22); therefore flow cytometric analysis was also utilized to assess the 
quantity of protein following knockdown. Figure 3.22A shows 2 samples of cells 
from a class II (3 knockdown compared with isotype, control and unstained samples 
over a 72 hour time course. Although good knockdown at mRNA level is seen for at 
least 1 siRNA sequence per isoform, the protein data suggests that this was not 
translated into an effect on the protein levels, as over this time course no 
knockdown of the class II (3 isoform was seen. This is supported by western 
blotting analysis which was performed at 72 hours (figure 3.22B).
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Figure 3.19 N ucleofection  a ffects  V iab ility  but not functiona lity  o f freshly  
isolated T cells  Freshly isolated T lymphocytes (5 x 106 cells) were re-suspended in T 
lymphocyte specific nucleofecting solution (control) or were Nucleofected with 4 pM non­
targeting siRNA as described in Materials and Methods. Following nucleofection samples 
were transferred to RPMI-1640 and after 4 hours transferred to fresh RPMI-1640 
supplemented with 10 % FCS and IL-2 (20 units/ml). A) Viability of freshly isolated cells 72 
hours post nucleofection compared to activated T cells. B) Following 24 (left panel), 48 
(middle pane) or 72 (right panel) hours of recovery dead cells were removed and viable cells 
were chemotaxed to 10 nM CXCL12 see materials and methods. Data is expressed as 
number of cells moving across the filter (mean ± SD). The data are derived from a single 
experiment in triplicate that is representative of two other donors.
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Figure 3.20 Concentration dependent cellular uptake of Cy3 tagged siRNA by freshly 
isolated T lymphocytes. Pan T lymphocytes were analysed 2 hours (A, top left panel), 24 
hours (A, top middle panel) 48 hours (A, top, right panel) and 72 hours (A, bottom panel) 
post nucleofection. Briefly 5 x 106 cells were re-suspended in T lymphocyte specific 
nucleofecting solution and were or were not Nucleofected with 0.1 (green line), 1 (pink line), 
4 (blue line) or 10 pM (orange line) Cy3 tagged siRNA was delivered into the cell on the 
nucleofection program V24 as described in Materials and Methods. Following nucleofection 
samples were transferred to complete media after four hours, cells were resuspended at 1 x 
106 and cultured in complete media with IL-2 for up to 96 hours. Data was analysed by flow 
cytometry. B) A sample Nucleofected with 10 pM Cy3 tagged siRNA was analysed by 
confocal microscopy, with and without DAPI staining. Data is representative of 5 donors. C), 
Cells Nucleofected with 10 pM Cy3 tagged siRNA were then chemotaxed across a 5 pm 
pore size membrane after a 3 hour incubation at 37 ‘ C in 5 % C 02 (dark grey line) were 
compared to the original non-chemotaxed sample (light gray line) and a control non 
Nucleofected (black filled histogram) sample using flow cytometry. Data is representative 
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Figure 3.21 legend continues on next page.
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Figure 3.21 Class I delta, gamma, class II alpha & beta have no effect on CXCL12- 
mediated chemotaxis in day 3 T lymphocytes. Freshly isolated T lymphocytes (5 x 106 
cells) were re-suspended in T lymphocyte specific nucleofecting solution and were left 
untreated or were Nucleofected with class I delta (A), gamma (B), class II alpha (C), beta 
(D) siRNAs as described in Materials and Methods. Following nucleofection samples were 
transferred to RPMI-1640 and after 4 hours transferred to fresh media supplemented with 
10 % FCS and IL-2 (20 units/ml). Following 72 hours of recovery, dead cells were removed 
and viable cells placed on the upper membrane of a 96-well chemotaxis plate above lower 
chambers containing 10 nM CXCL12, Chemotaxis across a 5 pm pore size membrane was 
determined after 3 hour incubation at 37 ’ C in 5 % C02 as described in Materials and 
Methods. Data is presented as number of cells migrated. mRNA levels are expressed as 
mean ± SD. Data were analyzed by ANOVA. Total human RNA (5 x 106 cells) was isolated 
using the Qiagen RNeasy kit, RNA quantity was determined on a 2100 Bioanalyzer (Agilent 
Technologies), using the RNA 6000 LabChip kit. cDNA was obtained by RT-PCR followed 
by quantitative PCR as described in Materials and Methods, (class I delta (A, right panel), 
gamma (B, right panel), class II alpha (C, right panel), beta (D, right panel). The data are 
derived from one experiment in triplicate, which is representative of 3 different donors.
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Figure 3.22 PI3K Class II Beta Protein is present following target specific knockdown  
at mRNA level. Freshly isolated T lymphocytes (5 x 106 cells) were re-suspended in T 
lymphocyte specific nucleofecting solution and were left untreated or were Nucleofected with 
class II beta siRNA. Following nucleofection samples were transferred to RPMI-1640 and 
after 4 hours transferred to fresh media supplemented with 10 % FCS and IL-2 (20 units/ml). 
(A) Protein levels of PI3K class II Beta were analysed over a time course of 24 (A, left 
panel), 72 (A, right panel) hours post nucleofection. At each time point samples were fixed, 
lysed and incubated with the Class II beta antibody and analysed by flow cytometery. The 
expression profile of the targeted class II beta isoform (open pink histogram) was compared 
to control II Beta expression (open orange histogram), the respective isotype control (open 
green histogram) and unstained cells (closed purple histogram). Western blot analysis was 
performed at 72 hours (B). Briefly, protein lysates from 3 x 106 cells were resolved on an 
SDS gel. Membranes were immunoblotted with an antibody against II beta. The position of 
II Beta is indicated. The membrane was stripped and reprobed with an anti-AKT antibody 
(lower panel) to demonstrate loading (NT, Non-targeting). See appendix for probing 
conditions.
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3.17 Alternative functional readout
The limitations of looking at the contribution of PI3K isoforms in the migratory 
responses of T cells is 2 fold. First, due to the culture time necessary following 
nucleofection, the role of at least class I isoforms cannot be elucidated, due to the 
switch in sensitivity towards PI3K inhibition; second, although a 50-60 % inhibition is 
observed at the mRNA level, this does not appear to translate into a silencing of the 
class lip targeted isoform. However, an alternative functional readout may require 
less silencing at the mRNA level, to demonstrate an alteration in functional 
response. In the search for an alternative readout of functionality, our interest 
turned to a highly sensitive and high throughput technique which had been recently 
developed. Like the ELISA (enzyme-linked immunosorbent assay) it is employed to 
detect the presence of substances within a given sample. This technique was 
utilized to detect levels of Th1/Th2 cytokines expression with the human T cell 
samples as an alternative functional readout.
The first investigation (figure 3.23A-I) studied the effects of nucleofecting a non­
targeting siRNA into both unstimulated and CD3/CD28 stimulated cells and the 
effect this had on the production of 9 different cytokines. Unstimulated cells 
demonstrated low levels of cytokine production, which increased following 24 hours 
CD3/CD28 stimulation. The level of expression varied depending upon the cytokine 
under investigation. Following nucleofection with a non-targeting siRNA, the 
expression of each cytokine decreased, in some unstimulated cells, expression was 
undetectable (e.g. IL-5). Cells which had been Nucleofected and then stimulated 
with CD3/CD28, also showed reductions in expression, the extent of which 
depended on the cytokine of interest.
A further experiment was conducted to investigate the effects of specific PI3K 
isoforms on CD3/CD28 T cell cytokine production (figure 3.24 A-l). Cytokine 
production following nucleofection of a PI3K targeting siRNA, were compared to 
those Nucleofected with a non-targeting siRNA. As a control, levels of cytokine 
production following 24 hours of CD3/CD28 stimulation alone were assessed. 
Utilizing a non-targeting siRNA induced a detrimental effect on all of the assessed 
cytokines. Comparing the effect of a non-targeting siRNA or a PI3K targeting 
siRNA, no effect was seen on IL-1(3, IL-4, IL-5, IL-12 and IL-13 cytokine production.
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There was an observed an increase in IL-8 production following nucleofection with 
all PI3K isoforms and this was opposite to the decreasing effects of the non­
targeting siRNA. An interesting effect may be seen following targeting of class I 
delta on the production of IFN-y and TNF. However, it is difficult to determine and 
state categorically due to the detrimental effect following introduction of a siRNA 
molecule.
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Figure 3.23 Nucleofection of non-targeting siRNA has a detrimental effect on 
cytokine production. Supernatant from control or Nucleofected day 3 T lymphocytes 
stimulated for 24 hours with CD3/CD28 analysed for expression of A) IFN-G, B) IL-1 (3, C) IL- 
4, D) IL-5, E) IL-8, F) IL-10, G) IL-12, H) IL-13, I) TNFa. Human cytokine assays were 
performed in a 96 well format, the plate was blocked for 1 hour in 0.1 % (w/v) blocker B 
solution, washed 3X with PBS plus 0.05 % Tween. Undiluted supernatants or calibrator 
solutions were incubated for 2 hours with shaking at room temperature. Antibody detection 
solution (1.0 pg/ml) was dispensed into each well, the plate sealed and incubated at room 
temperature for 2 hours with shaking. The plate was washed 3X with PBS plus 0.05 % 
Tween and 150 pi of 2X read buffer was added to each well of the plate, and analysed 
immediately on the SECTOR™ Imager.
153























































I P  nCin r















Figure 3.24 Assigning PI3K isoform specific involvem ent in T cell cytokine production  
is inconclusive following delivery of targeting siRNA into hum an T cells. Supernatant 
from control or Nucleofected with PI3K la, (3, 5, class II a or p day 3 T lymphocytes 
stimulated for 24 hours with CD3/CD28 analysed for expression of A) IFN-G, B) IL-1 (3, C) IL- 
4, D) IL-5, E) IL-8, F) IL-10, G) IL-12, H) IL-13, I) TNFa. Human cytokine assays were 
performed in a 96 well format, the plate was blocked for 1 hour in 0.1 % (w/v) blocker B 
solution, washed 3X with PBS plus 0.05 % Tween. Undiluted supernatants or calibrator 
solutions were incubated for 2 hours with shaking at room temperature. Antibody detection 
solution (1.0 pg/ml) was dispensed into each well, the plate sealed and incubated at room 
temperature for 2 hours with shaking. The plate was washed 3X with PBS plus 0.05 % 
Tween and 150 pi of 2X read buffer was added to each well of the plate, and analysed 
immediately on the SECTOR™ Imager.
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3.18 A limited role for PI3K in CXCL12-mediated chemotactic 
responses of activated human T lymphocytes
T cell activators in vitro can induce activation through a variety of different 
mechanisms; lectins, by crosslinking of glycoproteins, superantigens by specifically 
binding and stimulating the TCR independently of antigen, and importantly
CD3/CD28 antibody stimulation. Each of these methods provides various levels of 
stimulation, subsequent T cell ratios, and growth environment. It is therefore 
essential to address if these different in vitro activation methods result in different 
biochemically or functionally relevant responses. In order to address this, a panel 
of T cell activators were studied.
Following activation of T lymphocytes by PHA (Figure 3.25 & 3.26), SEB (Figure 
3.27) or CD3/CD28 (figure 3.28), the responses of T lymphocytes were assessed 
using biochemical readouts and chemotactic assays. The biochemical readout 
chosen was the effect on the phosphorylation of PKB. PKB is a key
serine/threonine kinase that is recruited to the plasma membrane via its PH domain, 
at which time it is phosphorylated and activated, propagating the downstream 
signalling cascade. It has been shown to be activated following chemokine 
stimulation and as the phosphorylation of PKB is dependent on active PI3K it can 
be utilized as an indirect method to measure PI3K activation. The functional
readout within this study was the measurement of the migratory response to the
chemokine CXCL12. CXCL12 is a potent inducer of chemotaxis within activated T 
cells and it is from this response that the effect of PI3K inhibition was measured; in 
addition the effect on basal migration was also assessed.
3.18.1 PHA activation
Figure 3.25A & B left panel, shows that following preincubation with the PI3K 
inhibitors LY294002 and wortmannin, PHA activated T cells demonstrate no 
significant change in the CXCL12-mediated chemotactic response. In contrast, a 
significant decrease in the basal migration is seen. This result correlates to a 
percentage inhibition of 55-60 % (figure 3.25A & B right panel). Interestingly, 
CXCL12-induced PKB phosphorylation was robustly inhibited by both inhibitors in a
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concentration dependent manner (figure 3.25C), thus verifying that the 
CXCL12/CXCR4 axis was biochemically coupled and LY294002 was active.
To ensure that PI3K sensitivity of one T cell subtype was not being masked by the 
insensitivity of another, PHA activated T lymphocytes were further separated into 
CD4+ and CD8+ subtypes (figure 3.26). The CXCL12-mediated chemotactic 
responses of both CD4+ and CD8+ are comparable (figure 3.26A), inducing a peak 
chemotactic response at 10 nM. However, as seen with CD3+ T cells, both subsets 
show no significant decrease in chemotactic response following preincubation with 
LY294002 (figure 3.26C). CXCL12 optimum chemotactic response could not be 
inhibited with 30 pM LY294002, yet phosphorylation of PKB was inhibited in a 
concentration dependent manner (figure 3.26B).
3.18.2 SEB activation
Following pre-treatment with either LY294002 or wortmannin, SEB activated T cells 
do not show a significant decrease in the CXCL12-mediated chemotactic response, 
compared to control (figure 3.27A & B). Furthermore, both inhibitors produce 
significant inhibition of basal migration (up to 60 %). This supports the data seen 
for PHA activation. Phosphorylation of PKB was inhibited in a concentration 
dependent manner, verifying that the CXCL12/CXCR4 axis was biochemically 
coupled.
3.18.3 CD3/CD28 activation
CD3/CD28 in vitro activation is the most physiologically relevant, and thus it was 
important to compare both PHA and SEB activation to this method. Preincubation 
with either PI3K inhibitor, showed no significant decrease in CXCL12-mediated 
response, interestingly the effect on basal was not as pronounced when compared 
to either PHA or SEB activation. LY294002 induced a 45% inhibition while 
wortmannin only induced a maximum of 25 % which was not statistically significant 
(figure 3.27A & B right panels). Phosphorylation of PKB was inhibited in a 
concentration dependent manner.
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Figure 3.25 CXCL12-mediated PHA activated T lymphocyte chemotaxis is 
insensitive to PI3K inhibitors. PHA activated T lymphocytes are resistant to increasing 
concentrations of PI3K inhibitors. Cells were pre-incubated with vehicle (open histobars, 
(A,B) or in the presence of 3, 10, or 30 pM LY294002 for 30 mins (A, right panel), or 30, 
100, or 300 nM Wortmannin for 30 mins (B, right panel), (closed histograms). Cells (8 x 104 
cells / 25 pi) were placed on the upper membrane of a 96-well chemotaxis plate above lower 
chambers containing 10 nM CXCL12. Chemotaxis across a 5 pm pore size membrane was 
determined after a 3 hour incubation at 37 'C  in 5 % C 02 as described in Materials and 
Methods. The percentage inhibition by Ly294002 or Wortmannin of basal (black lines) and 
CXCL12-stimulated cell migration (black lines) is depicted in the right panels. The data is 
taken from a single experiment in quadruplicates and is representative of 3 individual 
donors. Data is expressed as mean ± SD. Data were analyzed by ANOVA, and Dunnetts 
correction where required (*, p < 0.05). (Data from 3 donors were further analysed using 
ANOVA with repeated measures followed by Dunnets correction. Significance was observed 
at each concentration of inhibitor, P < 0.05). (C) Aliquots of T cells (2 x 106 cells/ml) were left 
untreated or stimulated in parallel at 37°C with 10 nM CXCL12 for 5 mins and lysed by the 
addition of 1 x sample buffer. Cell lysates were resolved by SDS-PAGE, transferred to 
nitrocellulose membranes, and immunoblotted with a phospho-specific PKB Ab with affinity 
for the active Ser473-phosphorylated form of PKB and protein was visualised with ECL. The 
blots were stripped and reprobed with anti-PKB Ab to verify equal loading and efficiency of 
protein transfer (lower panels).
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Figure 3.26 CXCL12-m ediated chem otaxis of CD4 and CD8 PHA activated T 
lym phocytes are insensitive to LY294002 inhibition. (A) Effect of increasing 
concentrations of CXCL12 on the chemotactic responses of CD4+ and CD8+ PHA activated 
T lymphocytes, and in the presence of LY294002 (B). Cells were pre-incubated with either 
vehicle (control, open histobars) or LY294002 (3- 30 pM, closed histobars) for 30 mins. 
Cells (8x104 cells / 25 pi) were placed on the upper membrane of a 96-well chemotaxis plate 
above lower chambers containing 10 nM CXCL12. Chemotaxis across a 5 pm pore size 
membrane was determined after a 3 hour incubation at 37 °C in 5 % C 02 as described in 
Materials and Methods. The percentage inhibition by LY294002 for basal (grey lines) and 
stimulated (black lines) is depicted in the right panels. The data is taken from a single 
experiment in quadruplicate and is representative of 3 individual donors. Data is expressed 
as mean ± SD. Data were analyzed by ANOVA with Dunnets correction where required (* 
P < 0.05). (Data from 3 donors were further analysed using ANOVA with repeated measures 
followed by Dunnets correction. Significance was observed at each concentration of 
inhibitor, P < 0.05). (C) Aliquots of T cells (2 x 106 cells/ml) were left untreated or stimulated 
in parallel at 37°C with 10 nM CXCL12 for 5 mins and lysed by the addition of 1 x sample 
buffer. Cell lysates were resolved by SDS-PAGE, transferred to nitrocellulose membranes, 
and immunoblotted with a phospho-specific PKB Ab with affinity for the active Ser473- 
phosphorylated form of PKB and protein was visualised with ECL. The blots were stripped 
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Figure 3.27 CXCL12-mediated chemotaxis of SEB activated T lymphocyte is 
insensitive to PI3K inhibitors. SEB activated T lymphocytes are resistant to increasing 
concentrations of PI3K inhibitors. Cells were pre-incubated with vehicle (open histobars, 
(A,B) or in the presence of 3, 10, or 30 pM LY294002 for 30 mins (A, right panel), or 30, 
100, or 300 nM Wortmannin for 30 mins (B, right panel), (closed histograms). Cells (8 x 104 
cells / 25 pi) were placed on the upper membrane of a 96-well chemotaxis plate above lower 
chambers containing 10 nM CXCL12. Chemotaxis across a 5 pm pore size membrane was 
determined after a 3 hour incubation at 37 ° C in 5 % C 02 as described in Materials and  
Methods. The percentage inhibition by Ly294002 or Wortmannin of basal (grey lines) and 
CXCL12-stimulated cell migration (black lines) is depicted in the right panels. The data is 
taken from a single experiment in quadruplicates and is representative of 3 individual 
donors. Data is expressed as mean ± SD. Data were analyzed by ANOVA, and Dunnett’s 
correction where required (*, p < 0.05). The data above is representative of further analysis 
using ANOVA, repeated measures and Dunnett’s correction. (C) Aliquots of T cells (2 x 106 
cells/ml) were left untreated or stimulated in parallel at 37°C with 10 nM CXCL12 for 5 mins 
and lysed by the addition of 1 x sample buffer. Cell lysates were resolved by SDS-PAGE, 
transferred to nitrocellulose membranes, and immunoblotted with a phospho-specific PKB 
Ab with affinity for the active Ser473-phosphorylated form of PKB and protein was visualised 
with ECL. The blots were stripped and reprobed with anti-PKB Ab to verify equal loading 
and efficiency of protein transfer (lowerpanels).
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Figure 3.28 CXCL12-m ediated CD3/CD28 activated T lym phocyte chem otaxis is 
insensitive to PI3K inhibitors. CD3/CD28 activated T lymphocytes are resistant to 
increasing concentrations of PI3K inhibitors. Cells were pre-incubated with vehicle (open 
histobars, (A,B) or in the presence of 3, 10, or 30 pM LY294002 for 30 mins (A, right panel), 
or 30, 100, or 300 nM Wortmannin for 30 mins (B, right panel), (closed histograms). Cells 
(8 x 104 cells / 25 pi) were placed on the upper membrane of a 96-well chemotaxis plate 
above lower chambers containing 10 nM CXCL12. Chemotaxis across a 5 pm pore size 
membrane was determined after a 3 hour incubation at 37 "C in 5 % C 02 as described in 
Materials and Methods. The percentage inhibition by Ly294002 or Wortmannin of basal 
(grey lines) and CXCL12-stimulated cell migration (black lines) is depicted in the right 
panels. The data is taken from a single experiment in quadruplicates and is representative 
of 3 individual donors. Data is expressed as mean ± SD. Data were analyzed by ANOVA, 
repeated measures and Dunnetts correction to compare responses in the presence and 
absence of PI3K inhibitors within CXCL12 stimulated groups (*, p < 0.05). (C) Aliquots of T 
cells (2 x 106 cells/ml) were left untreated or stimulated in parallel at 37°C with 10 nM 
CXCL12 for 5 mins and lysed by the addition of 1 x sample buffer. Cell lysates were 
resolved by SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted with a 
phospho-specific PKB Ab with affinity for the active Ser473-phosphorylated form of PKB and 
protein was visualised with ECL. The blots were stripped and reprobed with anti-PKB Ab to 
verify equal loading and efficiency of protein transfer (lower panels).
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3.19 CXCR3-mediated chemotaxis is PI3K independent
Upon T cell activation cells proliferate, release cytokines and chemokines and 
upregulate the receptor repertoire on the surface of the cell. This upregulation 
allows migration towards a greater number of chemokines. While CXCR4 is 
expressed both on freshly isolated and on activated cell types, CXCR3 is a receptor 
that is upregulated following activation. It has 3 known ligands, CXCL9, CXCL10 
and CXCL11, all of which have been shown to induce strong chemotactic 
responses in activated T cells.
In order to assess if the observation of PI3K independent chemotaxis extended to 
other receptor/ligand interactions, this study investigated if the CXCR3 ligands have 
a PI3K dependent component in their chemotactic response. Figure 3.29 illustrates 
the chemotactic responses of PHA activated T lymphocytes to increasing 
concentrations of the CXCR3 ligands, CXCL9, CXCL10 and CXCL11. Furthermore 
they demonstrate the effect of increasing concentrations of LY294002 and 
wortmannin on both the basal and peak chemotactic response for each ligand.
Chemotactic responses towards CXCL9, CXCL10 and CXCL11 demonstrate a 
concentration dependent response, with peak responses at 30, 1, and 10 nM (figure 
3.29A, B, and C left panels respectively). All 3 ligands elicit a strong concentration 
dependent chemotactic response with a potency of CXCL10>CXCL11>CXCL9. 
The peak response for each ligand was tested in the presence of increasing 
concentrations of LY294002 and wortmannin (figure 3.27 middle and right panels). 
Each response demonstrated limited sensitivity, with 30 pM LY294002 and 300 nM 
wortmannin, unable to significantly reduce the chemotactic response. As shown 
previously (figure 3.25) both LY294002 and wortmannin showed a significant 
decrease in the basal migration. Figure 3.29D demonstrates the percentage 
inhibition of LY294002 and wortmannin (right and left panels respectively) on basal 
migration and each of the chemotactic responses elicited by CXCL9, CXCL10 and 
CXCL11.
The previous experiments using CXCL9, CXCL10, CXCL11 and CXCL12, have 
focused on the effect on LY294002 and wortmannin inhibition on the peak 
chemotactic responses of each ligand. However, it was important to ensure that
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chemotactic responses are PI3K independent over a concentration range. Figure 
3.30 demonstrates a concentration dependent response to each ligand and the 
effect of 10 pM LY294002 on this response. No significant effect on chemotactic 
response is observed for any ligand at any concentration. These data further 
extend the observation that PHA activated T lymphocytes can, under certain 
conditions, chemotax in a PI3K independent manner.
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Figure 3.29 CXCR3-mediated chemotaxis of PHA activated T lymphocytes is 
class I PI3K independent. PHA activated T lymphocytes show concentration 
dependent chemotaxis towards CXCL9, CXCL10 and CXCL11 (a, b and c left panel 
respectively). CXCR3-mediated chemotaxis of PHA activated T lymphocytes are resistant 
to increasing concentrations of PI3K inhibitors (a, b, and c, middle and right panel. D, 
represents the effects of these inhibitors as a percentage inhibition). Cells were or were not 
pre-incubated in the presence of 3, 10, or 30 pM LY294002 or 30, 100, or 300 nM 
Wortmannin for 30 mins. Cells (8x104 cells / 25 pi) were placed on the upper membrane of 
a 96-well chemotaxis plate above lower chambers containing varying concentrations of 
CXCL9, CXCL10 or CXCL11 as noted in the figure. Chemotaxis across a 5 pm pore size 
membrane was determined after a 3 hour incubation at 37 "C in 5 % C02 as described in 
Materials and Methods. The data is taken from a single experiment in quadruplicates and is 
representative of 3 individual donors. Data is expressed as mean ± SD.
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Figure 3.30 CXCL9, CXCL10, CXCL11 and CXCL12-mediated chemotaxis of 
PHA activated T lymphocyte is insensitive to PI3K inhibition. PHA activated T 
lymphocytes are resistant to 10 pM LY294002 inhibition over a range of chemokine 
concentrations. Cells were pre-incubated with vehicle (black lines) or in the presence of 10 
pM LY294002 for 30 mins (red lines). Cells (8 x 104 cells / 25 pi) were placed on the upper 
membrane of a 96-well chemotaxis plate above lower chambers containing different 
concentrations of chemokines as noted above. Chemotaxis across a 5 pm pore size 
membrane was determined after a 3 hour incubation at 37 ’ C in 5 % C 02 as described in 
Materials and Methods. Data is expressed as mean ± SD. The data is taken from a single 
experiment in quadruplicates and is representative of 3 individual donors. Data were 
analyzed by ANOVA and repeated measures, no concentrations were significant.
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3.20 Ex-vivo culture of T lymphocytes determines CXCR4-mediated 
chemotactic sensitivity to PI3K inhibitors.
The studies presented in section II (figures 3.3 -  3.6) have demonstrated that 
freshly isolated T cells migrate in a PI3K dependent manner and the use of isoform 
selective inhibitors suggests a dominant role for PI3Ky. Interestingly, it has been 
observed that activated T cells can migrate in a PI3K independent manner. In order 
to investigate this further, it was essential to determine if this switch in dependence 
was determined through activation of the T cell or through culture. Surprisingly, 24 
hours of in vitro culture without activation (figure 3.31 A) was sufficient to render the 
CXCL12-mediated migratory response PI3K independent. CXCL12 induced a 
strong chemotactic response that could not be significantly inhibited with up to 30 
pM LY294002. This PI3K independent response was maintained over the 72 hour 
culture period (figure 3.31 B & C). Interestingly, basal migration was inhibited in a 
concentration dependent manner and this was evident up to 72 hours post isolation. 
Moreover, the biochemical response was inhibited in a concentration dependent 
manner, resulting in almost complete inhibition of the phosphorylation of PKB. 
Utilizing increasing concentrations of a broad spectrum PI3K inhibitor (LY294002), it 
is shown that the dependence on PI3K within CXCL12-mediated chemotactic 
response is diminished following ex vivo culture.
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Figure 3.31 CXCL12-mediated chemotaxis of cultured T lymphocytes (with or 
without IL-2) is insensitive to LY294002. PTO for figure Legend.
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FIGURE 3.31 CXCL12-mediated chemotaxis of cultured T lymphocytes (with 
or without IL-2) is insensitive to LY294002. Freshly isolated human T cells were 
maintained in culture for 24 (A), 48 (B) or 72 hours without IL-2 (C) or D) 72 hours with IL-2 
post-isolation. CXCL12-mediated chemotaxis of day 1 (A, left panel), day 2 (B, left panel) 
and day 3 (C, left panel) are resistant to increasing concentrations of LY294002. Cells were 
pre-incubated with either vehicle (control, open histobars) or Ly294002 (3- 30 pM, solid 
histobars) for 30 mins. T lymphocytes were placed on the upper membrane of a 96-well 
chemotaxis plate above lower chambers containing CXCL12 (10 nM), as described in 
Materials and Methods. Cell migration was determined after 3 hour incubation at 37 °C in 5 
% C02. The percentage inhibition by LY294002 of basal (black lines) and CXCL12- 
stimulated cell migration (blue lines) is depicted in the right panels. Data is expressed as 
mean ± SD. The data is taken from a single experiment in quadruplicates and is 
representative of 3 individual donors. The above data were analyzed by ANOVA & where 
appropriate Dunnets correction (*, p < 0.05). (N.B. Data from 3 donors were further analysed 
using ANOVA with repeated measures followed by Dunnets correction. No significance was 
seen in stimulated migration, in basal migration significance was seen at each concentration 
of inhibitor, P < 0.05). (E) Aliquots of T cells (without IL-2) (2 x 106 cells/ml) were left 
untreated or stimulated in parallel at 37°C with 10 nM CXCL12 for 5 mins and lysed by the 
addition of 1 x sample buffer. Cell lysates were resolved by SDS-PAGE, transferred to 
nitrocellulose membranes, and immunoblotted with a phospho-specific PKB Ab with affinity 
for the active Ser473-phosphorylated form of PKB and protein was visualised with ECL. The 
blots were stripped and reprobed with anti-PKB Ab to verify equal loading and efficiency of 
protein transfer. The data are derived from a single experiment performed in triplicate that is 
representative of three other experiments.
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3.21 Summary
By investigating the role of in vitro activation and culture of T cells the following 
observations were made:
o All PI3K isoforms except class II y are expressed in in vitro activated T cells, 
and the method of activation determines the expression levels within these 
cells.
o Within HeLa cells, PI3K siRNAs demonstrate a concentration dependent 
knockdown of target RNA and show limited effects on the other PI3K 
isoforms tested.
o Nucleofection of siRNA into activated T cells occurs in a concentration 
dependent manner, with T cells that undergo chemotaxis having 
incorporated siRNA.
o Activated T cells demonstrate decreased viability and functionality following 
nucleofection.
o Adenoviral delivery of shRNA is incorporated into 50 % of activated T cells 
by day 7, but no silencing of target RNA is observed.
o PI3K isoform specific mRNA is targeted and decreased by up to 60 %, but 
this does not translate into a knockdown at the protein level. A role for class 
II isoforms in chemotaxis and PI3K isoforms in cytokine production cannot 
be ruled out.
o PHA activation - Basal migration is significantly inhibited following inhibition 
using the broad spectrum inhibitors LY294002 and wortmannin. However, 
CXCL12 stimulated chemotaxis is not dependent on PI3K for directed cell 
migration. This observation is extended to the CXCR3 ligands CXCL9, 
CXCL10 and CXCL11. CXCL12 stimulates a PI3K dependent pathway, 
demonstrated by the PI3K dependent phosphorylation of PKB.
o The CD4+ and CD8+ subsets that comprise the activated T cells population 
demonstrate similar trends in PI3K independence.
o The method of T cell activation influences the dependence on PI3K during 
basal migration.
o Culturing of CD3+ T lymphocytes over a 24-72 hour period results in a loss 
of PI3K dependent migration, while maintaining PI3K dependent 
phosphorylation of PKB.
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o Nucleofection of T cells has a detrimental effect on Th1/Th2 cytokine 
production.
Within this section of work the difficulties involved within the Nucleofection of both 
primary and activated T cells were highlighted. The Nucleofection procedure was 
opitimised using the activated T cell model, however, the difficulties in obtaining 
viable and functionally competent cells demonstrated a limiting factor within the 
system.
Switching to the freshly isolated T cell model demonstrated successful results, in 
that greater viability was seen and functional responses could be restored. 
However, although silencing of the target isoform was achievable this did not 
correlate into a decrease of protein levels (as assessed by flow cytometery and 
western blotting).
Interestingly, the use of broad sprectrum PI3K inhibitors highlighted a switch in the 
dependence on PI3K within the migratory response. Freshly isolated T cells 
migrate in a PI3K dependant manner with PI3K y playing a pivitol role. Yet ex vivo 
maintenance of these cells (for as little as 24 hours), renders the migratory process 
PI3K independent. Basal migration retains the dependence on PI3K although this 
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Discussion
The aim of this study was to investigate the role of the PI3K family within T cell 
migration. To facilitate this process broad spectrum and isoform specific inhibitors 
were utilized as well as target specific siRNAs delivered by a novel technique 
termed Nucleofection. Functional and biochemical studies were performed 
following stimulation with a panel of chemokines.
These investigations began by characterizing the role of CXCL12 in the freshly 
isolated and activated T cell models. As a comparison to this response, the effect 
of CCL5 was reinvestigated as confusion surrounded the expression and functional 
response that this chemokine could evoke. Furthermore, the role of CCL5 
derivatives were characterised within T cells as these may have important 
implications in a clinical setting.
4.1 CCL5 and CCL5 derivatives in a clinical setting
CCL5 is a native CC-chemokine which has the potential to bind 3 receptors, CCR1, 
CCR3 and CCR5. When a role for the CCR5 receptor was established in the 
pathogenesis of HIV infection, the interest around this chemokine and its receptor 
intensified. With increased knowledge about this interaction, the hope emerged of a 
prophylactic treatment for HIV transfection.
Simmons et al demonstrated that the N-terminally modified chemokine AOP-CCL5 
was capable of blocking R5 tropic HIV entry in several different cell types (Simmons 
et al., 1997). This molecule resulted in agonist activity which was assessed via the 
dimerisation of the receptor, measurement of calcium flux and intracellular 
signalling (Rodriguez-Frade et al., 1999). As expected with an agonist it induces 
internalisation of the receptor, however, it internalised the receptor for increased 
periods of time compared to the parent CCL5 chemokine. The modification to the 
chemokine reduced the expression of the receptor on the surface of the cell, 
decreasing the possibility that the HIV virus binds the receptor.
Redundancy within the CCR5 receptor functions have been observed. Individuals 
who are homozygous for a 32 base pair deletion of CCR5, express no functional
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receptor on the surface of the cell, and show no adverse physiological symptoms 
(Quillent et al., 1998). This observation highlights the possibility that a modified 
CCL5 chemokine, that promotes sequestration of the receptor inside the cell, may 
provide a prophylactic therapy, as sequestration of the receptor should have no 
negative effects on the patient’s health. In the drive to develop potent HIV inhibitors 
several other ligands were developed, including PSC-CCL5. The aim of these 
ligands was to generate a profile in which there was limited agonist activity but 
increased sequestration of the receptor (Pastore et al., 2003; Sabbe et al., 2001).
4.2 Regulation of chemokine receptor expression
Many factors influence the range of chemokine receptors that are expressed on the 
surface of the cell. The health and age of the donor are contributory factors, as well 
as the method of in vitro activation and cytokine milieu that surrounds the cell, for 
example IL-2.
4.2.1 The importance of IL-2 in culture
The p and y chains of the IL-2 receptor are constitutively expressed in resting blood 
lymphocytes (Hatakeyama et al., 1989; Takeshita et al., 1992) while the a chain 
which is required for formation of the high affinity receptor is expressed only after T 
cell activation (Waldmann, 1991). It has also been shown that the IL-2 treatment of 
memory cells can induce the expression of this a chain generating the functional 
receptor (Harel-Bellan et al., 1986; Siegel et al., 1987). The generation of this 
functional receptor, has been shown to facilitate the upregulation of CC chemokine 
receptors on the surface of the cell, thus playing a part in the responsiveness of T 
cells (Loetscher et al., 1996b).
4.3 CCR1 and CCR3 are undetectable in freshly isolated and activated T 
cells
The expression of CCR1 and CCR3 are considerably lower than that observed for 
CCR5, with less than 3 % of human T cells within an inflammatory setting 
expressing these receptors (Bruhl et al., 2001). The expression of CCR1 and
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CCR3 was not detected within our investigations and it would therefore be tempting 
to surmise that all functional or signalling responses generated should be attributed 
to the CCR5 receptor. However, it cannot be ruled out that there was at least a 
small contribution from the CCR1 and CCR3 receptors that these investigations did 
not detect. These low levels of expression even within inflammatory settings may 
be difficult to detect and combined with the possibility that PHA may have a 
delaying effect on receptor expression (discussed below), may account for the 
limited expression profile. With such a limited expression profile it would be good 
practice to utilize several methods to detect these receptors, such as qPCR and 
immunoblotting.
4.4 CCR5 is upregulated following T cell activation
It has been shown by others that the receptors CXCR4 and CCR5 are expressed 
on specific subsets of freshly isolated cells, with CXCR4 being expressed on naive 
cells while CCR5 is expressed on memory cells, facilitating the entry into the 
periphery (Bleul et al., 1997; Wu et al., 1997). However, data shown within this 
thesis suggests that CCR5 is not expressed on freshly isolated cells but is 
upregulated following activation and culture. In support of these findings Loetscher 
et al utilizes northern blot and mRNA analysis to detect CCR5 expression and 
observes no expression of CCR5 until day 5 (Loetscher et al., 1996b). The 
differences between our study and Bleul and Wu et al, might be explained in 2 
ways; through the specific antibody used to detect this receptor and donor variation.
4.4.1 Is expression of CCR5 donor dependent?
Studying these conflicting reports it is possible that at least some of these results 
maybe explained through donor variation. Within freshly isolated cell populations 
CCR5 is only expressed on some memory cells (not naive cells) and expression of 
CCR5 may therefore be dependent on the donor’s nai've/memory T cell profile. As 
discussed earlier, due to a mutation within this receptor, a small number of 
individuals do not express CCR5, providing increased resistance to diseases which 
depend on this receptor. Furthermore, age can influence the expression of CC
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chemokine receptors due to the alteration of the naive/memory T cell profile (Jaruga 
et al., 2000).
4.4.2 Activation and IL-2 culture alters receptor expression and 
functionality
Activation and proliferation of T cells results in the upregulation of surface 
expressed receptors. This upregulation allows for the cells to chemotax towards a 
greater array of chemokines. Bleul et al specifically investigated the changes in 
chemokine receptor expression and correlated this with chemotactic responses. 
Bleul et a ifound that PHA activation upregulated the CXCR4 receptor, leading to an 
increase in CXCL12-mediated responses, while the culturing of these cells in the 
presence of IL-2 without PHA also had this effect. Furthermore, Bleul et al found 
that CCR5 was expressed on freshly isolated cells yet this expression did not 
increase during PHA activation and culture, but expression was increased following 
culture with IL-2 (Bleul et al., 1997). Data presented within this thesis suggests that 
following activation and culture in IL-2 expression of CCR5 is increased, however, 
investigations into the effect of activation or IL-2 alone were not investigated. 
However these studies would suggest it is an IL-2 dependent component.
4.5 CCL5 fails to induce chemotactic responses in freshly isolated T 
cells
Work presented within this thesis provides evidence that CCL5 cannot induce 
chemotactic responses with freshly isolated T cells and this inability to induce 
chemotaxis is maintained until 10 days post activation. Studies into receptor 
expression demonstrate that CCR5 is up regulated on the surface of the cell by day 
6, but this is not translated into a functional or biochemical response.
This might be explained by receptor density, as it has been reported that optimal 
functional response through the CCR5 receptor is determined through the density of 
the receptor on the cell surface (Desmetz et al., 2007; Desmetz et al., 2006). 
Desmetz et al suggest that although receptor expression does not increase 
dramatically from day 6 onwards, it may increase enough to surpass the threshold
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required for chemotactic responses, with an increase of functional receptor 
expression at the surface, leading to an increase in migratory responsiveness 
(Ebert and McColl, 2002).
4.6 CCL5 and PSC-CCL5 induce a chemotactic response in day 10-14 
activated T cells
Within our study T cells were activated with PHA and cultured with IL-2 and by day 
10 -14 an increase in chemotactic response was observed. Biochemical signals 
where also observed through S6 and were shown to be dependent on PI3K. This 
observation is supported by other studies that demonstrated no chemotactic 
responses of freshly isolated T cells, but if cells were cultured in the presence of 
PHA and IL-2 chemotaxis was noted by day 9 (Ebert and McColl, 2002). 
Interestingly, Loetscher et al observe that culture with IL-2 alone generated a 
chemotactic response that was observed from day 4, demonstrating that 
upregulation of CCR5 was not dependent on blast formation (Loetscher et al., 
1996b).
4.6.1 PSC-CCL5 induces a stronger chemotactic response than CCL5
Interestingly we observed that the modified chemokine PSC-CCL5 resulted in a 
significant chemotactic response in vitro, whereas the CCL5 response was not as 
robust. This may be due to the modified derivative having an increased affinity for 
the receptor, facilitating a stronger chemotactic response at lower concentrations. 
In day 10 and 14 activated T cells, CCL5 induced a small chemotactic response 
that slowly increased as the concentration of CCL5 increased. The profile of this 
response is still altered compared to PSC-CCL5, as PSC-CCL5, induced a 
definitive peak response, whereas CCL5 is more conservative.
It has previously been suggested that phosphorylation of the receptor is enhanced 
following stimulation with CCL5 derivatives (Vila-Coro et al., 1999). This 
phosphorylation results in rapid internalisation of the receptor that may explain the 
strong chemotactic response, as internalisation is a requirement for chemotaxis. 
However, as the exact mechanism surrounding the internalisation and
175
C h a p t e r  4  - D is c u s s io n
sequestration of the receptor has not been elucidated, this cannot be confirmed. 
Furthermore, although not tested in this investigation, as receptors are sequestered 
for increasing amount of time following PSC-CCL5 stimulation, it could be 
presumed that any re-stimulation with any of these ligands would not produce a 
chemotactic or signalling response (Lederman et al., 2006).
4.7 CCL5 and its derivatives induce similar signalling profiles
It has been suggested that downstream signalling events from CCL5 and its 
derivatives may differ, this was assessed in these investigations through the 
phosphorylation of S6 (Vila-Coro et al., 1999). Data presented within this study 
suggest that in freshly isolated T cells CCL5 and its derivatives induce no 
phosphorylation of S6, this would be consistent with the findings that no receptor 
expression, or chemotaxis is observed. By day 6, expression of CCR5 is observed, 
yet, no biochemical signalling through these receptors was observed. As discussed 
above, this may be indicative of low receptor density on the surface of the cell.
By day 10-14, all CCL5 derivatives and CCL5 induced stimulation of S6 at similar 
levels and this signalling was dependent on PI3K. These results suggest that at 
least at the level of S6 phosphorylation, signalling events initiated via CCL5 and its 
derivatives are similar. However, it is worth while noting that only 1 pathway was 
assessed and it is possible that other signalling cascades are differentially regulated 
by these modified chemokines. As increased sequestration of the CCR5 receptor is 
seen with CCL5 derivatives, it is clear that at some level the derivatives affect the 
intracellular machinery, as to prevent the recycling of the receptor to the membrane. 
However, this result would suggest that signalling events are at least triggered and 
that the sequestration of the receptor happens independently of this signalling.
Furthermore, recycling of the CCR5 receptor following stimulation by CCL5 and 
PSC-CCL5 has been demonstrated to be around 20 mins and 24 hours respectively 
(Mack et al., 1998). These investigations focused on the stimulation of S6 which 
occurs 10 mins after stimulation with the chemokines, thus focusing on the acute 
effects of these compounds on the subsequent signalling events; the kinetics of 
receptor recycling were not investigated (Lederman et al., 2006).
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4.8 Pharmacological investigations into the PI3K family
Following clarification of the functional and biochemical effects of CXCL12 and 
CCR5, attention focused on utilizing broad spectrum and isoform specific PI3K 
inhibitors to dissect out the role of class I isoforms in CXCL12 mediated migration 
and signalling.
4.8.1 The freshly isolated T cell model
The role of the PI3K family (in particular PI3Ky) in leukocyte chemotaxis has been 
established primarily in neutrophils, however the contribution of the PI3K family 
within human T cell responses had not been thoroughly established (Ridley et al., 
2003; Hirsch et al., 2000; Wang et al., 2002; Nishio et al., 2007; Hannigan et al., 
2002; Ferguson et al., 2007; Ward, 2006) The expression levels within freshly 
isolated T cells of PI3K isoforms were first established. These observations 
suggested that all isoforms were expressed with the exception of class II y, which is 
primarily expressed in hepatocytes (Wymann and Pirola, 1998).
4.9 Freshly isolated CD3+, CD4+ and CD8+ migrate in a PI3K dependent 
manner
Within freshly isolated CD3+ cells, a classical bell shaped chemotactic response 
towards the CXCL12 ligand is observed. Increasing concentrations of both 
LY294002 and wortmannin against the peak chemotactic response, highlighted a 
dependence on PI3K during both directed and random migration. Furthermore, 
investigations into CD4+ and CD8+ T cells demonstrated that both subgroups were 
dependent on the PI3K family for these responses.
4.9.1 A Dominant role for PI3Ky in CXCL12-mediated migration
The observation that freshly isolated T cells migrate in a PI3K dependent manner, 
was exploited with the use of class I isoform selective inhibitors. The use of these 
inhibitors revealed a dominant role for the class I y isoform in the signalling through 
S6 and migratory responses to CXCL12.
177
C h a p t e r  4  - D is c u s s io n
As with all pharmacological tools, in order to unequivocally attribute function to a 
particular isoform, it is essential to establish selectivity for these compounds. The 
PI3K inhibitors used within this study, exhibit selectivity between their primary 
target(s) and other members of the family (table 1 & (Knight et al., 2006)). At the 
lowest concentration used for each inhibitor, in which they display selectivity for that 
isoform(s), limited effects on the migratory response induced by CXCL12 were 
observed. Interestingly, the use of the inhibitor AS605240 indicates a dominant role 
for PI3Ky.
The observation that PI3Ky plays a dominant role within migration, is supported 
through other studies which have focused on loss-of-function mutants, although it 
has been determined that a dependence on other class I isoforms is required for 
optimal response (Curnock et al., 2003). Furthermore, studies in murine models 
support this observation in both in vivo and in vitro studies (Sasaki et al., 2000). 
The use of LY294002 highlighted a role for class I PI3K in basal migration and 
through the use of isoform specific inhibitors, this suggests a predominant role for 
PI3Ky with little interaction of the other isoforms. These observations suggest 
PI3Ky plays a role in both the migratory response and the directionality of migration.
4.9.2 A role for PI3Ka?
Within this study the inhibitor PI-103 was utilized to investigate the role of PI3K 
class I a. This inhibitor is selective for the a member of the PI3K family at 
concentrations below 100 nM, and at these concentrations the inhibitor has no 
effect on the migratory responses of freshly isolated T cells (table 1 & (Knight et al., 
2006)). However, this inhibitor does not distinguish between PI3K a and mTOR, 
and while mTOR has been implicated in the migratory response of cells, such as 
neutrophils and macrophages, to date it has not been identified as a mediator of T 
cell chemotaxis (Gomez-Cambronero, 2003; Fox et al., 2007; Liu et al., 2006). As 
PI-103 has no significant effect on chemotaxis, this data would support the notion 
that mTOR plays little role in these migratory effects. However, pre-incubation with 
PI-103 did decrease the phosphorylation of S6. As mentioned earlier the 
phosphorylation of S6 is dependent on the involvement of both PI3K and mTOR 
signals (Knight et al., 2006). The inhibition of this phosphorylation may therefore be
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due to the action on mTOR rather than PI3K class I a. In support of this 
observation, the use of the inhibitor rapamycin, which targets mTOR, shows a 
significant decrease in the phosphorylation of S6. The inhibition seen following pre­
treatment with rapamycin provides an explanation as to the significant differences 
seen between S6 phosphorylation and migratory responses.
4.10 Class IA and IB PI3K dependent Chemotaxis
This study would suggest a dominant role for PI3K class ly within freshly isolated T 
cell migration. Other studies have also highlighted a role for class ly as well as 
class IA. Dependence on PI3K for migration has been established within 
eosinophils, neutrophils, Thp1 and T cells towards both CC and CXC chemokines 
CCL20, CXCL8, CCL2 and CXCL12 respectively. As seen in this study, the class ly 
isoform has emerged to be of particular importance within migration but also the 
production of Ptdlns(3,4,5)P3, phosphorylation of downstream signalling molecules, 
and superoxide formation.
An invaluable tool within these investigations has been the p110y knockout murine 
models which have focused particular attention on the role of p110y within 
neutrophils (Hannigan et al., 2002; Hirsch et al., 2000; Sasaki et al., 2000; Thomas 
et al., 2005). In vitro studies on the p110y knockout neutrophils, show decreases in 
chemotactic response of up to 70 % towards fMLP and C5a while in vivo models of 
peritonitis also support this observation (Hannigan et al., 2002; Sasaki et al., 2000). 
Furthermore, neutrophils from p110y knockout mice demonstrate no 
Ptdlns(3,4,5)P3 production and have thus suggested a primary role for class IB 
within the production of Ptdlns(3,4,5)P3 in these knockout models (Li et al., 2000). 
In addition, the PH domain containing protein PKB which is a major downstream 
effector of PI3K, fails to be phosphorylated (Hirsch et al., 2000).
Contrary to the common belief that class IB is the sole PI3K isoform involved in 
chemotaxis, several studies have reported the involvement of members of the class 
IA family. Moreover, a recently published study suggests that it is in fact class IA 
that is primarily responsible for the chemotactic properties of human myeloid cell 
line PLB-985, (induced to express a neutrophil-like phenotype). Utilising transient
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expression of a dominant negative mutant of either p85a or p110y, stimulation with 
fMLP, shows a biphasic Ptdlns(3,4,5)P3 response. This is initially governed through 
class ly, with the latter stages and functional responses regulated through class IA 
(Boulven et al., 2006).
In human neutrophils, although a biphasic response is obtained, the dependence on 
PI3K isoforms is in fact sequential. The first phase is shown to be p110y dependent 
however, the second phase although largely mediated through p1105, (to some 
extent p and a), is inextricably dependent on the initial y dependent phase 
(Condliffe et al., 2005). Possible explanations for this discrepancy, is the use of a 
cell model (PLB-985) as opposed to TNF-a primed PMNs, and second, it is possible 
that following transfection of the dominant negative p110y vector, residual activation 
of the class ly may be capable of activating class 1 A.
Supporting the role for class I delta, is the use of a PI3K delta specific inhibitor, 
IC87114, which facilitates a 60 % reduction in Ptdlns(3,4,5)P3 production and a 
decrease in fMLP stimulated neutrophil migration (Sadhu et al., 2003). This 
observation was further corroborated using p1105‘A mice (Puri et al., 2004). Several 
studies also suggest a role for class IA through the use of protein tyrosine kinase 
inhibitors, which following chemotactic stimulus resulted in a decrease in 
Ptdlns(3,4,5)P3 production in neutrophils (Ptasznik et al., 1996; Thelen and 
Didichenko, 1997). Although a role for class IA in neutrophils has been established 
it would appear at least in T cell migration that this involvement is minimal, as the 
use of inhibitors at selective concentrations does not show significant reduction in 
migratory responses. The residual migration is therefore more likely to be driven 
through an alternate PI3K isoform or another signalling pathway.
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4.11 Targeting of the PI3K family using siRNA strategies
Following pharmacological intervention to determine the role for individual class I 
isoforms, attention turned to utilizing an siRNA strategy to assess the role of class II 
isoforms within activated and freshly isolated T cells. This began with validation of 
the siRNAs and optimization of the delivery technique.
The mechanism through which GPCRs couple to class II PI3K isoforms has not 
been fully elucidated. However, class II PI3K isoforms have been shown to be 
activated by several chemokines in leukemic T cell models (Foster et al., 2003; 
Sotsios and Ward, 2000). In support of a role for these isoforms in migration, class 
11 (3 and its lipid product Ptdlnd(3,4)P2 have been shown to play important roles in 
regulating lysophosphatidic acid-induced cell adhesion, actin reorganization and 
migration (Domin et al., 2005; Maffucci et al., 2005). In this research project, siRNA 
was utilized to clarify the role, if any, of the class II PI3K isoforms in the migratory 
response of freshly isolated and in vitro activated T cells.
4.11.1 PI3K isoforms are expressed in activated human T cells
PI3K isoforms are expressed within immune cells (Koyasu, 2003). It has been 
previously established that the class II y isoform is not expressed within immune 
cells but is predominantly expressed within hepatocytes (Wymann and Pirola, 
1998). Following in vitro activation of human T cells using PHA and CD3/CD28, 
qPCR analysis was performed on each of the samples and the absolute levels of 
these isoforms determined. CD3/CD28 stimulation of T cells provides the most 
physiologically relevant mode activation. PHA is a lectin which is commonly used to 
activate T cells in vitro by binding glycoproteins on the cell surface, and provides a 
robust activation of the celi. Our results support the finding that all PI3K isoforms 
(class I a,3,5,y, class II a, (3 and class III) except PI3K class II y are expressed in in 
vitro activated and cultured T cells. These early experiments were crucial to 
determine which of the isoforms had the possibility of being targeted within the 
following studies.
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4.12 Evidence that in vitro validation of siRNA is an essential pre­
requisite for RNA interference studies.
With the advent of RNA interference, came the requirement for strong siRNA 
design, not only for the siRNA to be target specific and effective at knocking out the 
gene of interest, but also that it does not affect other genes within the cell and 
importantly other isoforms within the same family (Pei and Tuschl, 2006). To 
ensure confidence in the experimental data, the choice of siRNA and the validation 
of the chosen sequences were thoroughly evaluated. When deciding on which 
siRNA to deliver, there are 2 schools of thought, the use of either pools of siRNA 
sequences or single siRNAs.
Pools of siRNA contain several sequences against the same gene. Pools of siRNA 
provide an advantage as several siRNAs are tested at one time and there is an 
increased likelihood that at least one of those sequences is potent against the 
target of interest. Furthermore, this is combined with the idea that the other siRNAs 
should target this gene with at least some affinity and produce an effect. However, 
it should be noted that randomly selecting siRNA have silencing activities as low as 
62 % (Ladunga, 2007). Currently designing an siRNA with no off-target effects is 
almost impossible and therefore by utilizing several siRNAs, each with different 
cross-silencing activity, the off-target effects will be diluted over a range of ‘targets’ 
where as just one siRNA would amplify this effect (Buchholz et al., 2006; Myers and 
Ferrell, 2005; Jackson et al., 2003).
The alternative to pooled siRNAs and the method chosen within this study, is to 
deliver one pre-validated siRNA, which shows strong potency for the target of 
interest. Although this approach may be more time consuming in the short term, 
long term this approach ensures maximum effect while maintaining limited off target 
effects (Ladunga, 2007). In order to allow for the off-target effects that are thought 
to be compounded when utilizing this single sequence method, at least 2 different 
siRNAs were validated and then taken forward for investigation. This would allow 
examination of targeted effects, by comparing the results of both siRNAs. If the 
effect that was observed with one siRNA was specific, the result should be 
confirmed with the observation from the second validated siRNA.
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The need for strong siRNA design and pre-validation was highlighted within this 
study when testing the siRNA against class I a PI3K. All siRNAs used within this 
study are commercially available, and we tested 4 different sequences against each 
target, and in most cases little difference was seen. Yet 2 of the siRNAs against 
class I a were ineffective at reducing the target mRNA, highlighting that while 
computer aided design of these siRNAs suggested these sequences were effective, 
in fact, experimental testing proved this was not the case.
4.13 Optimization of Nucleofection in activated human T cells is 
ineffective
Delivery of siRNA into primary cells has proved problematic, yet in 2003 Lai et al 
utilized a modified electroporation technique termed Nucleofection™ to introduce 
DNA into primary mouse T cells. Since then an increasing number of groups have 
used the Nucleofection procedure as an alternative to method to traditional 
transfection techniques, in both human and rodent T cells (Nakayamada et al., 
2007; Jurgens et al., 2006; Goffinet and Keppler, 2006; Keppler et al., 2006). Other 
primary cells, such as mammalian neurons (Zeitelhofer et al., 2007), B cells, 
dendritic cells and cell lines (Preiss et al., 2007; Boulven et al., 2006) have also 
benefited from this technique.
One of the most striking effects seen in our study was the detrimental effect on cell 
viability, with upwards of 90 % cell death (dependent on the donor), a point that is 
well reported within these articles (Merkerova et al., 2007). In an attempt to 
increase the viability of the cells, we investigated the T cell activator and age of the 
cell at nucleofection. PHA activation gave the highest level of viability compared to 
CD3/CD28, this may be due to the robust activation signal compared with the more 
physiologically relevant CD3/CD28 stimulation. This may provide a stronger 
survival signal that aids viability.
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4.13.1 Effect of Age on the in  v itro  activated T cell
During the optimisation process we tested the optimum age at which the T cells 
were Nucleofected to produce the highest number of viable cells while 
demonstrating the greatest functionality. Our results suggest that 5 times more 
cells survive if the cells are younger. The ex vivo lifecycle of the cell has been 
investigated with the use of the mitogen PHA and its progression studied through 
youth to senescence and apoptosis. Jaruga et al have detailed the in vitro T cell 
growth, and highlighted the important aspects within this cycle. They observed that 
the largest number of mitotic or actively dividing cells were within the first week 
following PHA stimulation. Within this population both CD4+ and CD8+ T cells are 
present, with CD8+ cells predominating at a ratio of 2:1. After this first week there is 
a slow cessation in cell growth accompanied by an increase the number of 
senescent cells, with the ratio of CD8+ to CD4+ being maintained up to day 17. 
Further culture of these cells, results in the apoptosis of the remaining CD4+ cells 
leaving the remaining senescent cells CD8+ (Jaruga et al., 2000; Barbano et al., 
1988).
Within this study cells were observed over a maximum 12 day time frame in which 
the CD47CD8+ T cell ratio would be expected to remain constant. The only 
difference between these 2 cultures of cells, is the number of mitotic vs. senescent 
cells (Jaruga et al., 2000). As we observed an increase in cell death as the age of 
the T cell increased, this may suggest that during the Nucleofection procedure 
senescent cells are more susceptible to cell death compared to cultures that contain 
an increased number of mitotic cells.
4.13.2 Transfection efficiency
Tahvanainen et al used the Nucleofection technique to transfect human 
unstimulated CD4+ T cells to study T helper cell differentiation. They observed a 
background of untransfected cells and from this developed a method to enrich the 
Nucleofected cells (Tahvanainen et al., 2006). Although they are using a slightly 
different T cell model, it is an interesting observation, as within these studies the 
results would suggest 100 % transfection efficiency. In order to reach this 
conclusion we utilized both FACS based assays and confocal microscopy. FACS
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analysis would suggest that at higher concentrations of siRNA (> 4 pM) 100 % of 
the cells were transfected. When using fluorescent siRNA it is a known problem 
that these molecules can bind to the surface of the cell and generate ‘false 
positives’ that cannot be distinguished from true positives. Utilizing confocal 
microscopy enabled slices to be taken through the cell, and this would suggest that 
the siRNA did enter the cells. However, we cannot rule out the possibility that some 
siRNA did bind to the surface of the cell, but our confocal results coupled to the 
knockdown of mRNA seen, would suggest this is not a problem within our system. 
Furthermore, as a general rule in order to reduce the amount of fluorescent siRNA 
that binds to the membrane, Nucleofection is advised as the delivery method of 
choice.
4.13.3 Decreased Functionality following Nucleofection
Following the full optimisation of the Nucleofection process, chemotactic assays 
were performed towards the chemokines CXCL12 and CXCL10. Over the 
concentration range tested, peak chemotactic responses were observed for both 
ligands in control and Nucleofected samples. This demonstrated that although 
reduced responses where observed within Nucleofected samples, these responses 
peaked at the same concentration in control and Nucleofected samples indicating 
no shift in the concentration dependent response.
However, the process of Nucleofection had a detrimental effect on the chemotactic 
responses and this was observed more acutely with the CXCL10 response. 
Interestingly this did not correlate with a decrease in chemokine receptor 
expression, suggesting that the problem was either a functional defect in the 
receptor binding the ligand, conformational change within the receptor to facilitate 
transduction of the signal, or a decreased coupling of the receptor to intracellular 
signalling events.
Taking into account the low cell viability, reduced function, and quantity of cells that 
are required and coupled with the economic costs of running these experiments this 
procedure was not a viable option for the study of activated T cells. Although no 
article has currently provided evidence for reduced functionality as a direct cause of
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Nucleofection, this effect was clearly established with our system. As this technique 
is relatively new, there is focus in the literature on transfection efficiencies, cell 
viability and expression of cell surface markers and it will be interesting to see over 
the next few months and years if our observation of diminished functionality is 
restricted to this particular cell system or if it is observed within additional cell 
models.
4.14 Adenoviral delivery of shRNA shows limited success in activated 
T cells
As an alternative to Nucleofection, adenoviral delivery of shRNA was assessed. 
The hallmark receptor utilised by adenovirus to infect a cell is the CAR 
(coxsackie/adenovirus receptor (Bergelson et al., 1997)) receptor, which is strongly 
expressed in heart, prostate and pancreas with less in liver, brain, colon and small 
intestine (Shaw et al., 2004). If the CAR receptor is present, the cells are dividing 
and there is a strong MOI (multiplicity of infection), transfection efficiency should be 
80-90 %, yet, as T cells do not express this receptor they are therefore are not 
susceptible to infection by this system.
However, T cells do express CD46 (MCP, Membrane Cofactor Protein (Nakanishi 
et al., 1994)) a receptor that can be utilised by subgroup B of the adenovirus family 
resulting in infection (Roelvink et al., 1998). With this knowledge, a chimeric virus 
was created commercially that utilised the CD46 receptor and following infection 
increases the expression of CD46 on the cell surface, thus allowing for increased 
rates of transfection. These advances in adenoviral delivery seemed to suggest the 
possibility that T cells could in fact benefit from this new system.
These adenoviral studies were performed in order to assess the level of knockdown 
which can be achieved within this system. As with the adenovirus which uses the 
CAR receptor for entry, adenovirus using CD46 should see maximum transfection 
in dividing cells which have been infected with a high MOI. Within these 
experiments a very high MOI of 5000 was used following activation of the cells with 
PHA. Although within our system less than half of the cells were transfected this is 
comparable to other chimeric adenoviral systems (Schroers et al., 2004). However,
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Schroers et a/did not look at the knockdown of mRNA (only the expression of GFP) 
so it is difficult to fully assess how successful their system was. Within this study no 
mRNA knockdown was achieved, therefore although in theory this technique should 
be successful, it is ineffective within this activated T cell model.
4.15 Nucleofection to deliver siRNA into freshly isolated T cells
The use of Nucleofection to deliver siRNA into activated T cells had been met with 
limited success, yet within this study, freshly isolated T cells demonstrated a greater 
percentage of cell viability, and also following 72 hours recovery, regained 
comparable chemotactic responses compared to control cells. This functionality 
and viability was coupled with successful siRNA delivery, assessed via flow 
cytometery, and knockdown of the targeted PI3K isoforms, assessed by mRNA. 
Although moderate knockdown of mRNA was achieved no effect was observed on 
the CXCL12 mediated chemotactic response.
Detection of mRNA knockdown was easily determined using qPCR, however, 
following nucleofection it was almost impossible to detect protein expression, and 
this was due to the low protein levels that were obtained following the nucleofection 
protocol. Therefore several scenarios could account for the lack of effect on the 
chemotactic response. Firstly, as seen with class I PI3K isoforms, class II may not 
play a part in the chemotactic response of ex vivo maintained cells. Secondly, 
although mRNA knockdown of up to 60 % was observed this may not correlate into 
a large enough decrease in the functional protein expression, as such, the 
chemotactic response is maintained through the residual protein levels.
In order to determine protein levels, we first attempted immunoblotting and due to 
the sensitivity threshold of this technique, this was in the most part ineffective. The 
most effective way of detecting protein expression was via flow cytometery. 
However, using this technique, the data suggested that over the 72 hour time 
course there was no silencing of protein levels. This data suggests that in freshly 
isolated T cells, the use of PI3K targeting siRNA delivered via Nucleofection is an 
ineffective method for elucidating function.
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4.16 Investigating PI3K independent migration
Curiously following ex vivo culture and or activation it was observed that the 
CXCL12-mediated migration was PI3K independent. In order to establish a fuller 
profile of this phenomenon the culture conditions, T cell activator and a panel of 
chemokines were investigated.
4.16.1 In  v itro  activation of PBMCs can skew the resultant T cell profile
Although the use of PHA is a commonly used method of in vitro activation, it 
induces activation and proliferation of specific subsets within PBMC population, 
resulting in a skewed distribution in the mature T cell culture. In particular, analysis 
of the expression of CCR7/CD45RA suggested that following PHA activation almost 
all cells were CCR7+, indicating that cells with effector function had disappeared 
(Duarte et al., 2002; Chen et al., 2006). This has a negative effect on functionality, 
with these studies concluding that the resulting pool of activated cells is not 
representative of the populations seen within in vivo populations. However, in vitro 
activation induced by CD3/CD28 stimulation closely mirrors the T cell populations 
that are activated and undergo proliferation in vivo. CD3/CD28 stimulated T cells 
also maintain a more comparable functionality to that seen in vivo and this is 
attributed to the subsets of T cells that are being generated.
T cells activated in vitro do not produce an exact physiological activation and by the 
nature of in vitro experiments we cannot expect it to. However, these experiments 
provide an invaluable insight into human T cell responses which would otherwise be 
elusive. During these investigations CD3+, CD4+ and CD8+ subsets, and their 
chemotactic responses following chemokine stimulation were studied. Although we 
have not delved further into the more specific subsets that comprise these 
populations generated via PHA, SEB and CD3/CD28, we have observed trends 
which highlight these differences at the CD3+, CD4+ and CD8+ level (Duarte et al., 
2002; Chen et al., 2006).
Following PHA and CD3/CD28 stimulation it was observed that the expression 
profile of PI3K isoforms differ following the method of stimulation. PHA routinely 
expressed higher levels of PI3K isoform expression compared to CD3/CD28, and
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therefore suggests that under these conditions PI3K expression is dependent upon 
the T cell activator.
4.17 CXCL12-mediated migration in activated T cells is resistant to 
PI3K inhibition
The dependence on PI3K in the role of directed cell migration has been well 
established (Hannigan et al., 2004; Barber and Welch, 2006; Sasaki and Firtel, 
2006; Huang et al., 2003; Comer and Parent, 2006). However there is emerging 
evidence that some cells can chemotax in a PI3K independent manner (Cronshaw 
et al., 2004; Huttenlocher, 2005).
Data presented with this thesis suggests that PHA activated cells migrate towards 
CXCL12 in a PI3K independent manner, while maintaining coupling to PI3K 
dependent pathways. Subsets of CD3+ CD4+ and CD8+ T cells also displayed this 
phenomenon. However, as other groups have demonstrated that the method of in 
vitro activation influences the subsequent T cell population (Kilpatrick, 1999; 
Zamoyska, 2006; Duarte et al., 2002; Chen et al., 2006), we sought to determine if 
the mechanism of T cell activation affected the dependence on PI3K for migration.
Activation with the superantigen SEB is seen under pathophysiological conditions 
and has the ability to activate large numbers of T cells (5-20 %) (Li et al., 1999). 
SEB activation of T cells also generated a population that undergoes PI3K 
independent migration. CD3/CD28 activated T cells, that have been shown to 
generate a more physiologically relevant T cell pool (Chen et al., 2006), also 
displayed this PI3K independent response.
CXCL12 is known to produce migration in both naive and activated T cells (Butcher 
et al., 1999). Therefore, although PHA, SEB and CD3/CD28 may generate different 
T cell pools, the responses and dependence on PI3K isoforms maybe conserved 
with respect to this particular chemokine.
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4.17.1 CXCR3-mediated migration is resistant to broad-spectrum PI3K 
inhibitors
The CXCR4 receptor is expressed within homeostatic and inflammatory conditions. 
In contrast to CXCR4, CXCR3 is upregulated on T cells following activation, and is 
therefore only expressed within inflammatory settings, primarily on the Th1 subset 
(Nakae et al., 2007). This provided an interesting comparison to the constitutively 
expressed CXCR4, in that we hypothesised that chemokines expressed solely 
within inflammatory conditions may induce migratory responses through differing 
signalling pathways than those expressed in homeostatic systems. All 3 CXCR3 
ligands, CXCL9, CXCL10, and CXCL11 provided robust chemotactic responses in 
PHA activated cells. However, these responses were not significantly inhibited by 
pre-incubation with LY294002. Others studies have also reported this effect in T 
cells cultured in IL-2 (Smit et al., 2003).
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4.17.2 Is CCL5 a poor chemoattractant? - The role of shear flow in 
chemotactic responses
At the beginning of this study we reinvestigated the role of CCL5 and found that it 
demonstrated small chemotactic responses within activated T cells. However, the 
CXCR3 ligands CXCL9, CXCL10 and CXCL11 all demonstrate robust migratory 
responses. Therefore what determines the strength of the migratory response; is it 
simply that CCL5 is a poor chemoattractant?
The observation that CCL5 and CXCR3 ligands induce weak and robust migratory 
responses respectively, is in agreement with other studies which have focused on 
the chemokine receptors CXCR3 and CCR5. A study by Stanford and Issekutz 
focused on the migration of radiolabeled lymphoblasts and spleen T cells to 
cutaneous sites injected with lymphocyte-recruiting agents in rats. They noted 
noted that CXCR3 ligands are more potent in vitro than CCL5, interestingly, this 
observation did not hold true for in vivo investigations (Stanford and Issekutz, 
2003). In vitro CCR5 ligands CCL3, CCL4 and CCL5 induced chemotaxis of 
activated T cells (potencies CCL5>CCL3>CCL4) but could not induce significant 
chemotactic responses on unactivated spleen T cells (Stanford and Issekutz, 2003). 
In contrast the CXCR3 ligands, induced strong chemotactic responses in rat lymph 
node activated T cells and to a lesser extent spleen T cells with a potency of 
CXCL10>CXCL11>CXCL9. However, during in vivo studies both CXCL10 and 
CCL5 induced comparable, robust and rapid recruitment of T cells (and to a lesser 
extend CXCL11, CXCL9, CCL3 and CCL4).
A possible explanation for this apparent difference in in vivo vs. in vitro data may be 
the immobilization of chemokines on the surface of the cell and the role of shear 
flow. This theory is supported by the observation that when CXCL12 is presented 
apically on the surface of endothelial cells in a flow chamber, this stimulates rapid 
transendotheial migration (Schreiber et al., 2007). As standard in vitro chemotaxis 
systems do not account for the role of shear flow, the full chemotactic property of 
CCL5 and possibly other ligands may have been underestimated.
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The apparent differences within these in vitro and in vivo observations, highlights 
how critical it is to assess the migratory responses seen in vitro against in vivo 
models. While the data that can be drawn from in vitro models, advance our basic 
understanding, we cannot underestimate the effect other chemokines and the role 
other cells play in how an organism functions as a whole.
When assessing expression of chemokine receptors in an in vitro setting, it is 
important that the method of assessment or even the antibody used is considered. 
This is essential as some groups have observed low levels of CCR5 on the surface 
of the T cell, while others have demonstrated higher expression levels. So what 
could account for these discrepancies? Lee et al studied the results of CCR5 
expression utilizing 18 different antibodies (Lee et al., 1999b). These antibodies 
showed differing affinities for the receptor and thus generate apparently different 
CCR5 expression levels within the same T cell population, highlighting the 
importance of antibody selection.
Using an antibody which recognised the highest proportion of CCL5, Lee et al 
further demonstrated that 14.1 % of whole T cell populations express CCL5 (Lee et 
al., 1999a). However, this total population could be further broken down into high 
and low expressers (memory and naive respectively). This observation correlates 
well with a study performed by Schall et al that shows migration of memory T cells 
(Schall et al., 1990). This observation may explain the findings highlighted within 
this thesis, as only total CD3+ cells and not subpopulations of T cells were 
assessed for migratory properties. Thus migratory responses of memory T cells 
may have been overshadowed by the non-migratory response of the other sub­
populations.
4.18 The method of In vitro activation of human T cells determines the 
PI3K dependence of basal migration
Although this study has established that in vitro activated T cells migrate in a PI3K 
independent fashion, it is intriguing to observe the effect of PI3K inhibition on basal 
migration.
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Basal migration of PHA activated T cells was inhibited in a concentration dependent 
manner, with significant inhibition seen following 3 pM LY294002 and 100 nM 
wortmannin. This observation was further extended to include PHA CD4+ and CD8+ 
subsets and SEB stimulated populations. However, within CD3/CD28 stimulated T 
cells this inhibition was less pronounced. Although there was a trend for inhibition 
this was not significant even at the highest concentrations of either LY294002 or 
wortmannin.
The observation that LY294002 and wortmannin significantly inhibit basal migration 
in PHA and SEB but not CD3/CD28 T cell population, is the first observation within 
this work that functionality may be altered depending on the T cell activator. 
Furthermore, although 2 out of 3 models show basal migration to be dependent on 
PI3K, it may be more accurate to conclude that in vivo activated T cells do not 
significantly depend on PI3K for basal migration, derived from the observation that 
CD3/CD28 T cells provide a more accurate reflection of the physiological situation.
For these in vitro models, it may be suggested that PHA and SEB activation 
generates cellular populations where PI3K contributes to the migratory response of 
the cell but not to the directionality. In contrast the regulation and the directionality 
of migration in T cells stimulated by CD3/CD28 may be independent of PI3K.
4.19 PI3K independent migration
Several studies have investigated the phenomena of PI3K dependent and 
independent chemotaxis leading to conflicting results. Described below is a 
selection of studies which have provided further evidence for PI3K independent 
migration.
In the p110y knockout models the failure of PIP3 to be generated and thus the 
failure to recruit signalling molecules to the cell membrane indicates the pivotal role 
that p110y plays within the signalling and chemotaxis of these cells, however a 
small but significant level of residual neutrophil chemotaxis was still present. 
Further investigations utilising a kinase dead knock-in model of p1105 and in 
addition the use of either LY294002 or wortmannin ruled out a role for p1105 or the
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other class I isoforms within this system (Thomas et al., 2005). Therefore, although 
these data suggest that p110y is the major isoform through which neutrophils 
chemotax, there is evidence that both supports and opposes the role for class IA 
within the chemotactic response, suggesting the resisdual response may be 
provided through anther signalling pathway.
This study has also highlighted the complexity surrounding the signalling and 
functionality involved within T cell migration. Discussed below are the possible 
mechanisms which may play a role within the switch between PI3K dependent and 
independent responses.
4.19.1 CXCR4 vs. CXCR7: the chemokine receptor switch
It has been recently determined that CXCL12 mediates chemotaxis of freshly 
isolated T cells not only through the receptor CXCR4 but also through the newly 
termed receptor CXCR7 (RDC-1)(Burns et al., 2006; Balabanian et al., 2005). This 
observation has far reaching implications, as it was thought that the 
CXCL12/CXCR4 axis was quite unique, in that one receptor (CXCR4) bound only 
one ligand (CXCL12) and vice versa. From this stand point, it provided a relatively 
simplified view of signalling and functionality in a chemokine system which is 
renowned for its promiscuity (Ward and Westwick, 1998).
This development within the chemokine field may provide a possible explanation as 
to how the naive T cell can chemotax in a PI3K dependent manner and activated T 
cells chemotax independently of class I PI3K. Through these investigations and 
others, it has been shown that CXCL12 induces chemotaxis and phosphorylation of 
PKB in freshly isolated T cells in a PI3K dependent manner. These cells have been 
shown to express both CXCR4 and CXCR7, with blockade of either or both of these 
receptors resulting in the decrease in chemotaxis (Balabanian et al., 2005).
Within activated cells, the situation is less clear, we have observed CXCL12 
induces chemotaxis in a PI3K independent manner while phosphorylation of PKB is 
maintained as a PI3K dependent mechanism. It is possible that this switch in 
dependence for PI3K may in fact be due to a switch in the use of these receptors 
following activation of the cell. For example, CXCR4 could be utilized by naive cells
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in a PI3K dependent manner, while following activation the primary receptor used in 
the chemotactic response could be CXCR7. This switch may also explain the ability 
of CXCR7 to bind inflammatory chemokines, as it has already been documented 
that although CXCR4 can only bind CXCL12, CXCR7 has the capacity to bind 
CXCL12 and the inflammatory chemokine CXCL11, suggesting a role for this 
receptor within an activated T cell (inflammatory) setting (Burns et al., 2006).
The situation may not be that clear, as other studies have suggested that the 
CXCR7 receptor is in fact an atypical receptor that does not induce calcium 
mobilization, chemotaxis or any signalling function. Instead it is suggested that this 
receptor acts to sequester available CXCL12. In the zebra fish lateral line, cells 
have been shown to restrict CXCR4 and CXCR7 to the leading and rear edge 
respectively, generating an intrinsic compass. Therefore, CXCR4 within the leading 
edge responds chemotactically to the bound CXCL12 and as the cell passes over 
the chemokine, the rear of the cell which contains a higher concentration of CXCR7 
receptors (and demonstrates higher affinity for CXCL12), binds CXCL12 
sequestering it, thus maintaining the polarised shape and molecular distribution 
(Dambly-Chaudiere et al., 2007).
4.19.2 Chemokine receptors -  the molecular switch
It is also possible that the same receptor or receptors are used, yet following 
activation T cells undergo a molecular switch, in that the chemotactic signal which is 
generated now depends on an alternate pathway to induce directed cell migration. 
Disscussed below are possible mechanisms (also see figure 4.1).
Dock2 -  One molecule which has gained interest over the last few years as a 
possible player in PI3K-independent migration is DOCK-2. This Rac-specific 
guanine nucleotide exchange factor has been identified as a candidate, as mice 
lacking this gene display a significant decrease in CXCL12 (as well as CXCL13, 
CCL19 and CCL21) induced chemotaxis (Nombela-Arrieta et al., 2004). 
Interestingly, in cells such as Neutrophils, in which PI3K has been characterised to 
play a role in the mediation of chemotaxis (Chung et al., 2001a; Devreotes and 
Janetopoulos, 2003; Ridley et al., 2003), DOCK-2 is not present (Nishihara et al., 
1999). Therefore, in T cells which are shown to contain both PI3K and DOCK-2, it
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may be the case that these cells chose to preferentially migrate with a DOCK-2 
dependent, PI3K independent manner. Although DOCK-2 was the overwhelming 
driving force behind the chemotaxis of murine T cells, it was also observed that 
PI3Ky played a small but significant role within CCL21 mediated chemotaxis, 
highlight a context dependent role for PI3K.
PLC(3 -  A recent publication highlights a role for PLCp within the chemotactic 
responses of T cells. Interestingly, they observed similar PI3K independent 
chemotactic responses (as were seen in this study) and investigated the possibility 
of PLC isoforms within this response. Utilizing murine models they highlighted a 
role for the PLC(3 isoform as an alternative mechanism that underlies the 
chemotactic response in T cells (Bach et al., 2007). Other studies have also 
highlighted a possible role for PLC in the chemotaxis of Th2 cells, however, in 
contrast Bach et al demonstrates a dependence on the production of IP3, while 
others suggests calcium independent mechanisms (Cronshaw et al., 2006). This 
data provides an exciting opportunity to address the requirement of human T cells 
both in the activated and freshly isolated T cell model and compare and contrast 
these observations. This data suggests that PLCp maybe a strong candidate for 
the underlying mechanism of PI3K independent chemotaxis.
Collectively these observations suggest that activated human T cells do not depend 
on PI3K for CXCL9, CXCL10, CXCL11, and CXCL12-mediated chemotaxis. 
However, care must always be taken when drawing conclusions from in vitro data 
and making assumptions for the physiological settings.
4.20 The role of in vitro culture on T cell responses
The observation that freshly isolated T cells are dependent on PI3K for their 
chemotactic responses and in vitro activated T cells migrated in a PI3K independent 
manner, posed an interesting question, how and when did this switch occur? In 
order to address this question, freshly isolated T cells were cultured in vitro without 
activation; furthermore, as IL-2 has been described as playing a role in the 
inflammatory process and in the upregulation of chemokine receptors, these 
investigations were carried out in the presence and absence of IL-2. Intriguingly,
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following 24 hours of in vitro culture, human T cells modulate their responses in 
such a way that they lose the dependence on PI3K for their migratory responses, 
while maintaining the dependence on PI3K for chemokinesis.
In this system it is observed that the dependence on PI3K is altered during culture. 
As discussed within the activated T cell model, it may be that a switch in 
dependence is due to a switch in the use of chemokine receptors, either CXCR4 or 
CXCR7. This may be initiaited via IL-2 instead of activation of the cell being 
responsible for this switch. This is supported by the observation that IL-2 can 
upregulate CC and CXCR4 on the surface of the cell. However, these 
investigations showed the functional response was altered after 4 days of IL-2 
incubation, and we observed a significant alteration in this dependence with 24 
hours. Furthermore, we tested the role of IL-2 within this system and found that 
even in the absence of this cytokine, cells chemotaxed towards CXCL12 in an 
independent manner following 24 hours ex vivo maintainence. Therefore these 
results would favour the opinion that neither IL-2 or activation plays a role in this 
altered PI3K dependence but if this is the case then what could this switch be 
dependent on?
4.20.1 Culture Shock
Following isolation cells are routinely transferred into medium for in vitro culture. 
This culture is performed in an artificial environment, in which cells are maintained 
in media that is further supplemented depending on the cell under investigation. 
This culture is routinely performed within a humidified environment with 5 % C02.
Due to this artificial system it is therefore possible the components of the media 
may themselves initiate altered responses within the cell (Berthois et al., 1986). 
Furthermore, it has been noted that within physiological settings, the amount of 
reactive oxygen species (ROS) is kept in check by the limited oxygen available, yet 
within an in vitro system, which has higher levels of oxygen, this leads to higher 
levels of ROS or ‘culture shock’ which results in a stress on the cells. This stress 
can possibly lead to alterations in the properties of the cell (Halliwell, 2003; 
Halliwell, 1997).
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Immune cells maybe particularly susceptible to this process. The Redox system 
has been identified to play a role in the T lymphocyte cell cycle, inducing the 
apoptosis of cells following resolution of inflammation. Activation of T cells is 
coupled to an increase in ROS production, although macrophages play a role in 
countering this response increasing or diminishing T cells anti-oxidant effects 
(Buttke and Sandstrom, 1995). Conversely, it has been suggested that cell culture 
media may contain anti-oxidant properties, with the ions and amino acids necessary 
for this process being found supplemented in media or added as a part of foetal 
calf-serum (Faure et al., 2004). The overall net effect of these pro- and anti­
oxidants has yet to be fully elucidated, however, it is clear the conditions of in vitro 
culture have important implications.
Taken together, this data provides evidence for reliance on PI3K in a context 
dependent setting for both chemotaxis and chemokinesis, generating intriguing 
possibilities for further in vitro study. To what extent ‘culture shock’ or the 
components of the media themselves have within this system is unclear, however, it 
posses an interesting question as to how we interpret data and the extent to which 
the functions and signalling we observe are in fact in vitro artefacts.
198
Chapter 4 - Discussion
c x c l i 2 c x c l i 2
G -P y D O C K 2
P LC pP I3 K y
DAGIP3
T e c 'G T P a s e s ' G T P a s e s
C alcium
M ig ra tio n M igration
Freshly isolated T cells Ex vivo maintained T cells
Figure 4.1 Model of PI3K dependent and independent biochemical signals 
utilised during CXCL12-mediated T cell migration migration. It has been shown 
that freshly isolated T cell migrate in a PI3K dependent manner, primarily through PI3K y. 
However, following ex vivo maintainance T cell chemotax through a PI3K independent 
process. Recent publications have suggested the involvement of PLCp or DOCK 2 as 
alternative migratory pathways.
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4.21 CXCL12 Signalling in cultured and activated T cells is sensitive to broad 
spectrum inhibitors
Interestingly, we observed that although CXCL12-mediated migration was 
independent of PI3K, CXCL12 signalling was biochemically coupled to PI3K (by the 
measurement of PKB phosphorylation). It has been published that freshly isolated 
T cells are dependent on PI3K for CXCL12-mediated migration, therefore it is an 
interesting observation that through culture and/or activation T cells lose there 
dependence on PI3K, while maintaining their reliance on PI3K for signalling 
(Butcher et al., 1999; Balabanian et al., 2005).
Activation of class I P!3Ks, in particular class I y following chemokine stimulation 
has been suggested to be a requirement for promoting the survival of developing 
thymocytes and memory T cells. Within the activated T cell model CXCL12 
mediated migration is independent of PI3K and yet we still observe a biochemical 
coupling. This response may be observed due to the activation and promotion of 
cellular survival and development pathways initiated through ligation of the 
chemokine receptor (Barber et al., 2006; Okkenhaug et al., 2006)).
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4.22 An alternative functional readout
An emerging body of work has highlighted a role for PI3K isoforms within the 
regulation of cytokine production (Okkenhaug et al., 2006; Okkenhaug et al., 2007). 
As an alternative functional readout to migratory responses we assessed the role of 
PI3K isoforms within Th1/Th2 cytokine production by utilizing PI3K targeting siRNA.
4.22.1 A role for class I 5 in cytokine production?
It is clear from the literature that the delicate balance between the Th1 vs. Th2 
subsets are essential for the ongoing health of an organism, the regulation of this 
system is therefore of utmost importance. With the myriad of diseases that are 
encountered from dysregulation of this system a thorough understanding of the 
mechanisms behind this process is essential if therapeutic strategies are to be 
developed. An interesting development in the regulation of cytokine production is 
the dependence on PI3K particularly class 15, for the generation of Th1/Th2 
cytokines (see figure 4.2) (Okkenhaug et al., 2006). Work presented within this 
thesis used nucleofection as a tool to deliver PI3K isoform specific siRNAs into 
freshly isolated cells and measured the Th1/Th2 cytokine expression levels. An 
ELISA based assay was utilized to determine if the release of Th1/Th2 cytokines of 
T cells that had been Nucleofected with PI3K isoform specific siRNAs. In order to 
generate measurable readings cells were stimulated with CD3/CD28 for 24 hours 
prior to analysis.
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Figure 4.2 A role for class 15 in Th1 cytokine production of in human T cells?
Metabolism of Ptdlns(4,5)P2 by PLCy and PI3K. PLCy hydrolyses Ptdlns(4,5)P2 to yield 
lns(1,4,5)P3 and DAG, both of which function as signalling molecules. lns(1,4,5)P3 
stimulates the release of Ca2+ from the ER into the cytosol, which triggers the nuclear 
translocation of NFAT. DAG binds to and activates Ras-GRP, which stimulates Ras and the 
Erk pathway, leading to AP-1-dependent transcription. Ras also binds to p110 and 
contributes to optimal PI3K activation. DAG binds to and activates PKC. By contrast, PI3K 
phosphorylates Ptdlns(4,5)P2 at position 3 to produce the membrane phosphoinositol lipid 
Ptdlns(3,4,5)P3. Ptdlns(3,4,5)P3 functions as an anchor and cofactor for proteins with 
Ptdlns(3,4,5)P3-binding PH domains such as Akt, Tec family kinases, and various GEFs and 
GAPs. Pdk1 is required to co-activate Akt. Akt phosphorylates and inactivates Foxo and 
GSK3. GSK3 can phosphorylate and inactivate NFAT. Akt stimulates mTOR through Tsc1 
and Tsc2. Tec kinases can phosphorylate PLCy and contribute to its optimal activity. PI3K 
signalling is antagonised by the Pten phosphoinositide phosphatase, which removes the 3- 
phosphate, and the SHIP phosphatase, which removes the 5-phosphate. The role of 
PI(3,4)P2-binding proteins is still unknown. Although PLCy and PI3K generate mutually 
exclusive second messenger signalling molecules, several of the pathways activated by 
these second messengers interact, and the signals are further integrated by the cell to 
promote gene transcription, cell growth and differentiation. p1105 seems to be the principal 
PI3K isoform in the context of antigen receptor signaling; however, p110a and p110(3 are 
also expressed in lymphocytes but their roles in antigen receptor signalling are unknown. 
(Taken from (Okkenhaug et al., 2007)).
Recent publications have highlight a role for the PI3K family within this regulation, in 
particular that of class 15, with evidence suggesting that murine models of inactive 
class 16, produce T cells that are deficient in the production of Th1/Th2 cytokine 
expression profiles (figure 4.2 (Okkenhaug et al., 2006; Okkenhaug et al., 2007)). A 
role for class 15 has also been highlighted in the secretion of TNF and IL-6 in mast 
cells (Ali et al., 2004). Within this study we observed that the process of 
Nucleofection had a detrimental effect on cytokine production, therefore it would be
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difficult to ascertain what responses have a true functional effect and what are 
attributed to artifacts of Nucleofection. Drawing any observations from most of the 
cytokines tested is difficult due to the low levels of expression prior to or following 
nucleofection. Although at this point within our study we can draw no absolute 
conclusions, it is interesting to note that following Nucleofection with class 16 
isoform siRNA, we observe a decrease in the expression levels of IFN-y and TNF- 
a, where other class IA isoforms fail to induce further effect. This would be in 
support of class I 6 playing a role in the Th1/Th2 balance. Although no role for 
class II p in cytokine production has been reported, within this study we also 
observe a decrease in TNF-a and INF-y and although not as pronounced as class 
16, this would be interesting to address.
Even though these investigations are in their infancy, it is intriguing that our initial 
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Summary & Future Work 
5.1 Summary
The observations made within this study suggest that freshly isolated T cells 
migrate towards CXCL12 in a PI3K dependent manner, and this signal is due 
predominantly to the class I y isoform. Interestingly, it was also observed that the 
role of PI3K within migration is context-dependent, varying according to ex vivo 
maintence and activation state. Preliminary studies may also support a role for 
class I 6 within cytokine production, however, these studies are in their infancy and 
no conclusions can be drawn upon at this time.
5.2 Future work
5.2.1 Elucidating the molecular mechanisms behind PI3K independent 
chemotaxis
This work has raised some intriguing observations. One of the main unresolved 
issues arising from these studies is mechanism behind the apparent switch from 
PI3K dependent to independent chemotaxis. The data generated suggests this 
may be observed due to culture conditions rather than triggered through activation, 
yet it is unclear as to the underlying mechanistic action. The observation that 
activated cells may chemotax in a PI3K independent manner has been observed in 
other studies, and recent publication has highlighted a possible role for the PLC(3 
isoform within the migratory response. It would be interesting to further this 
research by utilizing PLC isoform specific inhibitors to address this issue not only 
within the activated T cell model but also following ex vivo culture. Equally it would 
be interesting to look at other signalling molecules that are possible T cell 
chemotaxis modulators, such as DOCK2.
5.2.2 Investigating the role of PI3K isoforms in cytokine production
An interesting observation from the cytokine studies suggested PI3K class 15 plays 
a role in the cytokine production following CD3/CD28 stimulation. This may be 
addressed via an alternate method for siRNA delivery which displays a less
204
C h a p t e r  5  -  S u m m a r y  &  f u t u r e  'W o r k
detrimental effect on functionality. Furthermore, through the development of 
isoform selective inhibitors it would be interesting to determine what affect these 
compounds would have on cytokine production.
5.2.3 Clarifying the functions of the CXCR4 vs. CXCR7 receptors
Given the emerging complexity of the CXCL12/CXCR4 and CXCL12/CXCR7 axis it 
would be essential to characterise the roles that these 2 receptors play within this 
system. Initial observations would suggest a role for CXCR7 in chemotactic 
responses of T cells, thus by utilizing blocking antibodies it would be possible to 
further elucidate and characterise these receptors. Determining the contribution to 
migratory and signalling events with this system would provide an invaluable insight 
into this system. Given the complexity that has been shown to arise from 
dimerisation of chemokine receptors, it will be important to determine whether these 
2 receptors; heterodimerise to alter T cell function, homodimerise to modulate 
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Appendix
6.1 Buffers and Solutions
6.1.1 Solutions and buffers for SDS-PAGE and western blotting
Lysis Buffer 4 X Resolving gel Buffer
1 %  (v/v) Nonidet P-40 1.5 M Trizm a base
150 nM NaCI pH 8.8
50 mM Tris pH 7.5 0.4 %  (w/v) SDS
5 mM EDTA MilliQ water
10 mM sodium fluoride*
1 mM phenylmethylsulfonyl fluoride*
10 pg ml-1 leupeptin* 4 x Stacking gel buffer
10 pg ml-1 aprotinin*
1 pg ml-1 soybean trypsin inhibitor* 
1 pg ml-1 pepstatin A*
1 mM sodium orthovanadate*
0.5 M Trizm a base 
pH 6.8




NB * denotes added on the day of use
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SDS-PAGE running buffer 5 x SDS-sample buffer
25 mM Trizma base 
192 mM glycine 
0.1 %  (w/v) SD S  
MilliQ water
5 %  SDS
50 %  glycerol
200 mM Tris-HCI pH 6.8
MilliQ
Bromopnenoi biue 
5 %  2-mercaptoethanol
Semi-dry transfer buffer Tris-buffered saline (TBS)
39 mM glycine 
48 mM Trizm a base 
0.0375 % SD S  
20 % (v/v) methanol 
MilliQ water
20 mM Tris-HCI 
pH 7.5
150 mM NaCI 
MilliQ
Tris-buffered saline-Tween (TBST) Stripping buffer
TBS + 0.1 %  (v/v) Tween -20 62.5 mM Tris-HCL  
pH 6.8
2 %  (w/v) SDS
100 mM 2-mercaptoethanol
MilliQ
6.1.2 Recipes for SDS-PAG E gels
Resolving Gels Stacking Gel
7 . 5 % 1 0 % 1 2 % 4 X
4 X Resolving or 
Stacking buffer (ml)
5 5 5 3
MilliQ (ml) 9.84 8.17 6.84 6.85
Acrylamide 5.0 6.67 8.0 2.0
APS (10%) (pi) 150 150 150 150
TEMED (pi) 15 15 15 15
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Akt1 Goat 60 5 % 1:1000 1:10000
S6 Rabbit 32 5 % 1:1000 1:10000
phosphoSer235/236-
S6
Rabbit 32 5% 1:1000 1:10000
phosphoSer473-Akt Rabbit 60 1% 1:700 1:7000
PI3K class lip Mouse 165 5% 1:700 1:10000
1 Expressed as percentage (w/v) non-fat milk diluted w/v in TBST
2 Diluted v:v in 0.01% (w/v) sodium azide TBST
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